Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,35728,94,2.09 [0.67-6.59],0.2060641360091599
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,34731,91,0.80 [0.55-1.18],0.2678933047644121
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,40829,105,1.42 [1.06-1.91],0.0198876853321183
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,34552,89,1.65 [1.04-2.62],0.032072609031865
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,40589,107,0.94 [0.70-1.27],0.7092759933791895
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,40829,105,1.17 [0.91-1.49],0.2169084572707104
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,35699,94,0.91 [0.80-1.05],0.1853153601149919
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,34552,89,0.88 [0.64-1.21],0.4325515659703819
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",40092,103,1.03 [0.84-1.28],0.7646113051629988
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",35020,92,0.58 [0.38-0.89],0.013258685819802
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",35673,92,1.00 [0.80-1.24],0.9652568648363652
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,40623,107,2.46 [1.34-4.53],0.0036138670097021
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,35699,94,1.27 [0.61-2.66],0.5188981032254649
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,40295,104,1.12 [0.80-1.55],0.5114059415458139
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,34910,89,1.46 [0.83-2.55],0.1879405755232779
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,35522,93,0.99 [0.83-1.18],0.9003627452676803
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,41024,108,1.01 [0.72-1.42],0.9651307021093932
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,34646,90,0.77 [0.48-1.24],0.2830958549981727
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,41208,107,1.79 [1.15-2.79],0.0096421244998204
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,41334,106,1.63 [1.20-2.21],0.0016927504223102
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,35512,93,0.64 [0.37-1.12],0.1161708505170014
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,34646,90,0.59 [0.43-0.82],0.0015723026384954
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,34552,89,0.73 [0.38-1.39],0.3324992659975234
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",40295,104,1.79 [1.38-2.31],8.172607426490712e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,34552,89,1.12 [0.81-1.55],0.4990549414538001
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,40286,102,1.57 [1.07-2.29],0.0201855844497993
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,40656,107,3.17 [1.76-5.72],0.0001198624593422
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,41024,108,1.02 [0.77-1.35],0.8748590349191853
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,34552,89,1.33 [0.95-1.85],0.0984097678547715
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,34778,88,0.90 [0.66-1.23],0.5036621823230173
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,41489,105,1.63 [1.07-2.47],0.0233810110189525
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,40784,106,2.53 [1.80-3.55],8.755476624696249e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,34646,90,1.66 [1.17-2.36],0.0042212272676373
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40295,104,2.42 [1.40-4.20],0.0016663268377804
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40725,107,1.87 [1.16-3.00],0.0098977444230194
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,41489,105,2.23 [1.29-3.83],0.0039184964130203
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,41317,108,2.03 [1.16-3.57],0.0138015486753664
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,35522,93,3.93 [2.58-5.97],1.5777068080270219e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,34646,90,1.04 [0.55-1.96],0.9054593941369218
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,41523,108,0.46 [0.23-0.91],0.0249893323745196
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40829,105,2.27 [1.51-3.43],8.97226859768177e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40295,104,1.32 [0.88-1.97],0.180164813632742
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,34646,90,1.50 [0.91-2.48],0.1143741495446985
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,41133,105,1.01 [0.69-1.48],0.9390136314106764
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,35680,94,1.45 [0.82-2.56],0.2056066196294234
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,34731,91,1.63 [0.72-3.71],0.2424988778099278
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,35673,92,0.67 [0.41-1.10],0.1143049048808752
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,40092,103,1.24 [0.87-1.75],0.2296365014459207
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,34910,89,0.84 [0.63-1.12],0.2301681252615087
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,40656,107,1.61 [0.98-2.66],0.062619414759539
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,34910,89,1.70 [1.05-2.75],0.0295883867202204
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,35522,93,1.88 [1.37-2.58],0.0001020073720387
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,41183,104,3.38 [1.97-5.83],1.0994404480440173e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,41326,108,2.67 [1.78-4.00],1.841783819616194e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,35673,92,1.52 [0.75-3.04],0.2425419224857196
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,40829,105,1.41 [1.16-1.71],0.0005626042135534
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,41024,108,1.24 [0.66-2.32],0.4989355833689868
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,34580,87,0.89 [0.64-1.22],0.463787823995812
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,34910,89,1.10 [0.84-1.43],0.4921901867531763
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40295,104,1.02 [0.83-1.25],0.8644083876443158
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,35728,94,1.05 [0.79-1.40],0.7410098114187622
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,41396,106,5.58 [2.99-10.40],6.660828852663193e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,34552,89,1.14 [0.89-1.46],0.2817647668608295
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,34910,89,1.01 [0.80-1.29],0.904455822927644
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AFM,Afamin,35728,94,0.86 [0.31-2.37],0.7728218730216145
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,40596,107,1.00 [0.78-1.29],0.9726052528816628
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,34580,87,0.96 [0.77-1.19],0.6906654302554388
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,40911,104,1.18 [0.78-1.79],0.4268479769698478
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,39742,107,1.04 [0.87-1.23],0.6804369841133641
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,40026,103,0.94 [0.69-1.27],0.6783709930837593
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,41183,104,3.22 [2.21-4.70],1.1476823963317851e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,41489,105,1.35 [0.97-1.88],0.0775223596742675
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,35699,94,1.31 [0.58-2.95],0.5210867864614475
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,41024,108,0.97 [0.78-1.22],0.8143334616412969
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,41024,108,1.07 [0.83-1.37],0.6138895962338491
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,34731,91,1.96 [1.18-3.24],0.0091677268856614
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,34731,91,2.13 [1.28-3.55],0.0036603384305515
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,35512,93,1.00 [0.74-1.34],0.9830701992883278
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,35699,94,2.26 [1.15-4.43],0.0182389491295062
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,40957,106,0.98 [0.80-1.19],0.822810911761454
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",34721,91,1.26 [1.05-1.50],0.012284505194741
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,40092,103,1.02 [0.73-1.42],0.9250322877652292
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,34731,91,0.90 [0.61-1.32],0.5761868285659724
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40761,105,1.04 [0.89-1.23],0.6059738646678361
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AK1,Adenylate kinase isoenzyme 1,41024,108,0.96 [0.74-1.26],0.7781853498866915
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",35607,94,1.01 [0.84-1.22],0.8996747069172462
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,34910,89,1.72 [0.82-3.62],0.1496083474649927
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,40092,103,1.02 [0.81-1.29],0.8543328244496058
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,34721,91,0.76 [0.53-1.10],0.148872203885484
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,40295,104,0.93 [0.65-1.31],0.6647732203363164
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,34646,90,1.12 [0.85-1.48],0.4049984066092703
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,40070,107,0.94 [0.73-1.22],0.6555988869572512
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,35622,93,0.89 [0.76-1.04],0.142210753532151
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,39898,103,0.67 [0.49-0.92],0.0130518869391099
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,41523,108,4.28 [1.91-9.58],0.0004123159752879
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,41030,106,1.26 [0.94-1.70],0.1278119411619615
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",35512,93,1.05 [0.72-1.52],0.7927049371698788
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40912,105,0.97 [0.75-1.26],0.8353754798744164
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",35622,93,1.09 [0.73-1.65],0.666912865790996
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,35020,92,0.76 [0.45-1.26],0.2867972992432259
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,34646,90,1.07 [0.91-1.26],0.407428509072947
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",40829,105,1.19 [1.03-1.38],0.015933363269873
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,40286,102,1.77 [1.32-2.37],0.0001507280268088
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,41336,105,3.19 [1.41-7.20],0.0052080744466206
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,35680,94,1.29 [0.59-2.78],0.5238541133557106
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,40070,107,1.08 [0.84-1.39],0.5536728998102207
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,34721,91,1.00 [0.67-1.50],0.9874896442827936
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,40829,105,1.25 [0.59-2.63],0.5619628325199497
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,40286,102,1.07 [0.74-1.55],0.7013955952148543
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,34910,89,0.67 [0.40-1.15],0.1456126659290454
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,35388,93,1.22 [0.85-1.75],0.2719360562317078
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,35607,94,1.38 [1.06-1.80],0.0171829489390375
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,33412,89,0.94 [0.62-1.42],0.7735475877723702
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMY2A,Pancreatic alpha-amylase,39457,105,0.99 [0.68-1.42],0.9358304142359952
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMY2B,Alpha-amylase 2B,38245,99,0.97 [0.67-1.40],0.8593736033355841
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,40915,106,2.03 [1.31-3.14],0.0014263759196778
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,40865,104,0.81 [0.66-0.98],0.0339561208728003
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,41396,106,2.01 [1.37-2.97],0.0004013482497381
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,40440,106,1.92 [1.08-3.41],0.0264701721671673
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,41048,104,2.21 [1.46-3.35],0.0001877499927186
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,41042,106,2.33 [1.44-3.75],0.0005202370446175
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,41123,104,1.91 [1.32-2.77],0.0006385412688694
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,41396,106,1.33 [0.84-2.11],0.2183284514453016
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,34552,89,0.99 [0.74-1.32],0.9283322066652698
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,34646,90,0.74 [0.57-0.96],0.0232437601243625
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,34425,87,0.99 [0.68-1.44],0.9658347559763862
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,40092,103,1.11 [0.84-1.47],0.4746497859882722
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,34731,91,0.89 [0.52-1.54],0.684753478630955
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,41107,106,1.14 [0.62-2.08],0.6819043942419467
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,34705,88,1.04 [0.67-1.62],0.862836305546854
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,40070,107,1.05 [0.85-1.28],0.6548343298564979
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,40909,105,0.88 [0.68-1.12],0.29333094926032
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,34216,90,1.33 [1.05-1.69],0.017122969654768
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,41317,108,0.77 [0.60-0.98],0.0326653246915752
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,40828,107,0.83 [0.65-1.05],0.1217384603072141
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,39947,107,1.18 [0.68-2.06],0.5575219780869964
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],40286,102,1.02 [0.75-1.38],0.9040056521716956
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,41173,106,1.78 [1.02-3.11],0.0425545684354419
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,35512,93,0.91 [0.71-1.17],0.4562829231953578
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,34721,91,0.95 [0.62-1.44],0.8002472345269316
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,35522,93,0.98 [0.76-1.27],0.8699934589358829
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,35607,94,0.83 [0.54-1.28],0.3979502382550757
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40829,105,1.40 [1.03-1.90],0.0326067752675676
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,35403,94,1.62 [0.91-2.88],0.0988716989876491
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,41272,106,0.94 [0.70-1.26],0.6710232216974015
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,41024,108,1.14 [0.83-1.59],0.4186295608064225
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,35728,94,0.73 [0.34-1.59],0.4269400933132935
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,35699,94,1.45 [0.98-2.15],0.0658304201485929
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,35728,94,1.37 [0.86-2.20],0.1869013302443064
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,35699,94,1.76 [0.74-4.22],0.2025751623119748
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,34731,91,1.07 [0.66-1.74],0.770956025578146
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,35659,94,0.79 [0.46-1.35],0.3875461764590813
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,34106,91,0.81 [0.47-1.40],0.4469046696036507
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,35728,94,1.15 [0.93-1.43],0.1964391629129668
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,35699,94,1.15 [0.55-2.44],0.7067959361201285
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,41030,106,1.39 [0.89-2.16],0.1503310520482804
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,35699,94,1.19 [0.89-1.59],0.2507595383722355
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,41114,106,0.72 [0.39-1.31],0.2842204757830374
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,40972,106,0.87 [0.67-1.13],0.297413406953829
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,34910,89,0.90 [0.75-1.07],0.2417173632276226
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,40664,106,1.17 [0.81-1.68],0.40861561176364
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,35020,92,1.10 [0.83-1.45],0.5190498122989042
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,40829,105,1.22 [0.85-1.75],0.289424806019125
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,35522,93,0.98 [0.81-1.18],0.8182489255814249
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,35622,93,0.93 [0.70-1.25],0.6354931207812677
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,40823,103,1.21 [0.87-1.68],0.2558748348121137
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",35512,93,0.84 [0.51-1.40],0.5128018210892132
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,40092,103,0.99 [0.68-1.44],0.9565591511739718
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,40092,103,0.95 [0.71-1.28],0.7362535183837995
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,35020,92,1.24 [0.81-1.91],0.3186292688420926
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,34910,89,0.80 [0.62-1.04],0.0906129627375469
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,34425,87,1.15 [0.91-1.46],0.2398041490519947
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,35607,94,0.84 [0.68-1.05],0.1261284761057201
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,35622,93,1.01 [0.81-1.24],0.9534790350429022
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,40976,105,0.95 [0.80-1.12],0.5420671095473295
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,34580,87,1.09 [0.84-1.42],0.5074997779089575
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,34580,87,1.10 [0.66-1.81],0.7184141239742214
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,40070,107,0.93 [0.60-1.43],0.7290226543365924
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,34552,89,0.93 [0.69-1.26],0.6574542937113956
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,34552,89,0.56 [0.33-0.95],0.0329924364923565
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,34580,87,0.87 [0.60-1.27],0.4802073185696461
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,40286,102,1.20 [0.78-1.85],0.3998901430696879
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,34552,89,0.95 [0.63-1.43],0.7974861622227274
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,41030,106,0.99 [0.68-1.45],0.9702138194911512
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,40829,105,0.98 [0.72-1.34],0.9130663474962656
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,41173,106,2.00 [1.25-3.21],0.0038651662440918
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,34580,87,1.13 [0.85-1.49],0.3993095579279345
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,40286,102,1.21 [0.88-1.66],0.2376279864959205
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,35355,93,1.09 [0.72-1.65],0.6756969670751183
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,40725,107,0.87 [0.65-1.16],0.3432512963873206
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,40725,107,2.78 [1.77-4.37],8.714189638319274e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,35699,94,3.87 [2.09-7.18],1.775186295030756e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,35673,92,0.94 [0.45-1.95],0.8652574651497398
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,35622,93,0.80 [0.59-1.08],0.1440172321319335
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,34731,91,0.90 [0.74-1.10],0.3070765983438284
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,34552,89,0.87 [0.67-1.13],0.2854443020819929
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,40070,107,0.93 [0.70-1.23],0.6008907242697494
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,34425,87,1.05 [0.57-1.92],0.8713177536585177
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,35522,93,1.00 [0.80-1.27],0.9681595230542612
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,40092,103,1.08 [0.81-1.44],0.6065853077324297
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,41133,105,1.38 [1.08-1.77],0.0111128135982269
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,34552,89,1.28 [0.94-1.75],0.1163726376622003
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,34552,89,1.46 [0.83-2.57],0.1883043315426115
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,34552,89,0.83 [0.47-1.47],0.5219130839468535
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,34425,87,0.62 [0.35-1.09],0.0945117103297294
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,34552,89,1.17 [0.89-1.54],0.269426546184366
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",34552,89,1.03 [0.71-1.50],0.86932566584351
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",41183,104,0.89 [0.77-1.04],0.1539014401266147
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",40070,107,1.14 [0.79-1.65],0.4845044111068204
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,40092,103,1.17 [0.80-1.72],0.4180617127172512
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,40829,105,0.92 [0.46-1.82],0.8003539231480652
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,39994,107,1.14 [0.89-1.47],0.2882945608646418
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,34731,91,0.99 [0.75-1.31],0.9643706636050908
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,34552,89,1.02 [0.83-1.26],0.8518884562299636
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,35522,93,1.91 [1.46-2.50],2.0079871497720514e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",35728,94,2.53 [0.78-8.22],0.1223910566637576
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,40070,107,0.99 [0.78-1.26],0.9613447695692156
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,34580,87,0.76 [0.59-0.97],0.0304418983251083
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,35622,93,0.87 [0.56-1.36],0.5520040788397758
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,35607,94,1.04 [0.76-1.43],0.7871254479921521
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,40976,105,0.91 [0.76-1.09],0.3265172095285967
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,41173,106,4.71 [2.88-7.70],6.275041647157631e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,35622,93,0.89 [0.62-1.29],0.5386295889638064
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AZU1,Azurocidin,39766,105,0.99 [0.79-1.23],0.9077927647954392
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,35728,94,1.85 [1.51-2.27],3.7070468508006196e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,34552,89,1.90 [0.87-4.16],0.10947377769949
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",34731,91,2.28 [1.32-3.93],0.0030289418182397
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",41183,104,5.78 [3.51-9.54],6.029863299361805e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",41030,106,1.38 [0.69-2.75],0.3614673806856565
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,34646,90,0.77 [0.36-1.63],0.488981621313989
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,40976,105,0.91 [0.72-1.16],0.4598300919504249
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,40656,107,1.10 [0.71-1.70],0.6728130756892098
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,34646,90,0.99 [0.66-1.50],0.97185566213422
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,40295,104,1.38 [0.87-2.19],0.1752382623614921
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,40092,103,1.18 [0.90-1.54],0.228063562905304
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,40092,103,3.95 [2.82-5.52],1.0867737507818505e-15
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,40976,105,0.94 [0.80-1.10],0.4542847993923534
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,35607,94,1.17 [0.92-1.50],0.2064831868725407
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,34721,91,0.96 [0.75-1.24],0.7675613226324745
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,40010,107,1.01 [0.84-1.23],0.8964592458893382
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,41030,106,2.65 [1.43-4.90],0.0019019584862652
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,40725,107,0.76 [0.47-1.25],0.2782254944685537
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",35673,92,1.96 [1.23-3.13],0.0048918420141593
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",34580,87,0.92 [0.61-1.39],0.6977943770990886
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,35031,93,1.11 [0.55-2.27],0.7671460434177366
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,35522,93,1.87 [1.56-2.25],1.814367531540584e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,35607,94,0.92 [0.75-1.12],0.3817272656093231
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40976,105,1.31 [0.85-2.00],0.2185172821314465
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,34646,90,1.17 [0.86-1.58],0.3098695720128086
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,34425,87,0.94 [0.67-1.31],0.7084775970904352
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,35512,93,0.95 [0.61-1.49],0.8378853095034448
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,40976,105,0.98 [0.81-1.18],0.8070909833521182
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,35680,94,0.62 [0.50-0.76],6.795148446737735e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,34731,91,0.98 [0.70-1.37],0.8895205275254102
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,34425,87,0.80 [0.48-1.33],0.3859621029729744
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,35680,94,1.45 [1.16-1.82],0.0009386395958866
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,40026,102,1.33 [1.16-1.53],5.244201886258477e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,34580,87,0.71 [0.52-0.97],0.0339448455794623
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,34552,89,1.10 [0.50-2.44],0.8062207623601669
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,40976,105,0.95 [0.73-1.23],0.6788764161231982
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,41030,106,0.90 [0.75-1.09],0.301035475993972
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,40092,103,0.89 [0.67-1.18],0.4227435843884455
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,41523,108,1.28 [0.77-2.15],0.342153287411731
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,34646,90,1.59 [1.07-2.37],0.0218733121500535
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,34580,87,1.15 [0.90-1.46],0.2593340079191238
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,35607,94,0.68 [0.40-1.15],0.1460342763155352
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,41030,106,1.10 [0.86-1.42],0.4343198506465618
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,34910,89,0.97 [0.48-1.97],0.9292772329594954
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,40656,107,1.11 [0.78-1.59],0.5597817713936819
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,40229,104,0.85 [0.56-1.29],0.455945771829419
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,34910,89,3.04 [1.86-4.96],9.598764261038588e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,35673,92,1.60 [1.00-2.56],0.0514684784134933
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,34646,90,1.53 [1.03-2.26],0.0340846383378283
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,40295,104,1.49 [0.71-3.11],0.2897039639591658
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,34580,87,1.26 [0.91-1.74],0.1569626019838309
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,34731,91,0.92 [0.63-1.33],0.6491940949369333
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,33507,87,0.74 [0.61-0.91],0.0034155939001586
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,40938,107,1.22 [0.93-1.60],0.1426254292973177
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,35611,92,1.32 [0.99-1.74],0.0551725455344231
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,35190,93,0.89 [0.74-1.06],0.1943086421732577
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,35020,92,0.88 [0.45-1.75],0.7229666878068486
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,34580,87,1.67 [1.14-2.46],0.00855415464654
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,34552,89,1.00 [0.66-1.53],0.9927854908403771
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,34552,89,1.79 [1.11-2.88],0.0162455315936213
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,40070,107,1.22 [0.84-1.77],0.3056829929696564
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,34580,87,1.04 [0.64-1.70],0.86297723450121
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,35622,93,1.07 [0.65-1.78],0.788582020355895
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BSG,Basigin,41416,105,5.38 [2.56-11.33],9.06623696577814e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BSND,Barttin,34425,87,0.45 [0.22-0.96],0.0375283027069765
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,41387,108,0.78 [0.59-1.05],0.1006364851856817
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,41387,108,1.58 [1.24-2.01],0.0001947619906887
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,40092,103,0.87 [0.68-1.11],0.2656691950985294
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,35728,94,0.92 [0.36-2.35],0.8536826210012297
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,34425,87,1.18 [1.00-1.41],0.0516704803831878
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,35444,93,0.78 [0.44-1.39],0.4066982737877969
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,41183,104,4.59 [2.77-7.61],3.3319755594740103e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,40976,105,2.40 [1.76-3.27],3.3501844036390575e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,34425,87,0.91 [0.52-1.57],0.7250539627211683
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,40070,107,1.26 [1.01-1.56],0.0383354086050653
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,34552,89,1.18 [0.65-2.16],0.5833277640854598
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,41281,105,3.13 [1.58-6.19],0.0010439438261446
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",35622,93,1.11 [0.88-1.41],0.3746098546487332
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,34646,90,0.51 [0.31-0.85],0.0097010101521352
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,41173,106,1.44 [0.99-2.09],0.0593959736716583
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,34910,89,0.86 [0.51-1.47],0.5916518240965091
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,35622,93,1.45 [0.87-2.41],0.1556599575110165
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,34844,89,0.84 [0.57-1.25],0.393311279422355
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,35728,94,1.82 [0.88-3.76],0.1046697819289641
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,35661,94,4.01 [1.44-11.16],0.0077490474666427
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,35728,94,1.41 [0.57-3.51],0.4566810025300771
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C2,Complement C2,41114,106,1.61 [0.71-3.66],0.256494558491714
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,39994,107,0.91 [0.60-1.37],0.6356730905263446
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,34721,91,0.81 [0.54-1.22],0.3186141453990863
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C3,Complement C3,33910,88,1.16 [0.78-1.73],0.471802701681862
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,41133,105,1.52 [1.00-2.30],0.0476263201678253
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C5,Complement C5,35728,94,0.79 [0.21-2.93],0.7191153951695792
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,34873,93,2.32 [1.29-4.19],0.0051376073359055
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,35607,94,1.37 [0.71-2.62],0.3450647899653338
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,35728,94,1.41 [0.74-2.68],0.2984312630469529
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,35699,94,2.33 [1.59-3.43],1.6091616693297166e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,35522,93,1.20 [0.95-1.52],0.1186173568500736
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,40128,103,1.28 [0.96-1.70],0.0867826221003199
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,40092,103,1.17 [0.72-1.91],0.5209710846060215
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,40829,105,1.96 [1.26-3.04],0.0026944856830763
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,40562,106,0.90 [0.76-1.05],0.1854510411349003
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,41396,106,1.13 [0.70-1.83],0.6193847828382156
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,40895,105,1.22 [0.97-1.55],0.0955283152080093
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,41459,108,1.14 [0.87-1.49],0.3356458961268782
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,41523,108,1.53 [0.77-3.05],0.2274705629529182
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",40295,104,1.18 [0.99-1.41],0.0709225984634859
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,40899,105,0.80 [0.61-1.05],0.1044579409370525
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,35020,92,0.82 [0.44-1.54],0.5325149032207125
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,34646,90,1.62 [1.07-2.45],0.023033226190692
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,41396,106,0.94 [0.65-1.37],0.757351247946184
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,34721,91,0.92 [0.67-1.27],0.6188586919618216
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,34580,87,1.25 [0.71-2.20],0.4496041213754146
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,34552,89,0.93 [0.63-1.36],0.7045852554031302
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,34580,87,1.17 [0.85-1.60],0.341049776270019
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,35622,93,0.95 [0.75-1.20],0.6667263180044072
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,34840,89,0.86 [0.71-1.05],0.144903108867221
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,34721,91,0.99 [0.61-1.61],0.980251190142178
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,40829,105,1.84 [1.26-2.69],0.0016653988802073
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,40070,107,0.86 [0.47-1.58],0.6385649954293444
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,40649,107,1.37 [1.09-1.73],0.0076681010186407
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,35607,94,1.43 [0.98-2.10],0.0657276916010757
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,41269,106,0.97 [0.82-1.14],0.691898162597838
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,34731,91,0.97 [0.75-1.27],0.8464852568595523
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,34552,89,1.30 [0.86-1.97],0.2192728022420564
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,40092,103,1.37 [0.96-1.96],0.0860212632753006
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,34721,91,0.63 [0.40-0.98],0.0408397528198803
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,35622,93,1.03 [0.86-1.24],0.7192884233592174
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,40894,107,5.88 [2.61-13.20],1.8238083635100243e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,40755,104,1.48 [1.14-1.92],0.0035866357972175
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,35512,93,1.08 [0.66-1.78],0.7635826569641455
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,35607,94,0.98 [0.80-1.21],0.8644307240979109
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,40070,107,0.91 [0.65-1.27],0.5840075335744823
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,34721,91,0.97 [0.60-1.58],0.9179701156200956
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,40070,107,1.04 [0.82-1.33],0.7286383856519325
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,40070,107,1.03 [0.81-1.31],0.807176245045016
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,40976,105,0.77 [0.60-1.01],0.0578923057788475
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,41523,108,0.94 [0.77-1.14],0.5146241294543514
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,35020,92,0.85 [0.74-0.99],0.0321269629308302
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,35607,94,0.85 [0.67-1.07],0.1678218347140786
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,41274,105,1.05 [0.80-1.37],0.7250625846337478
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,34646,90,0.75 [0.53-1.06],0.1052075941660364
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,34552,89,0.91 [0.58-1.43],0.6891187563250574
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAT,Catalase,35164,93,1.20 [0.85-1.70],0.2974353356634091
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,40970,108,0.87 [0.70-1.08],0.2045921872165796
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,34580,87,0.77 [0.57-1.03],0.0820581603724758
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,41396,106,0.79 [0.46-1.35],0.3932070300501192
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,34731,91,1.25 [0.88-1.78],0.2119502323074947
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,34552,89,1.02 [0.62-1.68],0.9486496274766484
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40725,107,1.01 [0.80-1.27],0.9653859381293096
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,35607,94,0.71 [0.44-1.16],0.1696606542957931
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,35512,93,0.87 [0.57-1.32],0.4999404238908184
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,34721,91,0.90 [0.45-1.79],0.7588310460174142
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,35622,93,0.87 [0.65-1.16],0.3430269864835152
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,41024,108,2.23 [1.48-3.37],0.0001244015755432
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,34731,91,1.17 [0.85-1.59],0.3323663570346987
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,41489,105,1.20 [0.76-1.88],0.4323014735639392
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,41422,105,0.93 [0.72-1.19],0.5665807058610721
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,40915,106,1.90 [1.39-2.58],5.390943441234955e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,41523,108,2.10 [1.52-2.90],6.223216892174258e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,41523,108,1.61 [1.15-2.25],0.0056502838502074
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,40930,104,1.32 [1.10-1.59],0.0025870712944205
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,40451,105,1.42 [1.21-1.68],2.235037493483009e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,41387,108,1.02 [0.89-1.16],0.8100014176200251
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,40656,107,1.43 [1.05-1.94],0.0221659035935502
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,41489,105,1.25 [1.06-1.46],0.0060619805720148
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,41183,104,1.66 [1.25-2.21],0.0004868892678399
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,40579,103,1.75 [1.33-2.31],6.135947879230731e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,41183,104,2.09 [1.41-3.09],0.0002494659418892
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,41123,104,1.22 [0.99-1.50],0.0568660632258743
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,41489,105,1.45 [1.03-2.04],0.0333199407020452
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,40976,105,1.00 [0.83-1.21],0.9694248959462384
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,41024,108,1.18 [0.89-1.56],0.2419011859656449
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,40838,105,1.48 [1.15-1.91],0.0021263774954725
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,40976,105,1.52 [1.34-1.72],3.865527765980252e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,41057,104,1.41 [1.20-1.66],2.6901354036381312e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,41173,106,1.04 [0.88-1.23],0.6616268872283362
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,40976,105,1.31 [1.04-1.66],0.0244206882758256
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,41336,105,1.23 [0.93-1.64],0.1518172512037467
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,40762,104,1.04 [0.82-1.30],0.761984159113844
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,40996,103,0.74 [0.54-1.00],0.0518107862881329
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,41453,108,3.34 [2.34-4.78],3.854886204281831e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,41396,106,1.40 [0.94-2.08],0.0975865886898522
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,41030,106,0.97 [0.62-1.50],0.8760036746185623
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,35020,92,0.98 [0.57-1.68],0.949333193817424
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,34646,90,0.91 [0.70-1.18],0.4872713124357931
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,40725,107,0.83 [0.57-1.19],0.3100529721551335
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,40092,103,1.31 [0.93-1.83],0.1194757492013731
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,35522,93,0.80 [0.51-1.23],0.3077111720973402
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,41030,106,1.51 [0.90-2.54],0.1159609351503763
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,40186,105,3.17 [2.34-4.30],1.1953895037172473e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,41489,105,2.09 [1.52-2.87],5.918454432330763e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,41173,106,2.49 [1.77-3.50],1.5602184512124097e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,41030,106,1.19 [0.67-2.10],0.5464378827301981
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,34721,91,0.83 [0.47-1.48],0.5334659858463985
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,40969,106,0.92 [0.81-1.05],0.21101427365764
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,41133,105,1.17 [0.57-2.40],0.6613988260758057
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,34552,89,1.12 [0.69-1.80],0.6448887625731214
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,40976,105,3.89 [2.52-6.00],7.38930901189891e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,40842,105,1.56 [0.97-2.49],0.0640938777855422
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,40097,104,0.70 [0.45-1.09],0.1142717672164672
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,41119,108,0.76 [0.49-1.17],0.2146690105281755
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,41489,105,1.41 [0.94-2.11],0.099202879056895
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,34646,90,0.52 [0.32-0.86],0.0108022411309486
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,41489,105,1.67 [0.91-3.08],0.0973062272037616
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,35680,94,0.99 [0.61-1.61],0.9691518443316812
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,41133,105,1.99 [1.36-2.89],0.0003421196469416
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,40725,107,2.92 [2.14-3.98],1.5047347809029936e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,40984,104,2.89 [1.81-4.60],7.838837653412355e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,40092,103,2.35 [1.78-3.10],1.5195127068963484e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,41024,108,1.17 [0.90-1.51],0.2467876613467726
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,34910,89,3.73 [2.12-6.56],5.119950365866758e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,41387,108,2.86 [1.87-4.38],1.2602921797146382e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,41261,104,2.96 [2.12-4.13],1.8304294658630872e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,41396,106,1.85 [1.34-2.56],0.0001890572213709
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,41030,106,1.55 [0.99-2.42],0.0571600526390271
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,40829,105,3.09 [1.97-4.83],8.136769944435827e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,41133,105,1.28 [1.02-1.62],0.037113343256123
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,41244,107,1.53 [0.76-3.08],0.2320873285603503
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,34646,90,1.49 [0.98-2.25],0.0610649878138843
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40829,105,3.53 [2.21-5.65],1.3623291016147901e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,34580,87,0.76 [0.38-1.52],0.43932666268567
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,35020,92,0.52 [0.25-1.07],0.0756012027894642
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,34646,90,0.97 [0.77-1.23],0.8095769207077497
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,40902,105,1.94 [1.39-2.71],8.803693177702917e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,40997,104,1.19 [0.85-1.67],0.30874284554984
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,41489,105,0.95 [0.77-1.19],0.6735171106263028
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,40780,106,2.47 [1.59-3.83],6.210157132635154e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,41123,104,2.45 [1.41-4.26],0.0014571685201678
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,41336,105,2.07 [1.31-3.28],0.0018620167606625
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,39587,97,2.69 [1.84-3.94],3.622101360142201e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,40915,103,3.46 [1.30-9.23],0.0131370485661827
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,39547,103,3.97 [2.51-6.28],3.65042371362252e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,35542,93,0.59 [0.38-0.90],0.014318616915318
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,41416,105,0.97 [0.70-1.34],0.8463426094074818
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,40656,107,0.83 [0.60-1.15],0.2639129289168183
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD69,Early activation antigen CD69,40834,107,0.91 [0.75-1.10],0.3463149977833518
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,34580,90,1.47 [0.97-2.23],0.0679961652199455
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,40976,105,3.21 [2.31-4.46],4.383928484666541e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,34910,89,4.35 [3.10-6.09],1.4004341363552482e-17
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,41387,108,5.58 [3.92-7.95],1.8531072403053328e-21
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,41489,105,3.63 [2.82-4.66],6.258018716848255e-24
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,35673,92,6.52 [4.54-9.35],2.6333291587594037e-24
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,35020,92,0.60 [0.32-1.11],0.1063282304915608
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,40976,105,5.83 [3.97-8.56],2.210397236137812e-19
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,40976,105,0.29 [0.17-0.50],7.20351184712945e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,35522,93,2.19 [1.16-4.13],0.0159509555668996
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,41387,108,1.68 [1.24-2.29],0.000959409676603
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,39467,102,3.36 [2.12-5.31],2.250533322481478e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,41030,106,3.42 [1.52-7.66],0.0028405215406471
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,41030,106,3.31 [1.73-6.35],0.0003038111141895
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,35610,91,0.94 [0.61-1.43],0.7577072667518425
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,35607,94,1.39 [0.69-2.79],0.3572224358429289
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,34425,87,1.04 [0.76-1.41],0.8222421251538664
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,34425,87,0.93 [0.55-1.58],0.7836427684320457
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,35456,93,0.99 [0.75-1.32],0.9672483938148086
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,40092,103,1.10 [0.83-1.46],0.5114173246440996
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,41133,105,0.98 [0.80-1.21],0.8641114723437522
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,35522,93,0.98 [0.81-1.19],0.8186332273812346
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,40725,107,1.99 [1.53-2.60],2.962116013435708e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,39639,101,1.52 [1.08-2.13],0.0154490670527628
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,41311,108,0.98 [0.73-1.32],0.919488090984646
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,41024,108,1.05 [0.83-1.34],0.6810173163463888
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,41024,108,1.93 [1.22-3.04],0.0046006555271758
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,35020,92,1.48 [0.83-2.65],0.1878740230984891
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,35607,94,1.29 [0.63-2.61],0.4858583426271103
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,41387,108,2.66 [1.83-3.88],3.0226719353278706e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,34580,87,1.04 [0.67-1.59],0.8745358192968598
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,41523,108,2.26 [1.34-3.79],0.002054675181332
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,41024,108,1.09 [0.70-1.70],0.6962766395817626
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,40070,107,1.20 [0.84-1.73],0.3194273001731998
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,40829,105,1.30 [1.03-1.65],0.0296318678813221
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,41024,108,1.27 [0.81-1.99],0.2896364863464949
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,34425,87,1.56 [0.91-2.67],0.1092649513982136
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,35622,93,0.58 [0.38-0.86],0.007539162037232
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,34580,87,1.16 [0.82-1.63],0.4127395941340337
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,40829,105,1.05 [0.89-1.23],0.5903968432989868
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40829,105,0.87 [0.73-1.04],0.1210346464270363
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,40829,105,1.68 [1.11-2.53],0.0145843495241712
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,41056,104,0.84 [0.44-1.60],0.592327122771249
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,41357,104,1.92 [1.31-2.83],0.0009323356577416
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,41068,105,3.65 [1.73-7.68],0.0006687704138537
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,35522,93,0.92 [0.72-1.17],0.5038725170993017
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,35020,92,0.99 [0.74-1.33],0.9400873417989908
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,35522,93,1.47 [0.93-2.35],0.1017082853936865
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,35020,92,1.63 [1.21-2.20],0.0013483148075499
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40976,105,1.29 [1.07-1.55],0.0084768347712483
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,40092,103,1.11 [0.78-1.57],0.5522987916058962
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39554,102,1.34 [1.05-1.73],0.0212953729101621
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,35680,94,1.21 [0.77-1.89],0.4021281438618473
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40295,104,1.04 [0.74-1.46],0.8320382744164827
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,34646,90,0.90 [0.50-1.62],0.7212870155551556
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,40295,104,1.32 [0.88-1.99],0.1832821705744008
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,35680,94,0.94 [0.68-1.29],0.6890563662975009
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,41454,108,1.01 [0.75-1.35],0.9566177860441109
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,34910,89,2.32 [1.26-4.27],0.0071182151776883
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,34646,90,1.41 [0.90-2.21],0.1291506925007534
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,34580,87,1.12 [0.82-1.51],0.4777210050573304
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,35020,92,1.19 [0.85-1.67],0.3002999760292287
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,35020,92,0.89 [0.66-1.21],0.476250691992821
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,34552,89,0.83 [0.49-1.41],0.4895906195248104
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,34425,87,0.96 [0.59-1.58],0.8857609597184608
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,40286,102,0.76 [0.53-1.10],0.1449065847405551
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,34731,91,0.96 [0.74-1.26],0.7891971654572956
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,40092,103,1.03 [0.81-1.30],0.8120642861512832
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,35020,92,1.10 [0.78-1.56],0.5858082123294992
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,34425,87,1.07 [0.62-1.85],0.8092747453873512
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,39978,103,1.01 [0.79-1.30],0.9280906287150114
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,40092,103,1.01 [0.77-1.33],0.9215428405425886
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,40070,107,0.90 [0.68-1.19],0.4407706528660851
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,41113,108,0.98 [0.79-1.21],0.8175334189291805
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,40829,105,0.83 [0.59-1.14],0.2498423751209831
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,40829,105,1.02 [0.80-1.30],0.8454775750594264
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,40070,107,0.82 [0.63-1.07],0.1369482253525616
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,35522,93,0.67 [0.52-0.88],0.0038423106929638
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,35080,91,2.54 [1.39-4.66],0.0025136618038454
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,40092,103,1.29 [0.93-1.79],0.1292382196409417
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,35728,94,2.01 [1.00-4.04],0.0496208097410222
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,33659,86,2.52 [1.08-5.90],0.0334020147088535
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,35472,94,1.00 [0.71-1.41],0.9959813462205592
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,35663,94,1.34 [1.00-1.79],0.0494277720307285
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,35234,93,1.22 [0.75-1.97],0.4293615347278504
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,35728,94,2.37 [0.90-6.23],0.0805504525272555
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFP,Properdin,35728,94,1.14 [0.50-2.58],0.7520665526643344
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,41030,106,1.72 [1.41-2.10],7.375862947174397e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,35699,94,0.89 [0.54-1.47],0.6552659317273867
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,34721,91,0.99 [0.59-1.66],0.9583086862432824
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,41024,108,1.78 [1.22-2.60],0.00283392606952
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,40092,103,0.92 [0.68-1.25],0.595149183655854
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,34910,89,1.14 [0.77-1.70],0.505871332583584
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",35607,94,2.08 [1.50-2.90],1.3497532103048627e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,35512,93,1.89 [1.20-2.99],0.0060762772057395
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,40295,104,1.33 [0.82-2.18],0.2510155698933882
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,35680,94,1.19 [0.98-1.46],0.0801436346431304
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,41245,107,2.05 [1.38-3.03],0.0003619959798179
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,40119,102,1.29 [1.06-1.57],0.0109229817664651
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,41201,107,1.06 [0.93-1.20],0.3821846089725519
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,41109,106,1.43 [0.85-2.43],0.179816510170488
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,34721,91,1.03 [0.74-1.43],0.8650902476975566
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,40725,107,0.93 [0.75-1.15],0.4864725436655511
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,35673,92,0.78 [0.55-1.11],0.1624077879970403
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,34580,87,1.17 [0.93-1.48],0.1806979412395246
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,41123,104,2.10 [1.24-3.54],0.0055660723249516
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,41024,108,1.11 [0.81-1.54],0.5053245221331452
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,34721,91,1.19 [0.73-1.96],0.4792357842422888
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,41133,105,1.01 [0.76-1.32],0.965551915536789
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,35680,94,1.10 [0.77-1.59],0.5987015262129601
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,35020,92,0.83 [0.50-1.37],0.4656862475345658
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,35522,93,0.95 [0.77-1.16],0.6010665021037126
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,34721,91,1.51 [1.07-2.14],0.018985427043083
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,41290,105,3.42 [2.35-4.96],1.0518459820878032e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,35680,94,1.35 [0.97-1.87],0.0788354667590592
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40856,103,0.76 [0.62-0.91],0.0040557228791963
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,34425,87,1.05 [0.80-1.38],0.7029485592610568
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,40959,107,0.82 [0.62-1.07],0.1440487969467426
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,40725,107,1.37 [0.86-2.19],0.1871034753170647
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,40954,106,0.67 [0.48-0.96],0.0267015047805191
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,34646,90,2.92 [1.55-5.50],0.0008924167783293
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,41030,106,3.19 [2.03-5.03],5.085833553848617e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,40295,104,3.98 [2.63-6.02],6.645522284923745e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,41387,108,0.88 [0.74-1.05],0.1478144549073579
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,34721,91,1.25 [0.91-1.73],0.1699663044607693
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,34894,91,0.52 [0.20-1.34],0.1777719242961645
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,40976,105,0.53 [0.34-0.82],0.0042822049600419
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,40976,105,0.83 [0.58-1.20],0.3299470916101081
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,40976,105,1.22 [0.93-1.60],0.1450863535651452
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,40976,105,1.65 [0.99-2.75],0.0547967319245415
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,35618,93,0.63 [0.42-0.93],0.0213673706009225
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,40897,108,1.35 [0.78-2.35],0.2798447824717229
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,40092,103,2.06 [1.52-2.78],2.687264893216906e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,41489,105,2.27 [1.56-3.30],1.769170839764977e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,34721,91,0.83 [0.52-1.33],0.4334562970941784
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,34721,91,1.63 [1.07-2.49],0.021706458514287
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,34425,87,0.80 [0.49-1.32],0.383679634245238
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,40976,105,1.00 [0.86-1.16],0.9990313625004852
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,41396,106,5.88 [3.17-10.89],1.7557816183281265e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,34721,91,1.14 [0.65-2.00],0.6457943840691835
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40649,107,1.04 [0.87-1.24],0.6739597825297399
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,40957,106,1.16 [0.91-1.47],0.2342698835744329
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,39994,107,1.04 [0.65-1.67],0.8566222166048951
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,40070,107,1.13 [0.83-1.52],0.4395974181280609
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,41489,105,0.82 [0.52-1.29],0.3818455135310483
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,35607,94,2.49 [1.64-3.78],2.0544996213260023e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,40295,104,1.03 [0.71-1.48],0.8927244363882665
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,35728,94,1.28 [0.80-2.05],0.3072617061500147
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,40959,108,0.96 [0.66-1.40],0.840650260361186
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,35673,92,0.93 [0.75-1.16],0.5240690767605498
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,35512,93,0.88 [0.69-1.12],0.2890905513496739
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,41173,106,0.70 [0.50-0.98],0.0364198781505183
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,34580,87,1.02 [0.70-1.48],0.9246618212079823
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",34666,91,0.86 [0.66-1.11],0.2451110042171531
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,40295,104,0.88 [0.64-1.22],0.447425749062055
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,40829,105,0.94 [0.75-1.18],0.614165350181844
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNST,Consortin,41024,108,0.91 [0.78-1.07],0.2451790400148776
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,34580,87,1.01 [0.55-1.85],0.9721628565244036
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,41523,108,0.92 [0.50-1.70],0.7815609055986782
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,41396,106,0.79 [0.53-1.16],0.2275456701846757
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,41030,106,0.91 [0.53-1.54],0.7163790120411285
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,41030,106,1.15 [0.56-2.35],0.7026119892926896
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,41123,107,0.53 [0.33-0.86],0.0094038593883741
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,40976,105,1.71 [1.17-2.49],0.005876111503863
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,34721,91,1.05 [0.87-1.26],0.6301774990270755
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,35673,92,1.92 [1.32-2.80],0.0006597176463717
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,35680,94,3.50 [1.89-6.48],6.84277828186032e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,41191,107,8.34 [4.36-15.96],1.5471751975282908e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,41523,108,1.96 [1.02-3.77],0.0422925951506219
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,35522,93,1.63 [1.12-2.37],0.0112504090456993
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,34721,91,0.70 [0.53-0.93],0.0154953907670146
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,34731,91,0.70 [0.53-0.91],0.0091177523211821
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,35680,94,1.78 [0.79-3.98],0.1634797956229026
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,41024,108,1.89 [1.28-2.79],0.0014355981450116
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,34960,92,1.12 [0.76-1.65],0.573368991045373
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,34910,89,1.23 [0.75-2.00],0.4148091264708963
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,41523,108,3.74 [2.66-5.26],2.893897583563686e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,40976,105,1.47 [1.05-2.04],0.0228196726466847
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,35020,92,1.17 [0.80-1.71],0.4208181153378538
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,40984,104,4.41 [2.55-7.62],1.098780832523504e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,34731,91,0.98 [0.71-1.37],0.9162640920302112
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,35512,93,0.77 [0.44-1.32],0.3380155835680012
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,40585,105,0.96 [0.57-1.60],0.865747226332332
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,39862,103,0.94 [0.76-1.16],0.5498418491335362
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',34552,89,0.81 [0.49-1.33],0.3985118836385581
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,40070,107,0.90 [0.60-1.33],0.5900117736227652
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",34731,91,1.12 [0.73-1.71],0.609742458114426
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,40176,106,1.01 [0.83-1.22],0.9468442173340555
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,34580,87,1.10 [0.65-1.88],0.7182353324063069
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40829,105,1.11 [0.88-1.41],0.3840201432305625
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,35673,92,0.76 [0.40-1.43],0.3994136559121893
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,41523,108,1.13 [0.86-1.48],0.3725323035353018
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,41248,108,0.87 [0.67-1.13],0.2943058269738728
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,34218,87,1.07 [0.67-1.73],0.7719720524203105
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,41523,108,1.27 [0.98-1.66],0.0755613325521283
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,35659,94,0.69 [0.29-1.64],0.4024990601821364
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,41074,106,1.08 [0.69-1.70],0.7244299764528476
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,34425,87,0.79 [0.39-1.59],0.5066484579891604
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,41191,105,1.39 [0.86-2.26],0.1779769135187167
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",34646,90,1.05 [0.51-2.16],0.8931642387344685
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,41387,108,0.93 [0.72-1.20],0.5749410594176052
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,35611,94,0.79 [0.48-1.28],0.3384327796775204
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,34552,89,0.81 [0.47-1.42],0.4689700747918401
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,41332,105,1.81 [1.17-2.81],0.0080550837421896
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,41133,105,1.14 [0.89-1.45],0.29874606341119
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,35673,92,2.91 [1.73-4.87],5.264450663965783e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,35561,93,2.62 [1.57-4.37],0.0002294787566447
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,41173,106,0.95 [0.66-1.37],0.7845883314315505
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,40092,103,0.96 [0.78-1.18],0.7036880734975464
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,40649,107,0.88 [0.70-1.11],0.2808096677115556
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,34425,87,0.62 [0.39-0.99],0.0434963589821587
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,34425,87,1.00 [0.45-2.20],0.994188925120033
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,40479,103,1.60 [1.07-2.40],0.0219533917872471
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,34910,89,1.83 [1.08-3.11],0.0247011563120096
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,41123,104,1.24 [0.89-1.71],0.2012904075858175
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,40025,103,0.88 [0.72-1.08],0.2277649519635927
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,40984,104,2.01 [1.09-3.72],0.0261857239930206
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,40295,104,0.99 [0.75-1.32],0.972073386220196
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,41183,104,3.66 [1.77-7.57],0.000476810804501
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,40725,107,1.71 [1.22-2.40],0.0019707290883779
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,41396,106,0.85 [0.64-1.12],0.2477097596485526
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,35364,93,0.21 [0.11-0.38],4.537101533351323e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,41054,103,0.88 [0.75-1.03],0.1144757566885041
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,41183,104,2.64 [1.35-5.17],0.0047131445457078
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,39857,102,1.16 [0.89-1.50],0.2752704086600637
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,41523,108,0.67 [0.39-1.15],0.1498161533897906
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,40725,107,2.25 [1.64-3.09],4.939850368581196e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,34721,91,1.37 [1.00-1.88],0.0501157511621348
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,40295,104,1.02 [0.87-1.19],0.798281423620527
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,35673,92,0.84 [0.62-1.15],0.2828016524142949
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,35607,94,1.07 [0.84-1.37],0.5801949761298104
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,35607,94,0.90 [0.74-1.11],0.328622942185771
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,34580,87,1.02 [0.79-1.34],0.857727610158403
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,34731,91,0.93 [0.74-1.16],0.5057820169466316
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,34552,89,1.09 [0.94-1.27],0.2644568126301438
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,41183,104,8.06 [5.05-12.86],2.2719844990062935e-18
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,35699,94,1.87 [1.24-2.81],0.0027516950557706
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,34552,89,2.09 [1.45-3.00],6.651108027895182e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40725,107,1.11 [0.85-1.46],0.4427192036906826
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,34646,90,1.16 [0.72-1.87],0.5296594967783849
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,40286,102,2.28 [1.73-2.99],3.778081825076839e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,34646,90,0.94 [0.48-1.84],0.8556915490180413
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,35699,94,1.22 [0.76-1.96],0.4122325104640661
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,34646,90,0.76 [0.53-1.08],0.1293257287084141
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,35622,93,1.09 [0.70-1.68],0.7134092872195266
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,35680,94,1.88 [1.06-3.35],0.0315254379631287
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,34580,87,1.16 [0.79-1.70],0.4553673212830746
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,34552,89,1.14 [0.94-1.37],0.1824053090319665
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,30966,80,0.81 [0.65-1.01],0.0634762975472659
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,41105,106,4.93 [3.16-7.69],1.890930672628694e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,40263,106,1.46 [1.08-1.96],0.0132085069936728
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,39974,105,0.85 [0.59-1.22],0.3684922833814326
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,41057,104,1.09 [0.93-1.29],0.2937155726023674
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,40461,107,2.15 [1.55-2.99],5.1228789041577415e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,34950,92,0.72 [0.47-1.10],0.1314675200114519
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,35182,92,1.22 [0.58-2.58],0.6065263099474765
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,40295,104,0.84 [0.68-1.04],0.1031370014858471
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,35680,94,2.61 [1.44-4.75],0.0016124424193999
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,35680,94,1.14 [0.62-2.12],0.6757574506283301
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,34580,87,1.19 [0.71-1.98],0.5154869703253977
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,41030,106,1.13 [0.84-1.53],0.4128671226406767
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,40993,104,0.82 [0.63-1.08],0.1557500344520852
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,35607,94,0.92 [0.69-1.22],0.5701490064089554
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,41048,108,1.35 [0.99-1.83],0.0550984180889596
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,40913,102,1.13 [0.77-1.67],0.5367120199960594
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,38315,96,1.43 [0.97-2.10],0.071680326795469
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,34910,89,1.08 [0.73-1.58],0.7037762859466001
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,41133,105,0.75 [0.49-1.15],0.1811140984965757
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,40169,102,0.89 [0.70-1.13],0.3280527228792141
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,41024,108,3.87 [2.13-7.05],9.554191613702371e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,41489,105,2.06 [1.24-3.43],0.0055354196158742
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,32292,89,2.97 [1.33-6.62],0.0076903903768756
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,41267,105,0.27 [0.18-0.41],4.759216383917051e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,41036,106,3.00 [1.81-4.97],1.9151168559030737e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,34721,91,1.05 [0.63-1.75],0.8539966310382885
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,35313,93,1.23 [0.95-1.59],0.1137893927382887
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,40725,107,2.32 [1.49-3.61],0.000199710013415
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,40976,105,1.77 [1.34-2.33],4.8003357185761126e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,40928,102,0.90 [0.74-1.09],0.2834129002945955
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,41183,104,1.91 [1.62-2.24],8.517750210832934e-15
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,41387,108,1.35 [1.14-1.61],0.0005554160694069
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,40286,102,1.06 [0.68-1.64],0.7948066577965547
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,41387,108,1.64 [1.44-1.86],1.8975779154087476e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,40286,102,1.00 [0.75-1.35],0.9776840008434552
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,41453,108,2.67 [1.35-5.28],0.0046613487833208
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,41489,105,1.59 [1.14-2.22],0.0061161208775224
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,40997,104,0.78 [0.66-0.93],0.0056454125208146
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,40888,107,0.87 [0.75-1.01],0.0622745079854714
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,41489,105,1.04 [0.83-1.30],0.7346548012391907
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,40739,104,1.36 [1.12-1.64],0.0015598040611252
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,41183,104,2.11 [1.79-2.48],2.1424131414198471e-19
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,34425,87,0.93 [0.68-1.27],0.647705194951425
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,35115,92,1.09 [0.77-1.55],0.611284265383589
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",34552,89,0.92 [0.71-1.19],0.5196533065463136
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,34425,87,0.74 [0.52-1.03],0.0774266635569413
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,35680,94,2.14 [1.00-4.56],0.0496063684493059
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,34910,89,0.92 [0.72-1.18],0.5075109235133322
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,41396,106,0.97 [0.84-1.13],0.7281604005959277
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,41183,104,0.71 [0.49-1.03],0.0707617383543861
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,34646,90,0.74 [0.51-1.05],0.0951766013881809
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,34646,90,0.80 [0.54-1.20],0.2844638453885957
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40976,105,0.89 [0.78-1.02],0.0993892225202072
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",40649,107,0.93 [0.73-1.17],0.5253217786362399
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,35636,93,0.92 [0.78-1.08],0.2832577468463173
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,40844,106,1.01 [0.81-1.25],0.9481797467767238
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,34646,90,0.99 [0.66-1.48],0.9602940450200144
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,41183,104,0.90 [0.75-1.09],0.2791868565290658
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",41133,105,1.42 [0.88-2.31],0.1536635755351673
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,34721,91,0.69 [0.25-1.88],0.4672605224088906
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,34425,87,1.20 [0.91-1.58],0.1863650443928992
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,34425,87,0.86 [0.43-1.70],0.6642836883533032
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCN,Decorin,40295,104,2.73 [1.35-5.51],0.0050994194929805
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,34910,89,0.82 [0.66-1.01],0.0645273841051201
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,41396,106,1.10 [0.85-1.42],0.4862965824212691
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,40829,105,1.04 [0.87-1.25],0.6618257923184679
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,40070,107,0.90 [0.69-1.16],0.4127546378613398
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,41024,108,2.15 [1.30-3.58],0.0030193746684361
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,34580,87,1.05 [0.81-1.37],0.7162947099260384
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,34425,87,0.89 [0.67-1.18],0.4214847910635065
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,41133,105,0.94 [0.68-1.31],0.7272629296794246
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,34552,89,0.98 [0.58-1.64],0.9261243843630296
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40829,105,1.67 [1.20-2.32],0.0026004159159632
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,40970,108,0.83 [0.59-1.18],0.3063023045894721
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,35622,93,0.86 [0.64-1.17],0.3462536887584979
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,34910,89,1.08 [0.83-1.40],0.5604029063595037
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,41387,108,3.71 [2.14-6.45],3.2815930766380906e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,35680,94,1.40 [0.91-2.15],0.1232401266370221
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,35522,93,0.87 [0.57-1.34],0.5318178566995869
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,34721,91,0.33 [0.16-0.67],0.0021340154595026
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,34646,90,1.19 [0.53-2.68],0.6720253190232135
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,34646,90,0.76 [0.48-1.19],0.2313154447239784
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,34721,91,1.20 [0.70-2.04],0.5061413698048647
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,40092,103,1.32 [1.04-1.68],0.0230134068601761
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40976,105,0.99 [0.82-1.18],0.8751455345878465
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,40198,103,1.51 [1.18-1.94],0.0011230437575026
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,34386,89,1.20 [0.79-1.82],0.3907047299238664
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,34580,87,0.84 [0.55-1.26],0.3925629644452453
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,34580,87,0.81 [0.58-1.13],0.2103908427829616
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,34580,87,0.92 [0.62-1.36],0.6771750947813906
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,40429,105,1.12 [1.00-1.25],0.0550102636001556
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,34552,89,1.34 [1.00-1.79],0.0515466050306732
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,34646,90,0.63 [0.42-0.95],0.0268664844179847
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,41489,105,0.89 [0.68-1.15],0.3691702835840912
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,34580,87,1.08 [0.69-1.69],0.7288271889327753
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,34646,90,0.75 [0.50-1.11],0.147696345215952
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,40286,102,0.78 [0.47-1.31],0.3540046489595239
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,34552,89,0.83 [0.52-1.34],0.4536775343730506
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,35512,93,1.44 [1.02-2.05],0.0401489770472104
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,35607,94,0.77 [0.48-1.23],0.2709667948033794
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DIABLO,"Diablo homolog, mitochondrial",40897,108,0.90 [0.77-1.05],0.1623983484577166
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,34721,91,0.62 [0.35-1.09],0.0954931886271413
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,34910,89,1.47 [0.76-2.88],0.2550379777586208
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,41387,108,0.92 [0.70-1.23],0.5783526082030582
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,41523,108,1.22 [0.69-2.15],0.4980135751795429
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,40661,107,0.89 [0.61-1.30],0.5504133784060767
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,40829,105,1.11 [0.90-1.36],0.3467718291239344
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,35607,94,1.00 [0.76-1.32],0.9912673473730824
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,35622,93,0.80 [0.50-1.29],0.3613723541351299
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,41523,108,1.43 [1.06-1.93],0.0204795982044878
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,41133,105,5.32 [3.35-8.44],1.508752871802384e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,34731,91,1.00 [0.80-1.26],0.9989177501009532
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,34731,91,1.35 [0.98-1.87],0.0652656808459074
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,34731,91,1.08 [0.77-1.53],0.6407887537520183
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,34425,87,1.03 [0.67-1.58],0.9039620265973102
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,41363,105,0.96 [0.78-1.18],0.6852241982441925
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,35607,94,1.28 [0.99-1.67],0.0625004014728958
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,40829,105,0.86 [0.71-1.05],0.1435851942412501
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,35522,93,0.93 [0.68-1.27],0.661692721565913
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,34910,89,0.78 [0.53-1.16],0.2191804360829055
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,34576,88,0.83 [0.65-1.06],0.1267907772341103
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,40295,104,0.78 [0.55-1.12],0.1808423155728866
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,35607,94,1.74 [1.15-2.62],0.008228018390883
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,34731,91,1.03 [0.81-1.31],0.7894514001118924
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,35522,93,1.16 [0.90-1.50],0.247475391514653
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,40923,104,0.69 [0.35-1.35],0.2786808398557242
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,34580,87,0.81 [0.61-1.08],0.1547808736104036
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,35522,93,0.85 [0.72-1.01],0.0617046792118537
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,35622,93,0.97 [0.67-1.39],0.8515386085815057
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,40725,107,1.06 [0.81-1.40],0.6571001980459157
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,35607,94,1.65 [1.18-2.31],0.0033071104054563
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,41114,103,0.90 [0.64-1.27],0.5556771923749134
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,34721,91,0.99 [0.56-1.75],0.981941683003842
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,34580,87,0.99 [0.82-1.18],0.8773640969598795
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,35607,94,0.91 [0.79-1.05],0.2111113705407044
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DOK2,Docking protein 2,41024,108,0.97 [0.84-1.11],0.6528345155893381
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,40649,107,0.77 [0.55-1.08],0.1286993010447558
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,40829,105,1.39 [0.78-2.47],0.2670383121536752
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,40976,105,1.35 [0.86-2.12],0.1858416592147628
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,40255,103,1.22 [0.67-2.22],0.5115709952564416
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,40829,105,1.21 [0.73-2.00],0.4620709924743515
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,40695,106,1.00 [0.75-1.32],0.9758510953063976
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,41523,108,2.17 [1.10-4.30],0.0254014552266181
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,41272,106,1.53 [1.22-1.91],0.0002416319992644
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,40725,107,2.70 [1.87-3.89],9.558059284136433e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,40829,105,0.95 [0.70-1.29],0.7334633167697877
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,40555,105,3.21 [2.19-4.70],2.158380298262481e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,35622,93,1.54 [0.90-2.64],0.1160803056666964
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,41030,106,0.78 [0.41-1.48],0.4517536220774751
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,41269,106,1.34 [0.81-2.20],0.2519637769990378
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,40684,105,0.64 [0.46-0.90],0.0100455264451563
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,34910,89,0.91 [0.72-1.15],0.4442989830923679
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,35446,93,1.92 [1.36-2.71],0.0002017157203237
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,34721,91,0.69 [0.46-1.02],0.0636751144550834
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,40829,105,4.79 [3.04-7.54],1.2645268035692724e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,35673,92,0.97 [0.73-1.29],0.8324061377670375
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,40295,104,0.92 [0.71-1.20],0.5446132210981377
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,35512,93,1.17 [0.74-1.85],0.4918530810775414
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,34721,91,1.04 [0.78-1.40],0.7849647429114198
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,40070,107,0.82 [0.65-1.04],0.0956987883999947
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",35522,93,1.00 [0.82-1.21],0.977644268182287
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,35607,94,1.10 [0.72-1.69],0.6584256862800486
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,35512,93,1.07 [0.71-1.60],0.7493533604025087
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,34721,91,0.86 [0.65-1.13],0.2709948803736435
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,35512,93,0.78 [0.49-1.25],0.3015429277833791
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40725,107,1.06 [0.88-1.26],0.5562083696949449
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,41334,106,3.41 [2.31-5.04],6.505346778262636e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,40070,107,1.09 [0.67-1.76],0.7276292145188497
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",35673,92,1.09 [0.84-1.40],0.5262930320496602
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",34731,91,1.00 [0.81-1.23],0.9785883537355295
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,34552,89,1.05 [0.76-1.45],0.7508802547024609
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,34743,92,0.68 [0.42-1.12],0.1296034266920807
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,34580,87,1.09 [0.75-1.57],0.6637554091031623
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,41396,106,3.72 [2.70-5.13],1.1751530624493729e-15
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,40976,105,0.55 [0.45-0.68],7.1814241309645255e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,35512,93,0.97 [0.65-1.43],0.8654909544161633
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,34552,89,0.91 [0.50-1.64],0.7438039900767018
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,35622,93,0.98 [0.74-1.31],0.9027328628120664
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40295,104,1.42 [0.92-2.21],0.1170820798767757
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,34731,91,2.79 [1.53-5.08],0.0007958811762776
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,34646,90,1.01 [0.64-1.58],0.9781384188714388
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,35673,92,0.96 [0.78-1.20],0.7472320642860775
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,35522,93,2.19 [1.52-3.17],3.0013570550311896e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,35020,92,0.41 [0.21-0.78],0.0062138852939504
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,41104,106,2.93 [1.80-4.75],1.421192221446318e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,35622,93,1.72 [1.13-2.62],0.0116229364568246
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,40965,106,4.08 [2.57-6.47],2.416107181068433e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,40656,107,4.44 [3.08-6.41],1.4466683090009004e-15
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,34721,91,1.15 [0.84-1.56],0.3887765820131605
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,40934,104,0.85 [0.72-1.00],0.0522074683525866
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,40092,103,1.59 [1.08-2.34],0.0179646208940258
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,35522,93,1.83 [1.06-3.16],0.030803642655789
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,41523,108,0.54 [0.19-1.50],0.2376498916308133
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,40976,105,1.21 [0.94-1.55],0.1467623512325077
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,35673,92,0.96 [0.74-1.26],0.7841189164318978
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,34731,91,0.87 [0.73-1.03],0.1008570077340385
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",35607,94,1.01 [0.71-1.44],0.942260901425326
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",35398,93,0.98 [0.82-1.18],0.867515857241705
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,34552,89,0.97 [0.71-1.32],0.837095601741692
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,34731,91,1.23 [0.79-1.91],0.3631035982896311
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,40725,107,0.98 [0.72-1.31],0.8727070870730618
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,34646,90,0.89 [0.71-1.12],0.3345297368669988
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,41024,108,1.18 [0.92-1.52],0.1927268110157096
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,41489,105,1.07 [0.90-1.27],0.4533701162538361
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,35622,93,0.89 [0.65-1.21],0.4617708566514094
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,34552,89,1.07 [0.68-1.67],0.7715733962037126
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,40286,102,0.97 [0.54-1.77],0.9330477021089896
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,35622,93,0.88 [0.70-1.11],0.2841035972110093
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,34580,87,0.92 [0.71-1.18],0.5023868699833898
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ELN,Elastin,35673,92,2.61 [1.55-4.38],0.0002944982406023
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,40829,105,1.30 [1.02-1.66],0.031695562682325
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,34552,89,0.87 [0.50-1.53],0.6398399090942057
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,40286,102,1.37 [0.98-1.92],0.0672208997448376
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,32931,84,0.87 [0.58-1.30],0.4950148774282794
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,41523,108,2.94 [1.14-7.57],0.0258220131127297
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,40974,107,0.92 [0.74-1.15],0.4684326399363173
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,41387,108,0.83 [0.64-1.08],0.15941131683749
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,34731,91,0.80 [0.55-1.16],0.2362130705244648
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,35512,93,0.65 [0.45-0.95],0.0245081346500564
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,34552,89,1.29 [0.65-2.57],0.4609019845946507
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,34552,89,0.98 [0.61-1.57],0.932176774194875
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,41523,108,1.32 [0.71-2.46],0.3815092653971356
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,41183,104,0.86 [0.60-1.23],0.4026620642228086
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,34731,91,0.72 [0.42-1.23],0.2242281592726202
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39739,99,1.23 [1.00-1.51],0.0550590645259028
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,35512,93,0.64 [0.42-0.97],0.0372817827531385
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,40092,103,1.15 [0.77-1.71],0.4997108057748772
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40295,104,1.26 [0.56-2.85],0.5800885261172111
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40295,104,2.70 [1.32-5.52],0.0064095693576287
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,34731,91,0.90 [0.63-1.29],0.5646316518937393
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,34646,90,0.83 [0.42-1.64],0.5834523502701565
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,34721,91,0.99 [0.72-1.37],0.9600993212670548
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,40983,104,1.13 [0.95-1.35],0.1714252101318225
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,35512,93,0.39 [0.18-0.85],0.0181758401785014
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,41114,103,2.17 [1.27-3.70],0.0045764795721001
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,40070,107,1.06 [0.82-1.35],0.6681589646769681
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,39571,100,3.70 [2.55-5.38],5.933148267135598e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,34910,89,2.11 [1.05-4.22],0.0353248294735156
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,41523,108,6.28 [3.96-9.95],5.598376935813579e-15
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,40649,107,3.12 [1.90-5.13],7.302660987027898e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,40295,104,0.94 [0.70-1.27],0.6983036955813651
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,35020,92,0.93 [0.57-1.51],0.7559053891776912
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,40976,105,1.58 [1.38-1.82],5.528061239468938e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,34731,91,0.74 [0.55-0.98],0.0380952379949877
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,41334,106,2.17 [1.33-3.55],0.0020130698598644
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,41133,105,2.18 [1.09-4.37],0.0276243304560049
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,40861,103,1.60 [0.68-3.77],0.2840921495415502
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,41133,105,0.67 [0.33-1.35],0.2625740836488559
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,40829,105,0.96 [0.81-1.13],0.6267980555892487
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,34721,91,0.85 [0.62-1.16],0.3069763727081668
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,34425,87,1.14 [0.65-1.98],0.650807259577185
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,40649,107,0.80 [0.64-1.01],0.0595036835164163
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,35020,92,1.19 [0.68-2.09],0.5329940831104097
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,34646,90,1.00 [0.64-1.57],0.9876643484716868
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,35512,93,1.54 [0.98-2.40],0.0587495828925367
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,34910,89,0.89 [0.75-1.05],0.1760530304722271
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,40762,104,0.69 [0.35-1.35],0.2760430204489803
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,34552,89,0.67 [0.40-1.14],0.1435730405996509
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,41523,108,1.83 [1.11-3.01],0.0173082345165926
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,40984,104,0.94 [0.57-1.55],0.795966350499422
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,34425,87,0.81 [0.52-1.25],0.3384822455750128
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,34646,90,0.76 [0.48-1.18],0.2152446201201481
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,35607,94,0.91 [0.71-1.16],0.4514007404940899
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,34425,87,1.15 [0.73-1.80],0.5454641867131202
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,34646,90,0.95 [0.76-1.20],0.6853636289344988
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,35020,92,0.51 [0.25-1.04],0.0625026399582278
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,34552,89,1.49 [1.20-1.86],0.0003620405024814
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,34552,89,1.12 [0.76-1.65],0.5711828885981454
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,41387,108,4.44 [2.71-7.26],3.036994805240686e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,35699,94,1.21 [0.62-2.38],0.5773184960130707
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,35214,92,0.92 [0.47-1.77],0.7940144393358622
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,41030,106,0.95 [0.70-1.28],0.7182579034426766
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,35728,94,1.05 [0.66-1.68],0.8424313560826899
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,35542,93,0.84 [0.39-1.81],0.6597435634288459
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,35728,94,0.86 [0.23-3.18],0.8210112433724175
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,41123,104,0.83 [0.61-1.13],0.2347981846521214
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,41140,105,3.42 [1.92-6.11],3.1679519823876434e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,41115,106,1.25 [0.71-2.21],0.4353898282259825
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,41114,106,2.51 [1.00-6.27],0.0497285213260421
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",40984,104,1.26 [1.06-1.49],0.0074457614555611
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",41024,108,1.27 [1.04-1.56],0.0192346980557893
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",35673,92,1.89 [1.43-2.51],8.808618128297929e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",41523,108,1.93 [1.45-2.58],8.63265061398726e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,41259,107,1.08 [0.84-1.37],0.5585329339587034
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,40232,104,1.10 [0.82-1.49],0.5254748807321312
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,40976,105,1.00 [0.74-1.36],0.9943288267961738
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,41024,108,0.85 [0.68-1.07],0.1713029968100301
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,35522,93,1.01 [0.76-1.35],0.9401532563615752
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,35622,93,0.95 [0.84-1.09],0.4844599607814778
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,35512,93,1.35 [0.73-2.49],0.3347801913701067
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,34731,91,0.66 [0.47-0.93],0.0171745529610564
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,35673,92,2.16 [1.16-4.03],0.0157534982845752
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,40829,105,1.47 [0.90-2.43],0.1269222302429362
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,40970,108,3.37 [2.04-5.56],2.007171867435995e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,35522,93,1.21 [0.96-1.53],0.0985672295794987
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,41523,108,1.50 [0.81-2.78],0.198030497888161
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,34721,91,0.93 [0.69-1.26],0.6413186817311891
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,41395,108,1.73 [1.30-2.30],0.0001976484166525
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,41489,105,1.60 [1.01-2.52],0.0460920780236948
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,35680,94,2.94 [1.68-5.14],0.0001508805851163
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,34721,91,0.95 [0.67-1.33],0.7555854486144938
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",41024,108,1.12 [0.89-1.40],0.3305511583867904
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,35673,92,1.73 [1.35-2.22],1.4390667134920298e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,40976,105,1.15 [0.81-1.64],0.443655472387834
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,35622,93,1.46 [0.66-3.24],0.346209646696623
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,41030,106,1.95 [1.48-2.57],2.551759851185153e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40852,106,1.26 [0.90-1.76],0.1719238798620247
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,40092,103,1.02 [0.76-1.38],0.8758410580462132
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,41049,106,0.81 [0.58-1.13],0.2145220022214448
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,35636,93,0.86 [0.63-1.18],0.3458273169433901
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,40836,106,1.01 [0.66-1.53],0.9714832859351163
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,41024,108,1.49 [1.03-2.15],0.0354518373097116
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,41298,105,0.65 [0.45-0.95],0.0256342418622872
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,40286,102,1.12 [0.81-1.55],0.5098224037501775
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,41030,106,0.47 [0.35-0.63],8.14970288265197e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,40976,105,1.50 [1.16-1.93],0.0020027518300518
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,40092,103,1.42 [1.15-1.77],0.001232096669226
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",34552,89,1.19 [0.91-1.57],0.1969401667449325
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",34552,89,1.43 [1.10-1.86],0.006733330642011
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,40092,103,0.94 [0.71-1.25],0.6637200483466117
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,40092,103,1.31 [0.96-1.79],0.0922970442903257
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,41114,106,1.79 [1.03-3.09],0.0383454971619724
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,34892,90,2.59 [1.44-4.66],0.0014870513620969
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",35622,93,0.91 [0.71-1.17],0.458905118204543
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,34646,90,1.09 [0.74-1.61],0.6519959973918268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,34646,90,0.60 [0.36-1.00],0.0518619435277698
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,41183,104,1.03 [0.82-1.29],0.8008570238377317
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,40976,105,1.41 [1.12-1.78],0.0040974721243342
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,34646,90,0.50 [0.26-0.96],0.0359560229480935
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,41334,106,1.16 [1.01-1.32],0.0308529155895244
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,41334,106,1.36 [1.09-1.71],0.0069693997296743
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,34646,90,0.49 [0.21-1.17],0.1083034197256242
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,40286,102,1.17 [0.69-1.95],0.5627761366621276
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,34646,90,0.76 [0.42-1.37],0.3553324110609889
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,34425,87,1.03 [0.80-1.33],0.7937319220559738
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,34360,87,0.75 [0.46-1.22],0.251077636762925
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,41133,105,0.85 [0.50-1.44],0.5462248038316674
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,35680,94,0.92 [0.63-1.36],0.6844880338543999
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,35607,94,1.63 [0.97-2.74],0.06481011850196
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,41133,105,5.81 [3.19-10.60],9.433988740008084e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,34910,89,1.07 [0.73-1.56],0.7432238363416538
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,35699,94,1.56 [1.17-2.08],0.0026144264978876
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,40070,107,0.89 [0.65-1.21],0.4546968360535837
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",34580,87,1.06 [0.85-1.34],0.5969620470977564
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,34552,89,1.04 [0.69-1.58],0.8459699503322434
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,40070,107,0.77 [0.61-0.97],0.0285635087915414
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,40988,103,0.83 [0.66-1.05],0.1261476043619623
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,35622,93,0.89 [0.73-1.09],0.2715366008777163
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,41156,104,0.90 [0.77-1.06],0.2088822158775387
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40725,107,1.37 [0.93-2.03],0.1131858009297975
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40725,107,0.94 [0.79-1.13],0.5172390171964323
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39994,107,0.95 [0.65-1.39],0.7898447146982821
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,35522,93,1.06 [0.76-1.48],0.7350701249114099
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,40092,103,0.89 [0.76-1.05],0.169783617931595
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40725,107,1.89 [1.07-3.34],0.0293658982549411
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,40752,105,1.24 [0.60-2.56],0.5608776540748815
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,40092,103,0.38 [0.20-0.71],0.0025689150791747
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,41489,105,,
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,41133,105,1.54 [0.91-2.60],0.1044248108060288
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,40070,107,0.97 [0.74-1.27],0.8273653658139289
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,40092,103,1.20 [0.74-1.96],0.4651857465681716
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,35728,94,0.57 [0.27-1.20],0.1405629715807128
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,35607,94,1.06 [0.70-1.62],0.7726133866402486
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,35512,93,1.13 [0.66-1.95],0.6544394242625176
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,34646,90,0.88 [0.69-1.12],0.3049229703841395
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,40944,105,3.51 [2.17-5.68],3.287059800367035e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,41387,108,4.50 [2.76-7.33],1.4769979650200787e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,41004,105,1.05 [0.97-1.14],0.2234975681531296
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,34360,87,0.85 [0.48-1.53],0.5926241904104466
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,40070,107,1.12 [0.75-1.67],0.5874256518998172
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,34646,90,0.87 [0.54-1.40],0.5617581732613615
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,40976,105,0.94 [0.77-1.15],0.5513348957571379
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,40092,103,1.05 [0.88-1.26],0.5695900730761242
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,34552,89,0.93 [0.69-1.25],0.6153015819953321
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,34721,91,1.09 [0.61-1.95],0.7824904904178721
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,40594,107,1.03 [0.53-1.98],0.9322897512164644
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,34731,91,1.73 [1.30-2.29],0.0001743231522434
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FST,Follistatin,41123,104,1.00 [0.71-1.41],0.9824400802728857
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,34731,91,3.45 [1.73-6.87],0.0004456884615255
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,40921,104,4.42 [2.99-6.52],7.717725602513916e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,35541,94,1.14 [0.91-1.43],0.2576322773153259
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,41266,107,0.85 [0.70-1.03],0.1040137652241475
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,34910,89,1.54 [1.15-2.06],0.0036297677935987
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FURIN,Furin,41133,105,1.54 [0.92-2.56],0.0992773560114826
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,40031,103,1.35 [0.90-2.03],0.1483545491664437
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",34949,91,0.89 [0.63-1.26],0.5129159142819726
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,41387,108,1.74 [1.22-2.49],0.0021679336692856
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",40725,107,0.77 [0.57-1.05],0.0958544442577148
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",41396,106,0.92 [0.73-1.17],0.5095014557267621
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,40286,102,0.96 [0.73-1.26],0.7430097562690823
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,40957,106,0.89 [0.74-1.07],0.2086533495415765
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,34721,91,0.79 [0.52-1.20],0.2710409423260471
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,34580,87,1.25 [0.84-1.85],0.2747277229028736
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,35512,93,1.22 [0.85-1.74],0.2774518101523135
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,35020,92,0.98 [0.72-1.34],0.9057564135982126
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,34580,87,0.79 [0.54-1.16],0.2256359042640788
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,34425,87,1.04 [0.47-2.31],0.9144395291951224
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,34646,90,0.76 [0.45-1.29],0.31562356476496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,35020,92,0.77 [0.46-1.29],0.3171337748573051
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,34731,91,0.91 [0.62-1.35],0.6470539510816602
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,34425,87,0.96 [0.68-1.35],0.8107839765940011
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,41183,104,0.64 [0.49-0.84],0.0012037899074578
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40829,105,1.53 [0.84-2.80],0.1678543873519047
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,41396,106,1.21 [0.63-2.33],0.5577893823054043
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40286,102,1.83 [1.26-2.67],0.0016354531447513
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,35673,92,1.46 [0.74-2.89],0.2788974782213013
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,40829,105,2.20 [0.95-5.07],0.0641220312787737
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,34552,89,1.31 [0.83-2.07],0.2509078006012488
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,34146,88,1.13 [0.59-2.17],0.709241025751248
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,35622,93,1.09 [0.53-2.23],0.8203691696089127
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,35020,92,0.87 [0.57-1.33],0.5174130073592538
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,41257,108,2.22 [1.16-4.27],0.0161828920804205
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,34552,89,1.39 [0.88-2.21],0.1587912029347309
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,35607,94,1.16 [1.02-1.33],0.0247443760392764
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,34425,87,1.06 [0.49-2.29],0.8892193993657146
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",34731,91,1.00 [0.77-1.30],0.9977981504078434
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,34721,91,1.10 [0.77-1.58],0.5952060364214087
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,35542,94,1.92 [1.55-2.40],4.564373460139557e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,40286,102,1.41 [1.09-1.81],0.0082141780857143
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,40070,107,0.88 [0.61-1.27],0.4948475169777079
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,34552,89,0.85 [0.51-1.42],0.53515650123241
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,35728,94,1.04 [0.49-2.22],0.9170762921282762
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,35607,94,0.90 [0.75-1.08],0.2407461150291407
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,40092,103,1.02 [0.89-1.17],0.7679118871840123
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,34067,87,1.56 [1.17-2.09],0.0024759342876815
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,34552,89,1.13 [0.76-1.70],0.5428823150919663
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40829,105,4.59 [3.08-6.83],7.170263099029211e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,41523,108,1.88 [1.50-2.36],5.19608261047042e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,41024,108,0.58 [0.36-0.94],0.0264597342790022
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,40070,107,1.33 [0.87-2.03],0.1872388677710597
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,35673,92,1.28 [0.94-1.73],0.1137550639780268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,40026,103,1.08 [0.74-1.56],0.7034507575657873
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,40092,103,1.17 [0.90-1.53],0.2384886633051767
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,40092,103,0.95 [0.81-1.10],0.4863626276966578
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,41334,106,6.39 [4.03-10.15],3.527997730242628e-15
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,40829,105,2.55 [1.23-5.31],0.0121499450527482
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,40602,106,1.22 [0.67-2.24],0.5188877028406209
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,34558,94,0.70 [0.50-0.98],0.0369112848333549
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,40070,107,0.66 [0.47-0.92],0.0144662024038588
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,35673,92,0.94 [0.71-1.24],0.6453574601004786
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,35603,92,0.80 [0.53-1.23],0.3101202773868043
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,40326,102,1.66 [1.06-2.61],0.0276300726709947
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,40965,106,1.14 [0.82-1.58],0.4366867679938803
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,40725,107,2.58 [1.37-4.85],0.0032621688081827
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,40970,108,1.12 [1.02-1.22],0.0197848479804055
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,40092,103,0.87 [0.77-0.99],0.0370788679981256
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,34910,89,1.98 [0.97-4.03],0.0615587567779067
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,40070,107,1.27 [1.00-1.61],0.0455405493549149
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,41024,108,1.07 [0.87-1.32],0.5189274547342138
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,35622,93,0.62 [0.29-1.30],0.2066906177040763
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,35622,93,1.38 [1.09-1.75],0.0078058309987472
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,34910,89,1.27 [0.73-2.22],0.3941130000004205
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,34425,87,1.31 [0.93-1.83],0.1190148156686001
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,34731,91,1.04 [0.71-1.52],0.848569756301712
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,35607,94,3.34 [2.12-5.28],2.1962987762327738e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,35522,93,0.93 [0.76-1.13],0.4711693345326073
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,34646,90,0.77 [0.46-1.27],0.2998310493049125
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,34646,90,0.88 [0.71-1.09],0.2369952567023842
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,34425,87,1.10 [0.82-1.48],0.5308647494731394
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,39301,104,1.92 [1.09-3.41],0.0249581698619515
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,34840,89,1.23 [0.72-2.09],0.453286261494766
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,40725,107,1.13 [0.75-1.68],0.5611479563840165
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,34646,90,1.04 [0.57-1.92],0.8926800088824864
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,40295,104,1.25 [0.94-1.67],0.128201264932818
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLOD4,Glyoxalase domain-containing protein 4,40928,103,0.72 [0.44-1.17],0.1873354267163718
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,34580,87,0.67 [0.35-1.29],0.2291455743958188
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,40752,106,1.17 [0.87-1.56],0.2928319111162349
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",34910,89,0.98 [0.77-1.23],0.8307254845461254
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,40070,107,0.93 [0.63-1.38],0.7163344217697762
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,35512,93,1.00 [0.72-1.41],0.9779686680266776
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,34815,89,1.80 [1.39-2.34],9.537054265240314e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,35673,92,0.77 [0.58-1.01],0.0614253699682379
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,41489,105,1.00 [0.70-1.41],0.978869660020542
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,34910,89,0.76 [0.56-1.03],0.0771071355870785
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,35622,93,1.10 [0.89-1.36],0.3631593413352414
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,40092,103,1.01 [0.77-1.32],0.9489940980905276
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,34721,91,0.81 [0.51-1.29],0.376383290887746
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,41030,106,1.85 [1.37-2.50],5.569093053483727e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,34731,91,1.09 [0.62-1.92],0.7617836831490579
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,34910,89,0.59 [0.33-1.04],0.0664443550383051
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,35622,93,0.91 [0.70-1.19],0.5030034837371458
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,41387,108,2.87 [1.74-4.75],4.028794310099208e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40976,105,0.88 [0.74-1.04],0.1311835710947788
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,35522,93,1.08 [0.71-1.63],0.7227451638945874
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",35680,94,0.99 [0.61-1.58],0.9503154605154958
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,40842,104,0.72 [0.42-1.23],0.2294664591034871
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,34552,89,0.98 [0.72-1.32],0.874959680647815
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39789,103,0.80 [0.64-1.01],0.062300330402616
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,34910,89,0.36 [0.22-0.58],2.701449042098872e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,40957,106,0.86 [0.71-1.05],0.1324424075383953
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,40829,105,1.07 [0.95-1.22],0.2694069846538158
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,41396,106,2.11 [1.18-3.75],0.0114083449755676
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,40725,107,0.54 [0.40-0.73],5.676835197883696e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,35512,93,1.44 [1.02-2.03],0.0396426298846821
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,35522,93,0.79 [0.48-1.31],0.364647080705816
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,35699,94,0.95 [0.63-1.44],0.8085650767776952
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,35522,93,0.97 [0.74-1.27],0.8141449222050505
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,40070,107,1.54 [1.02-2.32],0.0421032305785573
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,39920,104,2.05 [1.12-3.74],0.0196637246015756
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,34580,87,1.10 [0.81-1.49],0.5585162504153626
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,35622,93,1.08 [0.64-1.85],0.7664714203938309
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,35522,93,1.30 [0.96-1.78],0.0905167406931553
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,40295,104,1.40 [1.07-1.81],0.0129011477297778
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,35512,93,1.05 [0.74-1.48],0.7975223261083124
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRAP2,GRB2-related adapter protein 2,41024,108,0.91 [0.80-1.04],0.1805818918036542
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,35673,92,0.83 [0.61-1.14],0.2557555697935088
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",35622,93,0.59 [0.33-1.05],0.0726632079739209
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",34580,87,0.89 [0.59-1.35],0.5914694343789877
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,40295,104,0.83 [0.57-1.21],0.3354429002871129
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,40834,106,3.23 [1.76-5.92],0.0001485521214364
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,34731,91,1.02 [0.70-1.48],0.9208088954080732
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",40829,105,1.26 [0.97-1.63],0.0789760399137988
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,34232,87,0.87 [0.67-1.14],0.315033295768744
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,40092,103,0.96 [0.77-1.19],0.7149534380515419
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,35562,94,0.62 [0.27-1.47],0.2815395671595345
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",35494,92,3.00 [1.35-6.64],0.0068471913735272
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,40959,107,0.98 [0.80-1.20],0.8311444173466962
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,40092,103,1.11 [0.89-1.39],0.3500283217425068
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,34552,89,1.08 [0.83-1.40],0.5658489681496106
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,39821,107,0.87 [0.67-1.13],0.2806282845393673
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,35607,94,0.96 [0.89-1.04],0.3638010143733019
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,35020,92,1.19 [0.95-1.48],0.1221213499400939
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,34721,91,0.84 [0.65-1.08],0.171711157071362
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,40820,106,1.96 [1.22-3.14],0.0054539335705173
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,35020,92,0.82 [0.61-1.09],0.1753946252791084
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,34552,89,1.34 [0.92-1.94],0.1284788795596571
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,41208,107,1.23 [0.94-1.62],0.1327748279729195
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",40295,104,0.85 [0.71-1.04],0.1089608239093674
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,41489,105,2.74 [1.93-3.89],1.6204527292308936e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,40976,105,1.18 [0.93-1.48],0.1671611132673611
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,40295,104,1.47 [1.29-1.67],1.26613401247237e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,34425,87,1.12 [0.78-1.60],0.541477308865409
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",34552,89,0.97 [0.70-1.33],0.8329858773990023
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",41274,105,1.17 [0.93-1.47],0.1824354285377361
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,41396,106,1.00 [0.87-1.14],0.9685458022048624
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",41030,106,0.96 [0.77-1.20],0.7070328090601641
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,41336,105,1.74 [1.38-2.21],4.294373083697931e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,41030,106,4.00 [2.82-5.69],8.39744280305768e-15
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,41274,105,0.57 [0.45-0.72],3.300868656217296e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,41396,106,0.96 [0.72-1.26],0.7570653693670053
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,35673,92,0.89 [0.73-1.07],0.2203028722232505
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,34552,89,0.90 [0.58-1.38],0.6182758177700025
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,41489,105,0.87 [0.64-1.18],0.3767198337087862
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,34646,90,0.71 [0.45-1.13],0.1472896186959051
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,34580,87,1.08 [0.81-1.45],0.5889353996021989
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,35522,93,0.78 [0.49-1.24],0.2892937612989416
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,41332,106,1.00 [0.83-1.20],0.9785798888071532
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,35607,94,0.92 [0.67-1.26],0.6016934941172192
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,40295,104,1.09 [0.81-1.47],0.5795567879822341
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,34910,89,3.37 [1.66-6.85],0.0007996551782592
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,35607,94,2.03 [1.29-3.19],0.002122798988923
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,35673,92,1.77 [0.82-3.84],0.1472257157123455
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,40976,105,0.95 [0.77-1.18],0.6388728184281411
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,41489,105,1.61 [1.02-2.54],0.0407812428030264
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,35365,93,0.80 [0.42-1.52],0.4976567310365458
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,40092,103,0.93 [0.74-1.17],0.5476771933760034
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,35607,94,0.94 [0.73-1.22],0.6516687795270018
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,34646,90,1.18 [0.92-1.51],0.1914995584537148
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,34552,89,0.97 [0.53-1.78],0.9147827295487804
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,35537,94,1.48 [1.11-1.96],0.0071484205143453
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,35622,93,1.48 [1.07-2.05],0.0173900476304872
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,40295,104,0.95 [0.50-1.78],0.8684247496937002
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",35622,93,2.47 [1.33-4.58],0.0042067423298063
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",40848,105,1.82 [1.18-2.80],0.0067710288244614
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",40976,105,4.79 [3.24-7.09],5.2576029988060436e-15
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,41396,106,1.52 [1.02-2.26],0.041021847124005
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,34844,89,1.03 [0.72-1.47],0.8634796883701217
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",34731,91,0.79 [0.52-1.22],0.2950026636310491
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",34552,89,0.93 [0.58-1.50],0.7719932366633125
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,34359,87,1.00 [0.65-1.53],0.9837596106621472
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,40577,107,1.91 [1.40-2.61],5.231440796811781e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,40070,107,1.09 [0.76-1.55],0.637780801006568
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,34721,91,1.04 [0.80-1.36],0.7640150238944104
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,40523,107,1.81 [1.29-2.53],0.0005581443309514
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,40165,104,1.03 [0.82-1.29],0.8003615388096945
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,35622,93,1.03 [0.69-1.53],0.8967678367802395
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,41489,105,0.91 [0.72-1.14],0.4128616167422564
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,40092,103,0.98 [0.62-1.56],0.9461146089987476
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,35206,91,1.12 [0.90-1.39],0.31430491172372
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,34955,92,1.05 [0.87-1.27],0.5908732678614421
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,34731,91,1.55 [1.01-2.40],0.0467794985863519
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,35542,93,0.73 [0.41-1.31],0.2910680798994777
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,34731,91,0.86 [0.68-1.08],0.1885212899893753
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40829,105,1.10 [0.70-1.73],0.689068793809311
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,41396,106,1.25 [0.78-2.00],0.360494429428606
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,34646,90,1.26 [0.71-2.24],0.4345734702242567
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,34731,91,1.08 [0.87-1.33],0.4873030937949637
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40976,105,1.04 [0.67-1.60],0.8754745087862396
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,35607,94,1.36 [1.00-1.85],0.0469945071528578
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,34552,89,1.32 [0.94-1.86],0.1074681595869883
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,34731,91,1.22 [0.82-1.83],0.3300932491186225
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,39885,107,0.84 [0.61-1.14],0.262108346516115
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,41114,103,0.83 [0.65-1.07],0.1589690335384253
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,35512,93,1.67 [1.12-2.48],0.0113489144040926
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,40366,105,1.00 [0.78-1.28],0.9983922265811692
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,41396,106,2.55 [1.79-3.62],2.1850517893955843e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40716,106,4.08 [2.70-6.16],2.665930225895152e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,34580,87,1.20 [0.97-1.47],0.0921274534410215
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,34580,87,1.28 [0.85-1.91],0.2338706374382797
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",41133,105,1.04 [0.79-1.38],0.7681877981050503
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,40782,104,1.73 [0.84-3.54],0.1349088440382376
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,41523,108,6.55 [3.27-13.11],1.0925257099090141e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,40286,102,0.89 [0.71-1.12],0.3131506243107758
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,40850,106,5.75 [3.84-8.59],1.5557644237741826e-17
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,41523,108,1.82 [1.06-3.13],0.0300041476432237
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,41523,108,1.45 [0.77-2.76],0.2524548816463776
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,40976,105,0.85 [0.62-1.17],0.3168458338982753
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,41024,108,0.96 [0.67-1.39],0.8386467780679688
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,40829,105,2.84 [1.17-6.86],0.0208788208651727
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,35020,92,0.77 [0.45-1.32],0.3471560705956434
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,40070,107,1.07 [0.75-1.53],0.6942720168834178
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",34731,91,1.35 [1.03-1.77],0.0273691920257117
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,41489,105,0.47 [0.08-2.84],0.4099220887171755
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,41396,106,1.19 [0.82-1.73],0.3541911096901383
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,34679,93,3.45 [2.49-4.79],1.1506202881961636e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,35020,92,1.33 [0.96-1.85],0.0887361101915968
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,35020,92,1.77 [1.17-2.67],0.0064290008603661
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,35522,93,1.10 [0.52-2.34],0.798015056239913
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,40286,102,1.52 [1.35-1.73],3.7384610643686546e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,41183,104,4.53 [2.64-7.79],4.6256501964028055e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,40725,107,1.31 [0.96-1.79],0.0905655697332318
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,40070,107,1.94 [1.49-2.54],1.0145115718317469e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,34580,87,0.88 [0.60-1.28],0.4929530128311482
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,40976,105,1.80 [1.32-2.45],0.0001922306978391
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,34552,89,1.03 [0.60-1.79],0.9104932027605752
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,34721,91,1.05 [0.66-1.65],0.8448135224419787
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,35622,93,1.03 [0.74-1.42],0.8710698334940646
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,34580,87,1.27 [0.92-1.76],0.1524568869096553
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,35680,94,0.93 [0.44-1.97],0.8545047751117305
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,40829,105,2.08 [1.22-3.53],0.0067422417203824
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,34552,89,1.19 [0.81-1.76],0.368686439817505
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,41030,106,3.76 [1.88-7.48],0.0001689748421559
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,41459,108,1.03 [0.89-1.18],0.7153585281340347
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,41454,108,1.46 [1.10-1.93],0.0089405026902187
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,41173,106,1.57 [0.86-2.87],0.144051762370359
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,40512,106,2.71 [2.09-3.51],4.1300306729786015e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,40843,106,2.60 [1.67-4.05],2.4192768368265428e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,41523,108,1.92 [1.27-2.92],0.0021510643924986
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,41024,108,2.11 [1.35-3.28],0.000952800749225
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,34646,90,1.12 [0.89-1.41],0.3358113195864302
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,34552,89,1.08 [0.76-1.52],0.6725430592123467
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,35667,94,0.33 [0.11-1.01],0.0529033515724808
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,34425,87,1.02 [0.82-1.27],0.8530471582419226
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,34731,91,0.62 [0.35-1.10],0.1035413312566066
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,40829,105,2.48 [1.88-3.27],1.412293602124439e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,41024,108,1.45 [0.85-2.46],0.1706957807837879
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,35673,92,1.12 [0.88-1.41],0.3540353292448036
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,40976,105,0.91 [0.75-1.10],0.3068950742724631
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,40092,103,1.17 [1.01-1.37],0.0414259778897655
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,40286,102,1.50 [1.32-1.71],8.338139116738327e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,40286,102,1.19 [0.93-1.51],0.1686648620079007
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,41183,104,2.65 [1.81-3.86],4.193963617462607e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,40286,102,0.89 [0.66-1.21],0.4523444178372335
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,40829,105,1.94 [1.62-2.33],7.708084951957969e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,41489,105,2.69 [2.02-3.59],1.552976428535082e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,40286,102,3.18 [2.25-4.49],5.955020282639089e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,34646,90,0.87 [0.52-1.45],0.5907782614018089
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,40286,102,0.94 [0.64-1.38],0.7337293350557965
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,40492,102,3.62 [1.71-7.70],0.0008015927875565
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,34580,87,1.41 [0.69-2.88],0.3506251040553366
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,40976,105,3.06 [2.09-4.49],1.003953119762152e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,40286,102,4.78 [3.12-7.32],6.095369123034747e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,41489,105,1.34 [0.94-1.90],0.1105880344333154
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,40222,102,1.70 [1.34-2.16],1.4785670513032677e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,40286,102,1.40 [1.15-1.71],0.0009164824720034
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,40286,102,1.29 [0.86-1.94],0.2229297361503429
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,40286,102,1.02 [0.81-1.27],0.8923081575718725
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,41030,106,1.09 [0.74-1.60],0.671902634332549
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,40459,104,1.38 [1.00-1.90],0.0532147209266996
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,40845,103,2.27 [1.70-3.03],2.8116246573105623e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,41173,106,5.89 [4.12-8.42],2.0833776323376704e-22
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,41489,105,2.87 [1.78-4.64],1.5859919116862133e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,40466,107,0.86 [0.77-0.97],0.0114561494910656
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,39996,105,1.53 [1.25-1.86],2.6342362763883395e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,40286,102,0.87 [0.61-1.23],0.4190164788361559
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,40099,101,0.90 [0.65-1.25],0.5299553193504385
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,40965,106,2.52 [1.28-4.98],0.0076438023298003
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,40926,104,0.41 [0.18-0.95],0.0364077328783715
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,41030,106,1.00 [0.68-1.47],0.993874168676158
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,41395,108,1.60 [1.11-2.30],0.0115698076534485
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,40286,102,1.16 [0.74-1.82],0.517021829722178
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,40918,103,1.59 [1.26-2.01],0.0001027516692206
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,40286,102,1.30 [0.74-2.29],0.361662372605272
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,40286,102,1.23 [0.94-1.62],0.1316734753960619
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,40286,102,1.23 [0.89-1.70],0.2138616034047765
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,34646,90,1.08 [0.67-1.73],0.7663511933946741
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,34646,90,0.81 [0.52-1.27],0.3620061288607668
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,35512,93,1.56 [1.25-1.94],8.642812262232499e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,40286,102,1.22 [0.87-1.70],0.2463241969456824
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,40286,102,0.73 [0.48-1.11],0.1405550392546712
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,34297,87,0.64 [0.36-1.16],0.13951024760354
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,40734,104,3.71 [2.71-5.06],1.9370792194443808e-16
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,40286,102,0.93 [0.57-1.50],0.7588356037646866
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,35512,93,1.55 [1.09-2.21],0.0155599499827798
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,34425,87,1.36 [0.94-1.97],0.107550973777274
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,34646,90,0.76 [0.49-1.17],0.2130314444292762
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,34515,90,1.72 [1.05-2.81],0.0324747516135521
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,40976,105,1.83 [1.33-2.53],0.0002309382871255
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,40286,102,1.60 [1.03-2.47],0.0353211178209006
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,40010,107,0.99 [0.61-1.60],0.9577648743270788
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,34646,90,1.03 [0.74-1.45],0.8458193019214292
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,34518,89,1.02 [0.76-1.37],0.8737216844978017
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,40286,102,1.53 [0.91-2.58],0.1109427269139399
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,40286,102,0.97 [0.80-1.16],0.7189738911798189
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,40976,105,2.10 [1.42-3.11],0.0002038309928251
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,40286,102,0.98 [0.86-1.11],0.7367863422694516
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,40976,105,0.33 [0.24-0.46],3.1307542438373797e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,40829,105,1.52 [1.33-1.73],8.29597988039439e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,40780,105,2.43 [1.48-3.98],0.000463008146012
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,41024,108,2.93 [1.17-7.34],0.0219579654702033
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,40976,105,0.95 [0.73-1.24],0.7017414346704538
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,41030,106,1.15 [0.83-1.58],0.4141627865899279
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,35020,92,0.74 [0.47-1.17],0.1969932123524165
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,40014,107,1.01 [0.75-1.36],0.9687403362981912
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,35512,93,1.87 [1.44-2.44],2.9798421453091485e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,40725,107,0.85 [0.64-1.14],0.2851898863722278
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,35607,94,0.99 [0.69-1.41],0.9459309097746086
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,34580,87,0.36 [0.15-0.83],0.0168487968139472
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,39994,107,1.15 [0.81-1.61],0.4342910214277765
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,34910,89,1.64 [1.15-2.33],0.0058149718321078
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,41030,106,2.01 [1.30-3.11],0.0017970060520695
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,40829,105,1.11 [0.81-1.52],0.5013618512299458
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",34731,91,0.87 [0.61-1.25],0.4528001115676821
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",35622,93,1.25 [0.84-1.86],0.2724135248150811
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40829,105,0.99 [0.83-1.18],0.9043997657241216
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,35607,94,1.16 [0.88-1.52],0.2910526994043703
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,35512,93,0.98 [0.65-1.46],0.9062671359040952
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,35522,93,1.11 [0.91-1.35],0.3007515747490574
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,34646,90,3.26 [1.04-10.21],0.04213773010233
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,40656,107,0.94 [0.77-1.13],0.5069459803225354
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,40829,105,1.31 [0.97-1.75],0.0763736705134088
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40295,104,1.05 [0.87-1.27],0.6176656097779494
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,40286,102,0.96 [0.74-1.24],0.7288077098139502
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,40976,105,0.88 [0.75-1.03],0.1173218876617969
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39487,106,1.30 [0.83-2.04],0.2524038442532141
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,40976,105,1.96 [1.37-2.81],0.0002217311352557
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,35680,94,1.02 [0.65-1.59],0.9292099270653308
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,35256,93,0.93 [0.76-1.13],0.4692716104324965
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,40976,105,0.70 [0.42-1.15],0.1557788437747662
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,34910,89,0.99 [0.55-1.80],0.9805967511443796
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,41030,106,2.86 [1.51-5.41],0.0012865860026029
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,40976,105,0.76 [0.53-1.08],0.1256917704693566
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,34646,90,2.09 [1.28-3.40],0.0030690545601718
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,41030,106,0.94 [0.55-1.61],0.8204098614492991
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,41396,106,0.26 [0.10-0.68],0.0058980644143286
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,35020,92,1.13 [0.80-1.60],0.4870023588674895
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,40980,106,1.90 [0.93-3.91],0.0804217415933605
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,40092,103,1.01 [0.66-1.56],0.9464096330847056
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,40295,104,0.96 [0.82-1.12],0.5655820330711043
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,40785,106,2.20 [1.29-3.74],0.0036985780175842
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,41133,105,0.98 [0.62-1.54],0.9165142871186922
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,40286,102,1.15 [0.64-2.05],0.6441293381883677
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,41396,106,1.15 [0.80-1.64],0.4503593237713815
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,35680,94,1.74 [1.09-2.79],0.0207337433183147
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,35728,94,0.94 [0.33-2.66],0.9002069890228177
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,41173,106,2.51 [1.58-3.97],9.27698720088374e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,35728,94,1.17 [0.56-2.42],0.6763781663380435
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,35512,93,0.72 [0.44-1.18],0.1934412935812584
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,40976,105,1.23 [0.93-1.62],0.1518663624464654
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,34552,89,1.08 [0.80-1.46],0.6123668226038281
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",34731,91,0.79 [0.57-1.10],0.1585603015645611
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",34580,87,0.48 [0.26-0.87],0.0153081832039358
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",40070,107,1.29 [0.96-1.74],0.0920361953141617
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,34425,87,0.64 [0.37-1.12],0.1219513735431942
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,41387,108,4.46 [2.75-7.23],1.324162677142365e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,34910,89,1.11 [0.75-1.65],0.5903776650431871
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,40286,102,0.78 [0.59-1.04],0.0914552445286431
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,34425,87,0.77 [0.51-1.16],0.2161820002229183
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,35522,93,0.88 [0.70-1.10],0.2628145886440459
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,40286,102,1.29 [0.99-1.67],0.0568698925085326
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40829,105,2.63 [1.75-3.96],3.6158922305659374e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,35522,93,0.94 [0.78-1.14],0.5304383686789813
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,34580,87,0.86 [0.56-1.31],0.4836769554409413
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,34721,91,0.67 [0.45-0.98],0.0407770184136262
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,40070,107,1.15 [0.86-1.54],0.3304421737075437
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,34929,92,1.57 [1.13-2.19],0.0068598726757756
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,34646,90,0.84 [0.63-1.12],0.2248844164019003
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,41133,105,2.29 [1.14-4.59],0.0192458687716291
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,40070,107,2.27 [1.43-3.62],0.0005158788203045
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,34425,87,0.94 [0.68-1.31],0.7205479832330868
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,34731,91,0.93 [0.68-1.27],0.6505481998962354
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,35607,94,1.53 [0.88-2.65],0.1326417155694151
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,35020,92,1.10 [0.84-1.46],0.4892493147732051
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,35020,92,0.83 [0.40-1.73],0.6232660824783209
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,35512,93,1.14 [0.84-1.55],0.391195285298084
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,34552,89,1.65 [1.17-2.31],0.0041342711017241
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,34580,87,0.91 [0.68-1.21],0.5266598046204984
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,34552,89,1.18 [0.99-1.40],0.0651835644001834
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,40829,105,0.97 [0.79-1.19],0.7590955902653549
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,35512,93,1.25 [1.00-1.56],0.0531585032507888
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,40092,103,1.20 [0.96-1.50],0.1049735676237234
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,35522,93,0.99 [0.88-1.11],0.808891111837024
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,40092,103,0.94 [0.82-1.09],0.4092308248904064
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,34425,87,0.87 [0.65-1.16],0.3428632284106727
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,34580,87,1.26 [0.98-1.63],0.0739124779835107
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,40070,107,1.73 [1.21-2.47],0.0026997381094465
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,41114,106,0.38 [0.21-0.66],0.0006433239287297
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,41024,108,1.14 [0.72-1.81],0.5712234630559032
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,40070,107,0.79 [0.63-1.00],0.049807910969632
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,34580,87,1.41 [0.92-2.15],0.1156408588970159
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,35622,93,0.94 [0.63-1.42],0.7861094841665985
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,40606,102,0.93 [0.80-1.07],0.2996861201273982
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,41007,104,1.77 [1.28-2.47],0.0006390870796702
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,40725,104,1.83 [1.26-2.66],0.0015408735635331
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,40092,103,1.05 [0.93-1.20],0.4275806831377968
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,40094,104,1.38 [0.95-2.02],0.0924665717652216
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,41396,106,1.19 [0.83-1.70],0.3366494458330596
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,35456,93,1.14 [0.77-1.68],0.5111212108929988
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,35680,94,1.16 [0.93-1.45],0.1917113381662805
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,41396,106,1.42 [1.13-1.79],0.0030864800169209
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,41069,105,2.22 [1.27-3.87],0.004901645326435
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,34009,88,0.81 [0.48-1.40],0.4555810151406535
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK8,Kallikrein-8,39635,99,2.34 [1.55-3.54],5.103218251513189e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,35014,93,0.53 [0.24-1.13],0.1004051200486957
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,41489,105,2.85 [1.90-4.26],3.634979641262808e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,34580,87,0.83 [0.55-1.24],0.3580257970179078
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,41489,105,2.31 [1.63-3.29],2.842998068998037e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,34646,90,1.30 [0.92-1.84],0.1318834957672081
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,35607,94,2.32 [1.75-3.08],6.200991524118474e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",38793,103,1.62 [1.03-2.55],0.0362014260559601
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",34552,89,1.22 [0.75-1.98],0.4310577575776146
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",40829,105,1.13 [0.92-1.38],0.2557297824987457
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",40912,105,1.31 [1.04-1.66],0.0208277206924016
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",40070,107,1.05 [0.75-1.48],0.7741939247355212
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",34552,89,1.30 [0.84-2.00],0.2393688107813589
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",34580,87,1.01 [0.74-1.38],0.9293428993214964
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,40954,108,0.90 [0.67-1.22],0.5147103445456437
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,41489,105,1.31 [0.91-1.88],0.1539187319568467
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,41133,105,1.47 [0.82-2.65],0.1998110300448012
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,35673,92,1.03 [0.82-1.28],0.8059085491373965
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,35441,93,0.86 [0.56-1.33],0.4924848722905193
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LACTB2,Endoribonuclease LACTB2,41024,108,0.87 [0.67-1.13],0.306101796475138
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,40829,105,2.36 [1.82-3.07],1.1520487444398663e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40984,104,2.75 [2.07-3.65],2.743374947608985e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40725,107,1.23 [1.03-1.46],0.0204829695109088
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,34552,89,0.96 [0.65-1.44],0.8599975982305534
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,41183,104,0.78 [0.46-1.32],0.3626902785383609
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,34731,91,2.71 [1.38-5.31],0.0036203782510268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,34697,90,0.40 [0.16-0.98],0.0448437681902857
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,39779,103,0.70 [0.29-1.67],0.4175588335968816
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,41416,105,2.72 [2.03-3.64],1.6619918980543848e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,35512,93,0.98 [0.61-1.60],0.9509594167608464
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,40286,102,1.28 [0.91-1.78],0.1505068328622888
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,35512,93,1.00 [0.73-1.36],0.9862935140809544
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,41489,105,0.89 [0.72-1.11],0.3110534304812914
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,40829,105,1.01 [0.88-1.15],0.936201228755034
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,34646,90,0.93 [0.73-1.19],0.5635933695312251
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,40649,107,2.84 [1.92-4.20],1.6916913482359052e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,41173,106,1.49 [1.14-1.97],0.004156904181642
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,41387,108,1.07 [0.85-1.35],0.5773757993907501
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,35699,94,2.14 [0.87-5.28],0.0992692078342826
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,35622,93,1.33 [1.04-1.70],0.0252662646278146
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,39788,99,1.19 [0.77-1.85],0.4349205957058198
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,35680,94,1.30 [0.89-1.90],0.179760153853016
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,41132,108,1.18 [0.86-1.63],0.2983135798338454
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,35622,93,0.83 [0.67-1.01],0.0641936558770199
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,35673,92,1.18 [0.88-1.58],0.2664849941303164
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,41334,106,0.98 [0.70-1.36],0.9039443641402094
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,33711,88,0.89 [0.66-1.21],0.4670213370970685
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,34580,87,0.88 [0.64-1.20],0.4150082276503759
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,35622,93,1.45 [0.97-2.17],0.0673851480340451
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LEP,Leptin,41024,108,1.22 [0.94-1.57],0.1308281161055323
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LEPR,Leptin receptor,41024,108,0.78 [0.44-1.36],0.3732738829987018
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,35622,93,1.38 [1.00-1.92],0.0516608978469513
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,41024,108,3.13 [2.15-4.56],3.031780046974222e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,41132,108,1.74 [1.01-2.98],0.0446994676692885
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,35728,94,1.69 [1.01-2.82],0.046110818590453
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,40984,104,1.69 [1.28-2.25],0.0002634581460614
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,40955,105,1.28 [0.87-1.88],0.2059987152095541
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,41387,108,1.16 [0.88-1.52],0.2847755014327031
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,40997,104,6.14 [4.18-9.02],2.1479577442393394e-20
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,41183,104,0.90 [0.55-1.45],0.6546396212743708
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,40092,103,1.02 [0.84-1.24],0.8650011109727588
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,41044,103,1.11 [0.83-1.47],0.4895294596426849
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,40070,107,1.22 [0.92-1.61],0.1629142219350867
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,40976,105,2.73 [1.54-4.84],0.0006058619030928
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,41030,106,1.93 [1.17-3.18],0.0104868422001677
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,35680,94,1.18 [0.96-1.45],0.110526669924987
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,34552,89,1.27 [0.91-1.77],0.1641101341099829
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40970,108,2.52 [1.53-4.15],0.0002834535971665
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,35673,92,1.18 [0.90-1.55],0.2352020009796822
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,41523,108,4.26 [2.34-7.75],2.103836368704682e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,41326,108,3.37 [2.04-5.55],1.9066127852816628e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40286,102,2.94 [2.10-4.13],4.5445146930672065e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,41523,108,1.36 [1.04-1.78],0.0237341646639593
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,34731,91,1.33 [0.97-1.82],0.0729782285839112
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,35452,93,1.19 [0.89-1.58],0.233891491304628
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,35607,94,3.37 [2.20-5.16],2.245756664139567e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,35622,93,1.80 [1.24-2.62],0.0021657138373466
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,34580,87,0.91 [0.64-1.29],0.5774049595173101
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",34731,91,1.05 [0.84-1.32],0.6675719170607234
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),34879,89,1.07 [0.95-1.20],0.2520223982593919
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,40829,105,1.20 [0.88-1.65],0.2433251928245974
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LPL,Lipoprotein lipase,41024,108,1.00 [0.70-1.43],0.9895201053223396
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,39681,104,1.27 [0.96-1.68],0.0949597073328466
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,34552,89,0.83 [0.61-1.14],0.2569800193629575
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,34552,89,0.86 [0.63-1.17],0.3466701127097945
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,34721,91,0.95 [0.61-1.48],0.8361839352115863
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,35728,94,4.29 [2.40-7.65],8.575890963371324e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,41274,105,2.34 [1.48-3.67],0.0002456956207421
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,34522,89,1.74 [1.08-2.82],0.0239427151710697
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,40829,105,2.26 [1.26-4.07],0.0065463834820126
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,41024,108,2.62 [1.73-3.99],6.328126182911957e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,34721,91,1.13 [0.68-1.89],0.633377601791119
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,34721,91,1.08 [0.87-1.35],0.4769246822109775
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,41387,108,1.05 [0.79-1.40],0.7319597990297946
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,40829,105,1.72 [1.24-2.39],0.0012976052256959
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,35522,93,1.09 [0.69-1.73],0.7194529709362811
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,34721,91,1.02 [0.67-1.54],0.9335467790745036
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,35673,92,0.98 [0.64-1.49],0.9150065784033709
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,35512,93,0.95 [0.62-1.43],0.7903755206372529
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,40286,102,0.68 [0.44-1.05],0.085211147059894
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,34721,91,1.61 [1.19-2.18],0.0018946658214705
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,35622,93,1.24 [0.62-2.50],0.5478194633108429
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,40092,103,1.13 [0.85-1.50],0.4173298625360877
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,35020,92,1.35 [1.15-1.58],0.0002146230443148
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,40976,105,1.50 [1.00-2.23],0.0478434319427616
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,40976,105,1.79 [1.30-2.47],0.0003826220614031
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,41396,106,1.63 [1.28-2.09],9.800113226311764e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,35512,93,1.14 [0.67-1.93],0.6274639613843946
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,41523,108,2.97 [1.92-4.60],1.127536010993631e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,40092,103,1.64 [1.34-2.01],1.6953264225873714e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,40789,103,4.88 [3.16-7.56],1.0688081662857972e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,40286,102,0.73 [0.45-1.19],0.2030196173882021
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,35512,93,1.77 [1.33-2.35],9.303709017093616e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LXN,Latexin,40538,106,0.99 [0.77-1.28],0.9574324240854072
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,40796,103,2.36 [1.71-3.25],1.4120065542611897e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,40976,105,1.29 [0.82-2.03],0.2714100576914355
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,40574,104,2.71 [1.56-4.71],0.0003999364028547
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,40725,107,0.57 [0.35-0.95],0.0323145914546025
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,40092,103,1.20 [0.92-1.55],0.1734145613890002
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,40829,105,0.98 [0.80-1.19],0.8064281060606229
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,40070,107,0.89 [0.65-1.22],0.4685780359890749
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,40806,105,1.66 [1.04-2.66],0.0332550362272651
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,40092,103,1.32 [1.01-1.73],0.0415664267199052
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,34580,87,0.83 [0.65-1.05],0.1252927722922039
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,34721,91,0.85 [0.67-1.06],0.1440047049033086
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,35728,94,1.59 [0.59-4.30],0.3568773022358267
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,34425,87,0.20 [0.10-0.42],1.7127134014189818e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,34910,89,0.72 [0.54-0.97],0.0291491114488102
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,34731,91,0.78 [0.43-1.40],0.4037835515592847
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40583,106,1.42 [1.13-1.80],0.0032242044918423
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,40092,103,1.28 [0.86-1.89],0.2276443645505316
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,34721,91,0.91 [0.60-1.40],0.6747831285808839
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,35020,92,1.04 [0.82-1.33],0.7381067527020624
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,40092,103,0.88 [0.61-1.29],0.5280770331599896
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,35673,92,1.67 [0.98-2.85],0.0602180511242725
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,35512,93,0.91 [0.64-1.31],0.6259005181756585
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",34731,91,3.39 [1.58-7.29],0.0017812158820876
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,35673,92,1.04 [0.75-1.46],0.8074182735526636
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",34425,87,1.40 [0.97-2.02],0.0722843852071312
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,41183,104,0.92 [0.80-1.05],0.2214031581586478
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,41133,105,3.85 [2.29-6.47],3.881486289615905e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,34552,89,0.82 [0.60-1.13],0.236726772785857
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,34580,87,1.09 [0.57-2.09],0.7893982766044476
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,34552,89,1.11 [0.85-1.45],0.4434272854385399
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,35607,94,1.35 [0.92-1.97],0.1254988668250603
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,35522,93,1.00 [0.73-1.36],0.9991958464672972
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40976,105,0.92 [0.78-1.09],0.3474368112536943
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,40092,103,1.00 [0.83-1.19],0.9652348791348816
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40649,107,0.95 [0.82-1.11],0.5437827213766292
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,34425,87,0.69 [0.41-1.16],0.1616794068626585
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,40976,105,0.74 [0.50-1.10],0.1309988800017151
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,35020,92,0.87 [0.66-1.15],0.3171752226020349
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,34425,87,1.05 [0.91-1.20],0.514146830207959
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,40070,107,0.99 [0.71-1.38],0.9486310396385949
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,41024,108,2.56 [1.35-4.85],0.0039463003861639
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",34840,89,0.81 [0.64-1.03],0.0913882073581589
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,40649,107,0.68 [0.33-1.40],0.2910743421789709
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,41056,104,1.16 [0.65-2.08],0.6128471954636039
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,40656,107,1.48 [0.89-2.45],0.1297544995096147
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,40092,103,1.01 [0.84-1.22],0.9000197188130212
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAX,Protein max,40070,107,0.99 [0.84-1.16],0.8709623682998965
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,41523,108,1.46 [1.11-1.92],0.0065681147745684
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,35225,92,1.03 [0.86-1.24],0.7167318183101075
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,41173,106,1.76 [1.09-2.84],0.0214456760925687
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",35622,93,1.16 [0.76-1.77],0.4910167028700564
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,34646,90,0.94 [0.75-1.18],0.6186315306857706
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,40829,107,1.03 [0.70-1.52],0.8644266435045264
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,35522,93,0.79 [0.35-1.78],0.568552118534779
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40725,107,0.92 [0.72-1.17],0.4807282840961103
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",35495,93,0.92 [0.56-1.51],0.7348429154003235
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MDK,Midkine,41011,105,1.41 [1.07-1.86],0.0133964450045156
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,34721,91,0.51 [0.26-1.01],0.0533710825173439
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",34731,91,1.05 [0.84-1.30],0.6737578398951432
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,40092,103,0.92 [0.73-1.15],0.4615241521938302
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,34552,89,0.93 [0.60-1.45],0.7550180291791851
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,40984,104,1.26 [0.81-1.94],0.3019629554378668
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,34552,89,1.17 [0.67-2.04],0.5890353284573677
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,41395,108,1.65 [0.75-3.63],0.2139719091862064
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,35673,92,1.06 [0.54-2.07],0.8598211671049936
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,34910,89,1.03 [0.42-2.55],0.9427833013581725
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,35522,93,1.03 [0.78-1.35],0.827290272389708
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MEP1B,Meprin A subunit beta,41024,108,0.89 [0.77-1.02],0.0861961521002618
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,40984,104,1.25 [0.62-2.51],0.5349328187041018
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,41489,105,2.01 [1.05-3.82],0.0342989606625805
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,41030,106,0.93 [0.81-1.07],0.3222506308971262
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,41127,108,1.81 [0.77-4.24],0.1727226681934059
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,40070,107,0.99 [0.55-1.77],0.9754962474022753
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40976,105,0.95 [0.77-1.17],0.6368651246399233
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,41334,106,1.00 [0.74-1.34],0.991310746527084
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,40295,104,1.07 [0.76-1.51],0.6846908713604738
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,34721,91,1.09 [0.83-1.44],0.5233690765582245
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,34910,89,1.48 [0.80-2.74],0.2161689273600991
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,41523,108,1.25 [0.82-1.89],0.3001176603255189
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,41030,106,1.65 [1.14-2.40],0.0085904282274857
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,41123,104,0.78 [0.65-0.94],0.0078926884695149
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,40976,105,0.93 [0.81-1.07],0.3022453788116416
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,41133,105,2.06 [1.39-3.04],0.0003094106255963
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,34721,91,1.08 [0.82-1.43],0.5747364193170027
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40976,105,1.03 [0.91-1.16],0.6085756157532263
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,40965,106,0.88 [0.69-1.14],0.3348554136041261
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,40286,102,1.81 [1.32-2.46],0.0001980906081035
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,35512,93,0.95 [0.79-1.14],0.5929645651661071
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,35607,94,0.93 [0.75-1.15],0.4998741946070705
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,40725,107,0.89 [0.75-1.05],0.1688129027138268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,34646,90,1.06 [0.65-1.73],0.8057890586359572
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,34425,87,0.83 [0.59-1.17],0.2784999804231963
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,40976,105,1.35 [1.11-1.64],0.0025998365338039
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,40829,105,1.08 [0.87-1.33],0.4841392312945256
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,39541,101,0.95 [0.78-1.15],0.5783664148288706
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,40929,103,1.17 [0.88-1.55],0.2853968425688158
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,41084,104,1.98 [1.51-2.61],9.798402324374768e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,40070,107,1.48 [0.88-2.49],0.1439118831141985
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,35673,92,1.48 [1.18-1.85],0.0005538642342152
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,41030,106,1.65 [1.21-2.25],0.0014596043946441
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,40230,104,1.80 [1.24-2.60],0.0017887660470955
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,41317,108,1.19 [0.96-1.49],0.1161204374055521
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,40968,105,0.98 [0.74-1.30],0.884436458041298
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",34552,89,0.65 [0.41-1.03],0.0689781865599281
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,34721,91,0.87 [0.60-1.28],0.4907621593336017
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,35020,92,0.84 [0.52-1.37],0.4837283785783356
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,40959,107,1.01 [0.86-1.19],0.903968456831138
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,34910,89,1.03 [0.76-1.40],0.8399418205881708
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,41396,106,1.78 [1.07-2.94],0.0259145385530102
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,35607,94,0.87 [0.41-1.84],0.7244246148491762
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,35020,92,0.87 [0.51-1.48],0.6093617359976378
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,34425,87,1.23 [0.75-2.01],0.4086609935487142
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,34425,87,1.12 [0.89-1.40],0.3330600906035641
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,40295,104,0.88 [0.69-1.12],0.2899919888573035
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,40829,105,1.02 [0.83-1.24],0.8662823497322728
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,41123,104,0.88 [0.71-1.09],0.2312908218180794
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,41030,106,1.31 [0.94-1.82],0.111093173755306
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,35441,92,1.03 [0.66-1.60],0.9119488491801367
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,35699,94,3.19 [1.78-5.74],0.0001037105527052
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,34721,91,1.02 [0.76-1.37],0.8973443877033438
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",34552,89,1.20 [0.76-1.89],0.4340361998462245
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",35622,93,0.81 [0.42-1.55],0.5272481787346608
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",40070,107,0.90 [0.47-1.71],0.747899010347068
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",34359,87,0.64 [0.28-1.46],0.2870982806588252
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",35622,93,0.95 [0.71-1.27],0.7287835203473324
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",34646,90,1.54 [0.93-2.57],0.0955125887619409
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,40768,105,1.66 [1.28-2.15],0.0001103128459737
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,34721,91,0.54 [0.29-0.99],0.0452147390217808
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,40917,107,1.38 [1.08-1.75],0.0104006036518759
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,41387,108,2.20 [1.56-3.10],7.385122805368e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,41133,105,0.88 [0.70-1.12],0.301286112390693
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,35159,93,1.00 [0.74-1.36],0.9935164503285724
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,40295,104,0.88 [0.64-1.23],0.4665099868487186
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,34646,90,0.98 [0.79-1.23],0.8873483473100133
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",35607,94,0.81 [0.36-1.86],0.6257327812509781
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,35020,92,0.91 [0.76-1.08],0.2838248856068773
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",35522,93,0.91 [0.73-1.15],0.4443822986975335
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,40295,104,1.17 [0.73-1.88],0.5200852888188268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,34552,89,1.40 [1.15-1.71],0.0008616045395016
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,35522,93,1.00 [0.84-1.19],0.9867525091584578
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,35512,93,0.87 [0.71-1.06],0.1648057655943438
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,35020,92,1.16 [0.83-1.61],0.3948377019814617
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,40070,107,1.41 [1.02-1.94],0.0354342775204433
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,40829,105,1.08 [0.98-1.19],0.131065862365854
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,35680,94,0.85 [0.69-1.06],0.1461616303780186
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,34425,87,0.87 [0.52-1.48],0.6167265626248631
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,40286,102,1.08 [0.87-1.35],0.4646231938393715
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,34910,89,0.73 [0.38-1.41],0.3523445426125411
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",35673,92,1.40 [1.10-1.78],0.0064500331822868
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",34731,91,1.16 [0.95-1.42],0.1536102310355554
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,35622,93,1.02 [0.76-1.37],0.90360132685994
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,35673,92,0.97 [0.79-1.18],0.7283279546879591
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,34552,89,0.90 [0.56-1.45],0.6571126078546646
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,34425,87,0.79 [0.46-1.34],0.3759597579508776
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,35680,94,1.07 [0.90-1.27],0.460248117349784
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",34552,89,0.89 [0.51-1.53],0.6659659156063676
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,34731,91,1.33 [1.03-1.72],0.0314424860152559
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,34731,91,1.53 [1.16-2.02],0.0028918875875712
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,34721,91,0.99 [0.79-1.24],0.9474991851153084
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",34721,91,1.11 [0.76-1.62],0.5840775097475508
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,35622,93,1.18 [0.73-1.90],0.4913822630866884
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,40286,102,1.08 [0.83-1.39],0.5755510746187202
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,41030,106,0.85 [0.58-1.23],0.3897609605867046
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,34580,87,0.92 [0.58-1.46],0.7163986297326748
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,34552,89,1.06 [0.72-1.56],0.7723858724197306
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,34910,89,1.14 [0.92-1.40],0.2407649298284001
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,41116,104,0.88 [0.63-1.23],0.4491512594057083
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,40092,103,1.01 [0.73-1.42],0.9340138679749406
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,34552,89,0.81 [0.54-1.21],0.2980059576950495
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,34721,91,0.92 [0.77-1.08],0.3082040019074725
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,40538,105,0.99 [0.74-1.32],0.9459550317467268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,35512,93,1.21 [0.87-1.69],0.2604998079432036
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NADK,NAD kinase,41024,108,1.19 [0.91-1.55],0.2095467009637568
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,34580,90,0.80 [0.53-1.22],0.3101476526528155
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,34666,91,0.69 [0.48-1.00],0.0475448570295717
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,34910,89,3.79 [1.55-9.29],0.0034995629382143
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,40092,103,1.06 [0.78-1.44],0.6929657129321584
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,35456,93,0.97 [0.60-1.55],0.8851412315952885
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,35607,94,1.26 [0.72-2.18],0.4178426136406424
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",35622,93,0.95 [0.62-1.43],0.7908309007409559
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,41133,105,4.26 [2.45-7.39],2.577095152304389e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,40286,102,1.22 [0.94-1.59],0.1347442497965698
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,41173,106,1.69 [0.98-2.89],0.0574681131441478
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,41030,106,1.44 [0.77-2.70],0.2521252828430756
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,41387,108,1.23 [0.78-1.93],0.3735911970709602
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,40909,105,0.99 [0.81-1.21],0.9196219856613606
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,41183,104,0.88 [0.75-1.04],0.1303526763257134
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,40286,102,1.16 [0.87-1.53],0.3113430599071561
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,40918,105,3.52 [2.33-5.30],1.980037765239988e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,35522,93,3.74 [2.49-5.61],2.133917926059856e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,41396,106,3.26 [1.84-5.75],4.707978431458647e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,40070,107,0.86 [0.63-1.16],0.311453197449356
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,35512,93,0.91 [0.64-1.29],0.5832746690631458
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,34583,90,1.07 [0.61-1.89],0.8178607063372504
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,35522,93,0.83 [0.66-1.05],0.1189605069987475
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",40092,103,1.16 [0.96-1.39],0.1172395673391753
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,34552,89,1.44 [0.96-2.15],0.0775154275463141
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,34552,89,0.88 [0.64-1.22],0.4456332001529487
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,34646,90,1.21 [0.68-2.15],0.524827009629232
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,40970,108,3.95 [2.58-6.05],2.724953943214181e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,41133,105,2.76 [1.87-4.07],3.525295022421799e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,34646,90,0.82 [0.55-1.22],0.33121726508072
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,34646,90,1.28 [0.77-2.13],0.340300342357843
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,39939,107,2.21 [1.68-2.90],1.1078716083164944e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,35020,92,0.88 [0.65-1.19],0.4157934644306812
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,41133,105,0.69 [0.46-1.04],0.0763593646365307
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,41183,104,1.02 [0.56-1.84],0.9584449818866324
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,35512,93,1.05 [0.89-1.24],0.5586955408055827
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,35622,93,2.14 [1.14-4.03],0.018133798288354
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,35699,94,1.00 [0.76-1.34],0.972695070206854
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,41489,105,2.18 [1.22-3.88],0.0084798789396094
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,34646,90,1.09 [0.87-1.37],0.4498454791123955
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40976,105,0.87 [0.73-1.04],0.1361705813734793
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40286,102,1.05 [0.79-1.41],0.727850177285315
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,34731,91,0.96 [0.73-1.26],0.7734618804216322
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,35622,93,0.68 [0.37-1.26],0.2230937783459919
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,34552,89,0.85 [0.64-1.13],0.2602516434835353
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,35020,92,1.09 [0.80-1.49],0.5796555720838351
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,40092,103,1.08 [0.75-1.54],0.6847937761477556
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",35522,93,0.99 [0.82-1.20],0.9147713486449082
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,34552,89,0.94 [0.69-1.29],0.7201323587544524
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,34552,89,1.11 [0.68-1.80],0.6799406335424371
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,40725,107,1.67 [0.46-6.09],0.4398209604044678
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,35673,92,1.25 [0.69-2.27],0.4667322696797161
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,35607,94,0.61 [0.23-1.64],0.331265093373387
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,34065,88,2.90 [1.52-5.56],0.0012782220531758
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,41042,106,1.31 [0.84-2.04],0.2271533563100771
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,41030,106,0.86 [0.68-1.08],0.2004475837092901
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,40092,103,1.19 [0.93-1.54],0.170839803553026
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,34731,91,0.74 [0.49-1.11],0.1431554599384664
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,35544,92,0.85 [0.65-1.11],0.2220318504080167
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,34721,91,0.90 [0.65-1.25],0.5377017813580228
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,34580,87,1.16 [0.79-1.71],0.4381015971300186
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,34646,90,1.00 [0.38-2.61],0.999195650291551
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,41056,104,1.11 [0.54-2.28],0.7726605050522212
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,35375,93,1.34 [1.04-1.72],0.0224252199681355
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40725,107,1.12 [0.92-1.38],0.2632601138747881
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,34425,87,0.55 [0.28-1.10],0.0915156853563417
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,35622,93,1.26 [0.99-1.60],0.0643326479521528
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,41030,106,2.84 [1.53-5.27],0.0009721309586129
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,34552,89,0.95 [0.78-1.16],0.6092210226873667
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",40070,107,1.46 [1.10-1.94],0.0093882782230649
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",34552,89,1.58 [1.05-2.39],0.029572286016566
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",40070,107,1.95 [1.65-2.29],2.4391078721011988e-15
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,41523,108,,
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,35680,94,1.37 [0.57-3.28],0.4852767444491075
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,41523,108,1.80 [1.12-2.91],0.0157878137991913
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,35081,91,2.63 [1.84-3.75],9.240404193025145e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,41024,108,3.17 [2.25-4.47],5.190286508364253e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,34646,90,1.27 [0.72-2.22],0.4057785545199457
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,34646,90,0.88 [0.70-1.09],0.2476628363127366
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,35673,92,2.14 [1.48-3.09],4.743819440464037e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,40295,104,1.06 [0.93-1.21],0.3822368499763818
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,40976,105,1.70 [1.24-2.33],0.0010389492196581
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,34552,89,0.61 [0.33-1.16],0.1301041388737962
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,40092,103,1.10 [0.91-1.33],0.3413921775762875
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,41030,106,1.79 [1.24-2.59],0.0019149969446217
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,35680,94,0.94 [0.52-1.70],0.8439980932010613
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,41024,108,1.50 [0.95-2.36],0.0812501663292295
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,41396,106,1.00 [0.77-1.30],0.9919106876482464
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,41024,108,2.98 [1.75-5.07],5.452035058005688e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,35699,94,0.78 [0.63-0.97],0.0251288374339365
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,35622,93,0.74 [0.38-1.44],0.3694260443933425
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,41249,106,2.91 [1.64-5.14],0.0002407859481251
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,41030,106,2.63 [1.62-4.28],0.000101004922289
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,40286,102,1.34 [1.01-1.77],0.0453445159963066
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,34721,91,1.43 [0.92-2.22],0.1143886116672416
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,41387,108,1.00 [0.77-1.29],0.971101626066387
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",35673,92,1.00 [0.77-1.32],0.9718643058026066
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,35607,94,2.37 [1.75-3.22],3.2507252461297924e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,40909,105,0.90 [0.74-1.09],0.2933856123626707
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,41133,105,1.27 [0.95-1.68],0.1011383818085272
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,40976,105,0.62 [0.38-1.03],0.0632516220110598
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,40092,103,1.09 [0.71-1.69],0.6820525130051802
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,41024,108,1.21 [0.62-2.34],0.5746038708552206
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,41387,108,0.87 [0.40-1.89],0.7204712184314799
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,41024,108,1.26 [1.09-1.45],0.0014603468285915
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,40976,105,0.92 [0.74-1.13],0.4257255430851293
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,35512,93,1.17 [0.98-1.39],0.0800644062681755
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,41327,106,1.35 [0.87-2.11],0.183567481197282
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,41489,105,1.05 [0.80-1.38],0.7265612765364113
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,34731,91,1.04 [0.48-2.23],0.929036137785096
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,34552,89,1.42 [1.11-1.82],0.0051523306725517
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,35461,93,1.05 [0.84-1.32],0.658598973915596
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40829,105,0.75 [0.55-1.04],0.0834781712718163
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,41030,106,1.05 [0.75-1.46],0.7874849293619387
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,34646,90,0.84 [0.66-1.08],0.1708532246400558
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,34552,89,0.89 [0.46-1.74],0.7393434727132665
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,34552,89,1.17 [0.68-2.00],0.5804647427978451
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,40070,107,1.42 [0.99-2.04],0.0551313447455414
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,34646,90,0.80 [0.41-1.54],0.4955374870703295
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,40596,107,0.80 [0.61-1.05],0.1015170689644233
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,35622,93,2.10 [1.50-2.93],1.5205212504963051e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,40010,107,1.11 [0.83-1.49],0.4873834180230376
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,35020,92,0.76 [0.52-1.12],0.1671571943119313
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,35522,93,0.90 [0.68-1.20],0.4893913709418148
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,40829,105,2.06 [1.27-3.34],0.0034261423805652
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,41030,106,2.70 [1.92-3.80],1.2054096543008044e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,35020,92,0.95 [0.68-1.32],0.7605362000061492
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,33597,87,1.23 [1.04-1.46],0.0181835794729564
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,40623,107,0.91 [0.68-1.22],0.5225224192094313
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,41183,104,1.82 [1.19-2.77],0.0055947528268084
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,40829,105,0.88 [0.68-1.14],0.3329288712424857
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,34580,87,1.06 [0.71-1.58],0.789513897398204
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,35607,94,0.88 [0.73-1.05],0.155269605506631
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,34731,91,1.02 [0.76-1.37],0.8806161938086817
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,40829,105,1.70 [1.34-2.15],1.11567115175103e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,35599,94,7.66 [3.72-15.77],3.382501925782464e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,35607,94,1.53 [1.13-2.08],0.0057255385702242
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,41056,104,2.60 [1.57-4.29],0.0001992378363352
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,40780,105,1.11 [0.88-1.41],0.3862764938119737
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,41249,106,6.65 [3.37-13.15],5.000347389397026e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,34721,91,0.67 [0.37-1.22],0.1892050688630782
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,34580,87,1.15 [0.82-1.62],0.4064441360523907
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,35522,93,0.93 [0.66-1.32],0.6979243489603377
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,35622,93,1.06 [0.78-1.44],0.71551968896099
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",34731,91,0.99 [0.74-1.32],0.9555031929035724
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,41387,108,1.05 [0.94-1.19],0.3768296129874686
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,40807,105,1.21 [0.78-1.87],0.3988699129059885
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,34552,89,0.88 [0.63-1.23],0.454371633754739
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,40286,102,1.28 [1.03-1.59],0.0232551708590058
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,40010,107,0.83 [0.64-1.08],0.166225447391957
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,40725,107,0.90 [0.78-1.05],0.1790303031414001
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,35622,93,1.16 [1.01-1.33],0.035916993666403
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",35020,92,0.62 [0.40-0.96],0.0332725134935505
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40295,104,1.20 [0.89-1.60],0.2307625498271198
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,34731,91,0.53 [0.31-0.90],0.0189538314140676
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,34360,87,0.98 [0.66-1.46],0.9295062553637816
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,40070,107,0.91 [0.68-1.22],0.5408486279210334
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,34646,90,1.32 [0.88-1.98],0.1831574587822868
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,35322,93,3.14 [2.12-4.64],9.953434718596798e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,35607,94,2.36 [1.65-3.38],2.866515809408394e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,34552,89,1.25 [1.04-1.51],0.0205679539169462
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,41313,108,2.10 [1.11-3.98],0.0232494336630732
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,41030,106,1.15 [0.61-2.15],0.6682495870219259
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,40286,102,1.02 [0.71-1.49],0.8981545450304256
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,35020,92,1.07 [0.83-1.38],0.5802904240421591
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,41030,106,0.97 [0.70-1.35],0.8723137993211272
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,40976,105,1.24 [0.98-1.56],0.0733722943125525
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,34910,89,1.13 [0.73-1.74],0.578616860089088
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,34425,87,1.21 [0.62-2.34],0.5741715305297859
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,40070,107,0.92 [0.65-1.30],0.6431271829565872
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,35522,93,1.26 [0.70-2.27],0.4358026394125972
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,34580,87,1.19 [0.99-1.43],0.0644271317859014
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,34836,89,1.49 [1.01-2.19],0.0424371116968136
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,35622,93,0.90 [0.69-1.19],0.4747877741842271
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,41354,105,1.68 [0.85-3.33],0.1391008635118559
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,35622,93,2.31 [1.25-4.29],0.0079371931228289
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,41024,108,2.74 [1.82-4.14],1.573868479290094e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,35522,93,1.03 [0.59-1.79],0.9293583293525146
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,35522,93,3.23 [1.86-5.61],3.093967608594375e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,35512,93,1.23 [0.76-1.97],0.3977685494338641
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,34425,87,0.84 [0.57-1.23],0.3707084999692616
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,35512,93,1.28 [0.89-1.83],0.1826162638832129
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,41523,108,1.46 [0.95-2.22],0.0814307992106241
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,35522,93,0.86 [0.67-1.12],0.2658643135134193
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,35673,92,0.81 [0.66-0.99],0.0436421662651133
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,41332,106,3.88 [3.00-5.02],6.881917573429454e-25
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,40829,105,2.42 [1.47-3.97],0.0004797453011374
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,41387,108,1.06 [0.79-1.41],0.6995225466140051
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD6,Programmed cell death protein 6,41024,108,0.98 [0.77-1.24],0.8771970510653986
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,34425,87,0.77 [0.49-1.23],0.2722185041741248
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",34425,87,0.59 [0.34-1.01],0.056656755781299
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",34552,89,0.79 [0.52-1.19],0.2529680554678803
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",34910,89,0.89 [0.73-1.08],0.2240536982538848
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,41523,108,0.68 [0.54-0.85],0.0008057387041724
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,41183,104,0.68 [0.56-0.82],8.476106207290451e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,40092,103,1.93 [1.19-3.13],0.0072769778926777
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,41024,108,1.79 [1.02-3.16],0.043359496621632
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,41523,108,1.50 [0.91-2.47],0.1110222254707182
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,34425,87,0.54 [0.29-0.99],0.0471625428587187
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,34910,89,1.19 [0.56-2.56],0.6522809864226693
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,35680,94,0.86 [0.62-1.19],0.3599534340323582
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,34425,87,0.82 [0.57-1.20],0.3131886782124774
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,35622,93,0.96 [0.81-1.13],0.6257730108754542
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,41183,104,0.95 [0.83-1.09],0.4592176520602341
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",40092,103,0.92 [0.64-1.33],0.6708189249184009
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,34721,91,0.99 [0.67-1.45],0.9424431982969652
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,34425,87,0.79 [0.49-1.28],0.3460982784639892
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,34552,89,1.16 [0.85-1.59],0.3403614158325085
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,34646,90,1.30 [0.86-1.95],0.2156844279245879
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,41523,108,1.13 [0.54-2.38],0.7491191698688653
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,41030,106,1.03 [0.77-1.38],0.8368502428908053
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,41030,106,1.29 [0.75-2.25],0.3596161301344786
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,34731,91,1.26 [0.68-2.35],0.4655799763709295
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,34910,89,1.83 [1.15-2.91],0.0107564776589521
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,35699,94,0.88 [0.42-1.85],0.7296991245492845
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,34646,90,1.02 [0.87-1.21],0.7775195247915929
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,35464,94,0.80 [0.65-0.98],0.0274699721575318
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,40070,107,0.95 [0.69-1.30],0.7433804359797318
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,34425,87,1.12 [0.79-1.59],0.5418737003989267
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,34721,91,0.90 [0.64-1.27],0.5559223829648806
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40762,104,0.94 [0.75-1.18],0.6084368982513177
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,35699,94,1.17 [0.89-1.55],0.2577654039123899
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",35673,92,1.00 [0.69-1.45],0.992947830716128
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,41489,105,3.10 [2.29-4.20],2.3047845967777225e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,41326,108,0.87 [0.58-1.30],0.4925907770636835
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,35272,92,0.92 [0.48-1.78],0.8109147882094776
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,34552,89,0.83 [0.57-1.23],0.3620125628812911
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,34721,91,0.88 [0.60-1.29],0.5062796401596343
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,34646,90,0.90 [0.70-1.14],0.3672685939371964
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,35622,93,0.95 [0.80-1.12],0.5242815564141927
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,35522,93,1.74 [1.25-2.41],0.0010299689459664
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,34425,87,0.95 [0.75-1.20],0.6605640917411912
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40725,107,3.19 [1.87-5.44],2.025465833788783e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,34910,89,1.11 [0.68-1.81],0.6793301121225509
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,35699,94,1.52 [0.69-3.37],0.3016464496085258
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PI3,Elafin,40483,103,1.78 [1.42-2.24],7.974769878367803e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",35622,93,0.77 [0.59-1.00],0.0473871186548582
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,40515,104,2.19 [1.45-3.32],0.0001991830126737
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40976,105,1.24 [0.95-1.62],0.1192565018859437
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,41030,106,4.07 [2.62-6.33],4.37663620590925e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,34646,90,1.08 [0.77-1.52],0.6498320099008699
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,41030,106,3.26 [2.22-4.80],1.771831902985804e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,41024,108,1.92 [1.38-2.66],9.828860075940508e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,34910,89,0.88 [0.66-1.17],0.3784642300319129
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,34360,87,0.65 [0.45-0.93],0.019960866461661
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,35673,92,1.74 [0.82-3.67],0.1473444805881553
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,34552,89,1.25 [0.92-1.70],0.1611511133849681
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,41054,103,1.23 [0.96-1.58],0.1079002936523501
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,35020,92,0.79 [0.60-1.05],0.1104279351371403
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,40725,107,1.22 [0.91-1.62],0.1873213418373506
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,41133,105,3.40 [1.93-6.00],2.330982825717843e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,41459,107,1.20 [0.81-1.78],0.3532845133449341
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",40933,106,1.43 [1.14-1.79],0.0021877471301837
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,41183,104,0.95 [0.78-1.15],0.5738124366494524
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,41030,106,2.41 [1.38-4.22],0.0020174532288118
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,41395,108,1.53 [1.10-2.13],0.0111573438827432
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,41030,106,1.67 [1.10-2.53],0.0162452193023678
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,40728,103,3.37 [2.00-5.69],5.470701607714467e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",35607,94,0.84 [0.61-1.16],0.2803456578706125
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",34646,90,0.73 [0.42-1.26],0.2624659061060381
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",35607,94,0.91 [0.75-1.12],0.3794781798514223
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,35607,94,0.89 [0.66-1.18],0.4097685548434991
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,34815,91,0.60 [0.24-1.47],0.2629539737704477
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,40070,107,1.26 [0.80-1.99],0.3272930275037765
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLIN3,Perilipin-3,41024,108,1.06 [0.72-1.57],0.7634362234257055
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLPBP,Pyridoxal phosphate homeostasis protein,41024,108,0.87 [0.67-1.12],0.2725717447420539
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,35549,94,0.92 [0.66-1.29],0.6470234097667931
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,41378,108,1.45 [0.90-2.36],0.1284844395594678
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,40092,103,1.13 [0.71-1.79],0.60625701931879
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,35607,94,0.80 [0.38-1.69],0.5616374823424161
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,40976,105,0.87 [0.71-1.07],0.1994066976025611
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,41339,108,2.49 [1.29-4.83],0.0068403506868604
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,40896,107,0.66 [0.45-0.95],0.0261210491566914
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40842,107,0.95 [0.87-1.04],0.2838373554540513
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,34552,89,0.75 [0.53-1.07],0.1179635538081759
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,34552,89,0.91 [0.65-1.29],0.6115394483848556
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,34721,91,1.15 [0.80-1.66],0.4535360063690163
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,40003,107,0.93 [0.80-1.07],0.2974060894205941
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,35699,94,0.91 [0.67-1.24],0.5572767903585738
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,35607,94,1.33 [1.05-1.69],0.0187442610282769
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,40984,104,1.00 [0.94-1.06],0.950466232498688
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,34731,91,0.87 [0.61-1.26],0.474525127196843
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,34580,87,1.08 [0.69-1.70],0.727882650889442
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40286,102,0.82 [0.68-0.99],0.0364172945561449
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,40829,105,3.02 [0.97-9.43],0.0564251900404953
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,41133,105,2.92 [1.66-5.14],0.0001969678914198
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,34646,90,1.30 [0.89-1.91],0.1743728968973492
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,34646,90,0.86 [0.42-1.76],0.6808488055382396
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40829,105,1.76 [1.31-2.39],0.0002217900833299
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,34731,91,0.88 [0.65-1.17],0.3676588632082144
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,35699,94,0.55 [0.30-1.02],0.0566382348373918
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,40295,104,1.57 [0.97-2.57],0.0681906033342812
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,41183,104,0.99 [0.55-1.79],0.9652139289337922
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,35680,94,0.90 [0.53-1.51],0.680888545023662
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,35459,94,0.73 [0.58-0.92],0.0068822676267371
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,41387,108,1.09 [0.76-1.56],0.6262156580864682
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,41043,107,0.92 [0.77-1.10],0.3625706068105627
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,35020,92,0.93 [0.66-1.31],0.6672227304003637
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",35680,94,0.81 [0.57-1.14],0.2209117403611713
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,34646,90,1.26 [0.72-2.21],0.4267752990083747
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,40092,103,1.61 [1.08-2.40],0.0198418590689207
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,34646,90,0.87 [0.60-1.27],0.4854921125847143
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,35673,92,0.84 [0.57-1.23],0.3624290399243011
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,40829,105,1.05 [0.79-1.39],0.7415643692825045
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,35512,93,0.93 [0.73-1.18],0.5558127267684839
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,41133,105,0.94 [0.78-1.13],0.4941242810877878
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,35020,92,0.94 [0.70-1.26],0.6801089853265161
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,35622,93,0.85 [0.65-1.10],0.2217501398184496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,35622,93,1.95 [1.40-2.71],7.221798898817382e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R2,Protein phosphatase inhibitor 2,41024,108,0.88 [0.71-1.09],0.2312700936711587
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,41489,105,1.15 [0.96-1.37],0.132214897153142
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,35522,93,0.91 [0.77-1.08],0.2944116765530368
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,40725,107,0.97 [0.64-1.47],0.9014276684178634
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,34721,91,0.82 [0.59-1.14],0.2353393681112111
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,40942,105,0.95 [0.80-1.12],0.5337577627665849
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,40092,103,1.25 [0.99-1.60],0.0647258843637385
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,34425,87,0.79 [0.35-1.81],0.5837805323047538
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,35680,94,2.05 [1.25-3.38],0.0046022632683578
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,35512,93,1.35 [1.05-1.74],0.0197847269234221
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,41272,106,1.82 [1.14-2.91],0.0126574904336176
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,39884,103,0.90 [0.73-1.10],0.3118467870689307
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,35100,94,1.21 [0.90-1.64],0.2109049456898005
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40286,102,1.19 [0.94-1.51],0.1381654974635695
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",41489,105,0.91 [0.71-1.16],0.4534574527569306
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,41396,106,1.01 [0.76-1.33],0.965451801446262
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,40286,102,1.21 [0.70-2.12],0.4925231353757334
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,40984,104,3.03 [1.50-6.11],0.0019751545094204
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,35680,94,1.17 [0.81-1.69],0.3944842179673359
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,35680,94,0.61 [0.42-0.88],0.0092647711560303
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40286,102,0.97 [0.70-1.34],0.8561649099952933
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,34721,91,1.57 [0.94-2.61],0.0841328673604295
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,41024,108,0.88 [0.72-1.08],0.2256039838818367
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,35536,93,0.89 [0.70-1.13],0.342569992136391
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,40286,102,1.05 [0.71-1.55],0.8133497285041935
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,34552,89,0.61 [0.34-1.11],0.1060849673142899
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,34910,89,0.91 [0.78-1.07],0.2684661211137478
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,40092,103,0.86 [0.66-1.12],0.2653808298353474
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,41387,108,1.04 [0.83-1.30],0.7345419597154021
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,35607,94,2.19 [1.59-3.01],1.3014780745269246e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,41114,106,0.76 [0.39-1.47],0.4174003909722588
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,34552,89,1.04 [0.60-1.80],0.9000262592088488
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,40976,105,0.88 [0.65-1.19],0.4096960074826932
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,35728,94,1.25 [0.58-2.67],0.5652187154993422
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,34662,89,1.15 [0.87-1.52],0.3141412849045432
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,34646,90,0.69 [0.41-1.15],0.1508647358422389
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,34731,91,2.45 [1.55-3.88],0.0001262136103812
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,41173,106,1.70 [1.32-2.17],2.855429600452441e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,34646,90,1.31 [0.80-2.14],0.2771532081685335
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRSS27,Serine protease 27,40897,108,0.84 [0.55-1.29],0.4350478030922401
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,35607,94,0.79 [0.48-1.32],0.3766209369674451
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,40855,102,2.46 [1.70-3.58],2.188335594651024e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,40070,107,0.92 [0.79-1.07],0.2755281194961446
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,41396,106,1.06 [0.53-2.12],0.8634365098346148
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,39979,103,1.30 [0.96-1.78],0.0910961143984377
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,35020,92,1.67 [1.05-2.67],0.0310659217582226
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,35350,92,2.16 [1.34-3.49],0.0016493075295827
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,35522,93,1.72 [1.19-2.49],0.0041150936950422
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,35522,93,1.02 [0.94-1.10],0.6269822763765658
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,40725,107,1.01 [0.87-1.18],0.860435539642838
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,40976,105,0.87 [0.65-1.17],0.3639595344649163
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,40092,103,0.97 [0.66-1.43],0.8798849421165512
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,34425,87,1.33 [0.70-2.54],0.378253843003728
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,35622,93,1.16 [0.80-1.69],0.4371696387899935
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,34721,91,1.09 [0.78-1.52],0.6080979202868486
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,40829,105,1.05 [0.78-1.42],0.7415047718867852
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,40664,106,1.33 [0.85-2.09],0.2157651618787689
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,40538,107,1.96 [1.25-3.05],0.0031813054447
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,40976,105,1.19 [0.86-1.65],0.3062058964427278
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,34646,90,1.13 [0.81-1.58],0.4686555146892288
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,40976,105,0.92 [0.76-1.11],0.3729759090734956
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,40092,103,0.63 [0.45-0.89],0.0097517740486204
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,33668,88,0.86 [0.71-1.03],0.0944256899115837
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",40070,107,0.65 [0.37-1.15],0.1394074553543708
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,40718,106,3.44 [2.40-4.93],1.9141588055726257e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,34383,90,0.81 [0.55-1.19],0.2779350850543243
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,35673,92,1.07 [0.85-1.36],0.5628775571851388
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,34721,91,0.95 [0.74-1.23],0.7177261304089559
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40976,105,1.47 [1.11-1.96],0.0075239226470916
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,40070,107,1.57 [1.01-2.43],0.0433665116069665
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,40295,104,1.75 [1.28-2.38],0.0003856256125374
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,34646,90,1.36 [0.99-1.85],0.0569230133075141
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40725,107,1.12 [0.91-1.39],0.2933960859280264
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,41123,104,0.82 [0.69-0.99],0.0340794668029483
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,34582,90,1.33 [0.87-2.04],0.1912648714072012
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,35673,92,0.91 [0.47-1.77],0.7775856221436553
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,35680,94,4.85 [2.48-9.49],3.954230921856296e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,41523,108,2.74 [1.52-4.93],0.0007788821165268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,35522,93,1.88 [1.33-2.66],0.0003597703423577
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,35522,93,2.05 [1.07-3.93],0.0310793001525286
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,40907,105,3.36 [1.71-6.62],0.0004504034546825
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40585,107,2.80 [1.75-4.49],1.958914938255404e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,35607,94,1.72 [1.07-2.75],0.0244223008625943
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,41523,108,2.12 [1.08-4.17],0.0292817213465459
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,35673,92,2.02 [1.14-3.58],0.0163236023326517
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,34910,89,0.72 [0.51-1.01],0.0581546906731065
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,39887,107,1.65 [1.28-2.13],0.0001273452496155
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,35020,92,1.34 [0.92-1.97],0.1302693148526917
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,40976,105,2.21 [1.45-3.37],0.0002481342944874
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,41208,105,0.83 [0.72-0.96],0.010470787426649
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,41387,108,1.32 [0.85-2.04],0.2104124309321375
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,35512,93,1.18 [0.90-1.56],0.2348582319696407
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,40070,107,1.24 [0.93-1.66],0.1394678059522548
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,34731,91,1.28 [0.84-1.96],0.2574566824204973
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,34552,89,1.06 [0.86-1.30],0.5830955257987515
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,35728,94,1.31 [0.92-1.86],0.1347131581982475
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",QDPR,Dihydropteridine reductase,40832,107,0.82 [0.55-1.23],0.3381582048596642
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,41077,106,1.19 [0.63-2.24],0.5927883079928602
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,35003,92,1.37 [1.03-1.82],0.0292243849268308
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,35673,92,0.67 [0.45-0.99],0.0427307329373138
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,35673,92,0.92 [0.76-1.10],0.3455561146784478
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,35673,92,0.97 [0.76-1.23],0.7911415927688336
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,35512,93,0.90 [0.65-1.25],0.546622554907811
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,34552,89,0.81 [0.59-1.12],0.1989050058115894
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,40286,102,0.79 [0.61-1.02],0.069353882434333
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,34552,89,1.09 [0.90-1.33],0.3821653604103073
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,34580,87,0.96 [0.66-1.39],0.8279613601454887
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,35512,93,1.02 [0.67-1.56],0.9128097195548606
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,40976,105,0.79 [0.54-1.15],0.2165928557519473
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,40070,107,0.88 [0.60-1.29],0.5216466958979897
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,34910,89,0.82 [0.63-1.08],0.1514628421510277
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,40092,103,0.71 [0.50-1.01],0.0566580815102428
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,40286,102,1.07 [0.81-1.44],0.6240715754415755
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,34721,91,0.57 [0.36-0.91],0.0182437046484042
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,40092,103,1.05 [0.72-1.52],0.8014674566685557
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,35020,92,1.26 [0.97-1.63],0.0845790005612447
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,34646,90,1.74 [0.97-3.13],0.0644625835724431
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,35512,93,1.02 [0.69-1.51],0.9130331778556444
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,34731,91,1.00 [0.68-1.46],0.996438534097658
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,34580,87,1.57 [0.91-2.72],0.1035165636851266
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,40092,103,1.28 [0.96-1.71],0.0975279954883064
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,34646,90,0.90 [0.64-1.25],0.5170315645322567
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,35020,92,0.85 [0.57-1.27],0.4342558172532637
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,40092,103,0.87 [0.50-1.53],0.6337550230810685
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,41249,106,1.72 [1.30-2.28],0.0001391375502462
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,40070,107,0.98 [0.59-1.65],0.9488371699934662
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,34425,87,0.74 [0.45-1.20],0.2182119371397677
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,40092,103,1.09 [0.82-1.44],0.552454416992418
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,35622,93,2.32 [1.78-3.03],5.331947407191963e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,40065,106,1.14 [0.81-1.60],0.4523010052504935
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,35622,93,0.90 [0.69-1.17],0.4314710407806151
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,34552,89,1.05 [0.69-1.59],0.8315457612219097
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,34425,87,0.92 [0.58-1.46],0.734143481067462
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,34721,91,1.24 [0.99-1.53],0.056647863723371
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,40829,105,1.47 [1.19-1.80],0.0002640226282466
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,40829,105,1.60 [1.22-2.09],0.0005812911807928
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,35522,93,1.16 [0.86-1.55],0.327419805291869
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,34646,90,1.22 [0.96-1.54],0.1018887930953443
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,34731,91,0.99 [0.81-1.20],0.8915804516586698
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,35512,93,1.11 [0.79-1.58],0.5476601157075367
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,40295,104,1.12 [0.80-1.59],0.5078427659449483
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,34731,91,1.01 [0.38-2.66],0.9831979282391278
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,35622,93,1.00 [0.73-1.38],0.9957694172903266
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,40777,105,1.87 [1.43-2.43],3.591214910714184e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,41523,108,1.79 [1.43-2.23],2.8535980863250205e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,41523,108,1.97 [1.61-2.42],6.596876813459524e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,35512,93,1.54 [1.00-2.37],0.049905457537926
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,41056,104,1.31 [0.94-1.83],0.1120056551107138
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,34646,90,1.14 [0.78-1.65],0.503018201179972
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,41030,106,4.68 [3.02-7.24],4.656275371303597e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REN,Renin,41024,108,1.10 [0.89-1.36],0.3708684741233071
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,34646,90,0.76 [0.43-1.33],0.3329464534477903
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,34425,87,0.85 [0.46-1.57],0.6000312935849099
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40829,105,0.85 [0.55-1.32],0.4676083619811952
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RETN,Resistin,40922,106,1.26 [0.86-1.85],0.2262152194330374
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",34552,89,0.89 [0.57-1.40],0.618835533228882
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,35512,93,1.29 [0.54-3.09],0.5626364946920266
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,35622,93,0.90 [0.70-1.17],0.4519206705521199
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,35020,92,0.96 [0.70-1.33],0.8210516667908045
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,41387,108,1.62 [0.95-2.77],0.0760223279532421
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,41387,108,2.46 [1.37-4.41],0.0025257076455433
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,35622,93,0.83 [0.59-1.17],0.2787303045982419
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,40286,102,0.90 [0.67-1.21],0.4918084162640425
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,40474,107,0.87 [0.76-1.00],0.0528783263919482
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,34646,90,0.78 [0.47-1.30],0.3478757041349699
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,34910,89,1.70 [1.20-2.40],0.0029844261273868
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,41274,105,1.08 [0.81-1.44],0.5845621509647708
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,35673,92,0.82 [0.67-1.00],0.0453387530025444
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,34552,89,1.29 [1.04-1.61],0.0217729699755703
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,35622,93,0.50 [0.25-0.98],0.0450650396470001
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,34850,89,0.88 [0.69-1.13],0.3119971769084372
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,35699,94,2.06 [1.18-3.60],0.0106102857417553
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,34731,91,1.22 [0.83-1.80],0.3122832257776836
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,40832,107,1.05 [0.91-1.22],0.4910612206166551
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,34526,91,2.57 [1.56-4.25],0.0002243687772959
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,35435,92,1.88 [1.33-2.67],0.0003692943758796
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,35622,93,0.89 [0.59-1.37],0.6075500753449403
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,41336,106,3.35 [2.17-5.16],4.258374096802492e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,34731,91,2.80 [1.78-4.41],7.781888611196989e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,34646,90,1.15 [0.73-1.82],0.5542920335483656
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,34646,90,0.37 [0.18-0.77],0.0079974924960042
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,35020,92,1.10 [0.83-1.45],0.5126863936856454
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,40092,103,0.93 [0.72-1.22],0.6147753167598422
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,35020,92,0.88 [0.60-1.30],0.5285493786567018
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,34731,91,0.90 [0.69-1.18],0.4435502427126485
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,41056,104,4.32 [2.43-7.68],6.3468265226608e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,41387,108,3.48 [1.79-6.78],0.0002504063509735
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,34731,91,5.45 [1.84-16.14],0.0022372218899396
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,41024,108,2.80 [1.68-4.69],8.615018291740126e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,40829,105,0.91 [0.60-1.38],0.6522804313780423
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,34646,90,1.09 [0.57-2.06],0.7978781003575424
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,35020,92,1.01 [0.76-1.34],0.952577583413984
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,34721,91,0.96 [0.58-1.59],0.8813017195845004
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,34731,91,0.64 [0.36-1.15],0.1358398742559
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,34552,89,1.14 [0.73-1.79],0.5605395585137078
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,34721,91,0.91 [0.77-1.06],0.2273314882383094
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,40092,103,1.68 [1.41-2.01],1.1439941422413114e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,40092,103,0.94 [0.73-1.22],0.6508420044174745
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,34580,87,0.98 [0.78-1.23],0.8628558107380893
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,40725,107,0.92 [0.56-1.50],0.7251731604247729
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,41396,106,3.31 [1.99-5.49],3.598161863087657e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,40829,105,1.51 [0.84-2.69],0.1655191190147366
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,34552,89,0.99 [0.67-1.48],0.9661347349844046
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",35622,93,0.99 [0.80-1.23],0.9176504514624968
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,41396,106,1.52 [0.97-2.38],0.0663870221173525
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,40092,103,0.78 [0.63-0.96],0.0199311609683871
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,41387,108,0.89 [0.68-1.17],0.3987768592451555
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,34552,89,0.97 [0.53-1.78],0.9253284976851244
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,40707,106,1.03 [0.73-1.46],0.8640958202834783
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,40448,104,1.07 [0.85-1.34],0.5568431100812796
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,34646,90,1.75 [1.10-2.79],0.0183368541254698
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,35622,93,1.19 [0.83-1.69],0.3371097584208985
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,40010,107,1.10 [0.84-1.44],0.4800458268430981
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,35512,93,1.34 [1.01-1.80],0.0451659134072183
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,41133,105,0.74 [0.55-0.99],0.0443454876607627
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,35622,93,1.49 [1.03-2.14],0.0327105142065082
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,40295,104,1.26 [0.97-1.64],0.0797008250420062
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,35728,94,1.25 [0.79-1.99],0.3344018485683621
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,35622,93,1.83 [1.14-2.93],0.0121063008335642
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,34580,87,1.09 [0.75-1.59],0.6617087355266182
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,40976,105,0.98 [0.77-1.24],0.8591083682841374
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,35020,92,0.88 [0.65-1.18],0.3900426924610277
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,35548,91,0.94 [0.78-1.13],0.50925619443034
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,34552,89,1.49 [1.06-2.10],0.0216935925436608
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,34552,89,0.91 [0.58-1.41],0.6643791412074569
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,35020,92,0.76 [0.54-1.07],0.1191347659118695
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,35622,93,0.67 [0.31-1.46],0.3165055178642919
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,35612,94,1.42 [0.82-2.46],0.2099151505648071
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,40829,105,1.10 [0.90-1.35],0.3303904714549698
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,41387,108,2.51 [1.47-4.27],0.00069120731829
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,40070,107,0.84 [0.59-1.20],0.3472983657202495
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,39949,103,4.69 [3.35-6.57],2.82265541583537e-19
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,41523,108,1.19 [0.81-1.76],0.3804175069045307
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,41387,108,2.50 [1.45-4.32],0.0010152580625596
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,41205,105,1.86 [1.11-3.13],0.0193181771258129
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,41056,104,1.92 [1.15-3.21],0.0133171884158422
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,41056,103,1.86 [1.33-2.60],0.0002540030217124
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,34552,89,1.58 [1.00-2.50],0.0502627985229537
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,34910,89,4.12 [2.02-8.43],0.0001042773709463
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,41123,104,0.99 [0.81-1.22],0.954243026746444
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,40286,102,1.34 [0.92-1.96],0.1305315571999103
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,34580,87,0.87 [0.64-1.18],0.3731495558340804
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,41274,105,1.21 [0.85-1.71],0.2869896050472067
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,34580,87,1.00 [0.65-1.54],0.983514542257354
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,34721,91,0.56 [0.25-1.22],0.143563315985448
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,34721,91,0.70 [0.37-1.32],0.2722656650189259
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,34580,87,1.10 [0.72-1.67],0.659680661041252
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,34731,91,1.01 [0.63-1.63],0.9509391881894412
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,40092,103,0.80 [0.61-1.06],0.1171900632154538
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,34606,91,1.06 [0.71-1.58],0.7885801313809373
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,35673,92,2.90 [1.90-4.44],9.185080548748288e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,34731,91,0.90 [0.71-1.15],0.3947607478462798
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,40976,105,1.07 [0.79-1.45],0.6548441005995338
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCT,Secretin,34721,91,0.81 [0.52-1.27],0.3623252964350406
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,41024,108,1.89 [1.35-2.65],0.0002097802307711
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,41024,108,0.21 [0.15-0.28],1.0014841769217683e-25
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,35512,93,0.96 [0.81-1.14],0.6420495496973252
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,35522,93,0.97 [0.72-1.32],0.8652687473774172
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,34910,89,1.16 [0.69-1.97],0.5734766731374737
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,34731,91,0.92 [0.71-1.19],0.509312546095013
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,34731,91,1.43 [0.93-2.20],0.1000809750733246
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,41523,108,1.37 [0.98-1.93],0.0667321486417631
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,35728,94,0.27 [0.12-0.64],0.0028926710635097
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,35728,94,1.24 [0.52-2.95],0.6209415731561455
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,41173,106,0.88 [0.65-1.19],0.3912950157270185
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,40976,105,0.62 [0.37-1.05],0.0727430838013381
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,41024,108,5.19 [2.90-9.31],3.1538709370775046e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,34910,89,1.56 [1.04-2.35],0.0303342118940686
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,40829,105,1.71 [1.14-2.56],0.0100851716317793
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,41387,108,1.20 [0.68-2.11],0.5269773951563337
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,34646,90,1.10 [0.52-2.33],0.8129533933221298
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,41395,108,2.03 [1.18-3.48],0.0102261983714944
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,35622,93,0.81 [0.61-1.08],0.1487959716012547
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,35020,92,0.90 [0.59-1.36],0.602379184449954
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,35534,94,2.50 [1.65-3.77],1.3730839948777971e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,40829,105,1.20 [0.68-2.12],0.5226668576037541
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,35046,92,,
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,41523,108,1.52 [1.00-2.30],0.0518503396724457
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,39862,104,0.98 [0.83-1.15],0.7817454323662055
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,35604,93,4.13 [1.84-9.26],0.0005722828309588
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,35062,93,0.54 [0.24-1.23],0.1450982171742008
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,35188,93,0.85 [0.44-1.62],0.6124434330029562
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,35728,94,1.25 [0.39-3.98],0.7068563324569284
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,35728,94,1.25 [0.44-3.58],0.67250221512869
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,40620,105,1.34 [1.07-1.68],0.0117466284603147
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,40903,105,0.90 [0.74-1.09],0.2713421974826107
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,40295,104,0.89 [0.63-1.26],0.5164377343713975
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,41253,107,0.94 [0.71-1.26],0.6886433397103713
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,41489,105,1.23 [0.97-1.56],0.0874249156271905
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,40725,107,0.74 [0.45-1.23],0.2502030769792951
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,35659,94,0.91 [0.25-3.41],0.8944046240623951
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,35659,94,1.27 [0.63-2.54],0.4999295340952916
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,41523,108,0.82 [0.64-1.04],0.1044815117732458
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,35673,92,0.71 [0.52-0.98],0.0375177846845428
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,35190,94,2.12 [1.07-4.18],0.0306534901594343
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,35047,94,1.79 [0.44-7.34],0.4195999882024942
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,35659,94,7.95 [3.04-20.78],2.3430904186580725e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,35020,92,1.06 [0.91-1.24],0.4734356941776334
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,34840,89,1.26 [0.66-2.40],0.4802924193217096
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,35522,93,1.02 [0.72-1.44],0.9095417103185544
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,40070,107,0.91 [0.69-1.19],0.4873214256524156
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,40596,107,1.20 [0.69-2.08],0.5247203638470057
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,34721,91,0.97 [0.50-1.87],0.9323719488985784
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,41133,105,2.16 [1.19-3.92],0.0112231244902261
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,40829,105,2.81 [1.55-5.09],0.0006885818659314
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,40829,105,1.00 [0.80-1.27],0.9688750412056872
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,40592,107,1.18 [0.81-1.73],0.3839767260151
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,34910,89,1.46 [0.89-2.39],0.1315923171869336
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,40092,103,0.90 [0.64-1.25],0.5149627137470062
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,40092,103,1.90 [1.47-2.45],9.378149464886012e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,41024,108,1.28 [1.00-1.65],0.0517240614727939
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,35072,91,1.10 [0.77-1.56],0.5996777504417177
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,40092,103,0.91 [0.76-1.09],0.2898346613145458
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,40976,105,1.09 [0.82-1.44],0.5497134939028325
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,34580,87,1.13 [0.84-1.52],0.4043298955339923
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,35522,93,0.87 [0.57-1.34],0.5374120843005843
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,34820,92,1.25 [0.99-1.57],0.0643779961929882
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,35607,94,0.94 [0.70-1.26],0.6903584792429049
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,35699,94,0.70 [0.48-1.01],0.0573040652676445
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,34425,87,0.86 [0.71-1.05],0.1384303137396233
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,34485,89,1.22 [1.03-1.45],0.0199404424465458
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,34646,90,0.79 [0.48-1.30],0.3498709397990619
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,35680,94,3.70 [2.57-5.32],1.5910461894944514e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",41123,104,0.92 [0.76-1.13],0.4430522996321603
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,35020,92,0.59 [0.32-1.08],0.0871458841543077
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,41067,104,1.07 [0.74-1.55],0.7138223897405483
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,41183,104,2.65 [1.90-3.68],8.334522793051458e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,40976,105,4.62 [3.22-6.64],1.0424535895092143e-16
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,40070,107,1.03 [0.83-1.27],0.8214524876304412
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,41030,106,1.24 [1.03-1.48],0.0222929502863972
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,41396,106,0.96 [0.57-1.61],0.8750422207801902
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,41024,108,2.01 [1.15-3.53],0.0149627688558594
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,34731,91,1.54 [1.00-2.36],0.0491840105518396
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,41336,105,1.48 [0.84-2.64],0.1779783969359613
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,34731,91,1.16 [0.68-2.00],0.5844981955924242
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,41123,108,1.45 [1.04-2.02],0.026446786969495
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,40915,103,2.33 [1.65-3.29],1.7005746630319295e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,34646,90,0.82 [0.61-1.12],0.2203838955686733
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,40829,105,0.93 [0.77-1.14],0.4939232057608921
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",40070,107,0.87 [0.62-1.22],0.4254126571515825
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,40286,102,0.77 [0.56-1.07],0.1159022904906733
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,40649,107,0.52 [0.41-0.67],2.3405696791257694e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,41183,104,0.90 [0.77-1.07],0.2307607997652672
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,34552,89,1.44 [0.97-2.13],0.0691959686959102
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,35622,93,0.87 [0.72-1.05],0.1516302946011958
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,40286,102,1.14 [0.84-1.54],0.3971517569534264
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,40092,103,2.44 [1.70-3.48],1.0463764092499166e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,40976,105,0.74 [0.55-1.01],0.0552634253118868
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,40092,103,3.54 [2.73-4.61],3.359705561084325e-21
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,34552,89,1.64 [1.03-2.60],0.0358478104689452
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,35512,93,0.77 [0.50-1.19],0.2377671197151964
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,40070,107,1.08 [0.81-1.43],0.5944323449281969
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,34721,91,0.80 [0.51-1.24],0.3183755805167877
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,40070,107,1.15 [0.91-1.43],0.238140343658218
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,34425,87,1.27 [0.97-1.66],0.0808902819544004
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,34425,87,0.77 [0.47-1.26],0.2948196169362317
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,40070,107,1.36 [0.87-2.13],0.1731447561359634
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,40976,105,1.27 [0.98-1.64],0.0685695861465754
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,34721,91,0.98 [0.73-1.32],0.8976314403591702
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,35680,94,1.18 [0.79-1.75],0.4259382393049491
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,34552,89,1.09 [0.85-1.41],0.4917466038931183
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,34910,89,0.81 [0.64-1.04],0.0989307422937958
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,35522,93,1.28 [0.96-1.71],0.0903061956748234
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",34425,87,0.92 [0.63-1.36],0.6748851764957893
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,40070,107,1.10 [0.80-1.50],0.5488998510138461
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,34646,90,0.87 [0.47-1.63],0.6733885073968964
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,41396,106,1.42 [0.92-2.17],0.1106535178711238
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,40295,104,1.38 [0.86-2.22],0.1821396277534157
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,35020,92,0.90 [0.67-1.20],0.4568351035172576
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,35522,93,1.11 [0.88-1.40],0.3899406647683774
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,35413,94,1.48 [1.01-2.17],0.0454588487285323
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,40092,103,0.85 [0.68-1.06],0.1460365845591713
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,35512,93,0.86 [0.64-1.16],0.3150584932314545
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,35512,93,0.95 [0.64-1.40],0.7866134542521405
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,40829,105,1.19 [0.50-2.82],0.688187517596909
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,40070,107,0.80 [0.61-1.03],0.087729800095323
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,34425,87,0.88 [0.58-1.33],0.5376646065049462
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,35522,93,1.04 [0.77-1.42],0.7976676594751244
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,41396,106,2.29 [1.43-3.69],0.0006283183719308
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,41183,104,1.74 [1.15-2.64],0.0084582039901437
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,41180,107,1.16 [0.83-1.62],0.3738731203158627
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,34646,90,0.90 [0.61-1.35],0.6210833723583135
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,41114,103,1.01 [0.78-1.32],0.91633329654535
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,35512,93,0.93 [0.70-1.24],0.633722778898288
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,34580,87,0.95 [0.68-1.33],0.7535875109579803
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,35543,94,0.97 [0.78-1.19],0.7594491334822668
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNAP23,Synaptosomal-associated protein 23,41024,108,0.85 [0.71-1.03],0.0922553359294825
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,34580,87,0.69 [0.44-1.08],0.1054554412991799
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,41133,105,0.97 [0.81-1.17],0.7835503913462918
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,35622,93,0.88 [0.62-1.25],0.4764567871185688
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,34910,89,0.89 [0.75-1.06],0.1962043755046262
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,40725,107,1.29 [0.99-1.68],0.0587988811453535
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",34731,91,1.36 [0.78-2.39],0.2797103685970584
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',35607,94,1.27 [0.94-1.71],0.1253005785311108
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,34552,89,1.00 [0.73-1.38],0.9880056692355872
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,34910,89,1.05 [0.72-1.53],0.7917879073650327
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,35522,93,0.71 [0.42-1.19],0.1891341595882961
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,35512,93,1.36 [1.13-1.65],0.0015261701984693
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,34731,91,0.76 [0.38-1.55],0.4578961745498886
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNX9,Sorting nexin-9,41024,108,1.07 [0.84-1.38],0.5660150908406064
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],40199,104,1.01 [0.71-1.44],0.960477408527127
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",41030,106,1.87 [1.29-2.73],0.001046858064734
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,35699,94,1.10 [0.83-1.46],0.4860057412168309
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,35622,93,1.49 [1.09-2.05],0.0135392468016985
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,40092,103,4.12 [2.77-6.11],2.2798057392548565e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,41204,105,1.13 [0.87-1.46],0.3517233726250246
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,40970,108,0.76 [0.48-1.20],0.2386404152745285
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,40970,108,1.23 [0.80-1.89],0.3556456189765707
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,34721,91,1.09 [0.75-1.59],0.6517010140932907
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,35557,93,1.15 [0.51-2.61],0.735490501211844
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,34721,91,1.90 [0.92-3.93],0.0839446196797592
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,35622,93,1.24 [0.67-2.29],0.4852800867499187
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,35622,93,1.09 [0.79-1.50],0.5965380599432668
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,41133,105,0.83 [0.66-1.05],0.1166352295991753
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,41036,106,1.50 [0.88-2.53],0.1333324088239641
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPART,Spartin,34910,89,0.86 [0.66-1.13],0.2846043316864431
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,35673,92,1.02 [0.54-1.95],0.9460166655172644
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,41030,106,2.13 [1.54-2.94],4.269046923818946e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,34910,89,0.25 [0.14-0.44],1.4633630626299097e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,40976,105,1.30 [1.02-1.67],0.0352905858055943
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,41030,106,1.42 [0.87-2.32],0.1648598731304229
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,41396,106,1.41 [1.02-1.94],0.0383504377412643
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,34552,89,1.12 [0.68-1.84],0.6626127274396869
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,40900,106,2.75 [1.71-4.43],2.892898116412996e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,41183,104,1.04 [0.68-1.60],0.8477658475883296
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,35522,93,0.92 [0.81-1.04],0.1851731671972993
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,40725,107,0.55 [0.28-1.08],0.0811040498236698
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,41056,104,1.86 [1.15-3.03],0.0117867512051182
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,40841,106,3.08 [2.01-4.74],2.8358547943289453e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,41454,108,2.38 [1.69-3.33],5.399701684982082e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",34646,90,1.00 [0.63-1.59],0.9882942385657956
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,34425,87,1.25 [0.96-1.65],0.1012960812215859
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,35020,92,0.96 [0.75-1.23],0.7503114926110568
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,35607,94,1.01 [0.75-1.35],0.9606706106366446
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,40286,102,1.00 [0.83-1.21],0.9917143443700432
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",34580,87,1.42 [0.82-2.44],0.2093357165101785
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,35607,94,0.72 [0.39-1.34],0.3027534965927839
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,41064,105,0.90 [0.78-1.03],0.1236913088842389
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,40829,105,1.09 [0.82-1.44],0.5551888255349435
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,40976,105,0.97 [0.79-1.19],0.7658586885172611
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,35673,92,1.56 [0.89-2.75],0.1197868663493668
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,40070,107,0.78 [0.55-1.11],0.1672659690620704
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",34646,90,0.88 [0.48-1.63],0.6932455494735947
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40970,108,1.04 [0.90-1.21],0.5652498744511412
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,41173,106,1.94 [1.31-2.89],0.0010175318065338
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,34425,87,0.61 [0.28-1.32],0.2095803645108958
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,35522,93,0.93 [0.63-1.38],0.722857388477655
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,34910,89,0.79 [0.55-1.14],0.2032700537482498
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40829,105,1.20 [0.82-1.76],0.3405952699857804
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",41523,108,1.55 [0.92-2.60],0.1015440552760822
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",34646,90,0.78 [0.46-1.31],0.3483146084160845
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,35680,94,2.98 [1.61-5.50],0.0004835025243392
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,35512,93,1.00 [0.59-1.68],0.9918875107729496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,40649,107,0.90 [0.68-1.18],0.4333480684550358
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,34646,90,1.03 [0.79-1.34],0.8477436208929119
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,40829,105,0.91 [0.80-1.03],0.1378687625445473
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,34425,87,1.07 [0.80-1.44],0.637131986035901
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,41387,108,2.50 [1.85-3.38],2.5469537787074162e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,40975,106,4.46 [2.27-8.77],1.5046758146410272e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,34580,87,0.97 [0.73-1.29],0.8288375791106104
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,40965,106,1.05 [0.81-1.36],0.7352289149266412
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,40295,104,0.89 [0.70-1.14],0.3649032307809497
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,40070,107,0.91 [0.69-1.20],0.5080264016912593
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STK4,Serine/threonine-protein kinase 4,41024,108,0.86 [0.70-1.04],0.1230364455932304
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",34425,87,0.97 [0.77-1.22],0.8006758159066618
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,40092,103,1.19 [0.91-1.55],0.2079955279876637
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,34721,91,1.10 [0.70-1.71],0.6845832680311825
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,35607,94,1.29 [0.85-1.97],0.2298196197151151
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,40829,105,1.16 [0.91-1.49],0.2330019774595291
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,34646,90,0.82 [0.46-1.44],0.4811338015572226
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,40092,103,0.97 [0.74-1.26],0.7943398488923605
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,34646,90,1.08 [0.72-1.62],0.7114902862135943
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,40976,105,1.18 [0.85-1.65],0.3320759075830511
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,35622,93,0.95 [0.74-1.22],0.6853617742316077
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,40092,103,0.90 [0.60-1.37],0.6326442620302142
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,35522,93,0.72 [0.42-1.22],0.2162079022197961
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,40092,103,0.94 [0.76-1.17],0.5816896377290981
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,41387,108,0.96 [0.84-1.09],0.5244740745949132
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,40976,105,1.43 [1.13-1.81],0.0029818107076939
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,34646,90,0.87 [0.60-1.25],0.4355962545371059
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,41387,108,0.99 [0.72-1.37],0.9659212670199846
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",35622,93,1.15 [0.86-1.55],0.3419293689046637
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,40295,104,1.01 [0.71-1.45],0.9424928350299586
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,41030,106,1.55 [0.92-2.62],0.0997653347426883
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,35512,93,1.39 [0.92-2.10],0.1137539919114633
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,34722,88,2.66 [1.48-4.78],0.0010824510061099
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,34721,91,1.03 [0.75-1.41],0.8768425647416289
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,35522,93,1.92 [1.40-2.64],4.5779415266525854e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,34910,89,0.80 [0.55-1.16],0.2335495981024102
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,34580,87,0.78 [0.51-1.18],0.239532980966585
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,35607,94,1.29 [0.87-1.90],0.2022757671959005
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,35673,92,0.94 [0.71-1.24],0.6625881113675127
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,35020,92,0.94 [0.77-1.13],0.4879356624667265
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,40829,105,0.95 [0.82-1.10],0.5109036963499345
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,36397,93,1.52 [0.83-2.79],0.1783477484624134
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,35512,93,0.66 [0.39-1.10],0.1125554366910135
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,40829,105,2.57 [1.70-3.89],7.550870767829792e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,34425,87,0.85 [0.59-1.21],0.3698647958155486
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,35548,93,0.97 [0.63-1.51],0.9040034222411948
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,40286,102,0.94 [0.72-1.21],0.6130904572829852
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,35020,92,0.66 [0.42-1.04],0.0721304300527837
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,40070,107,0.95 [0.76-1.18],0.6138664791497526
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",34721,91,1.04 [0.81-1.34],0.7680878820853038
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",35512,93,1.15 [0.69-1.91],0.5914420815630064
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,35607,94,1.04 [0.76-1.42],0.793400645821588
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,40070,107,1.00 [0.68-1.46],0.9838289674371858
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,40829,105,0.95 [0.78-1.15],0.6000534018096487
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,40976,105,1.00 [0.81-1.24],0.9965467114107484
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,34910,89,0.87 [0.68-1.11],0.2653478506988612
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,40725,107,0.96 [0.81-1.14],0.6529388475668705
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,40725,107,0.85 [0.69-1.05],0.1431703735256591
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,40092,103,1.01 [0.83-1.25],0.8872492961936304
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,34721,91,0.88 [0.55-1.40],0.5915112590805539
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,40662,106,1.17 [0.98-1.39],0.0812268499271067
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,40295,104,1.01 [0.81-1.25],0.9242934085682816
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,34971,91,1.09 [0.61-1.94],0.7632306041183605
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,41454,108,2.09 [1.37-3.19],0.0006275163926323
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,35673,92,2.15 [1.47-3.13],7.264126318523763e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,35020,92,1.06 [0.77-1.47],0.7048755060141008
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,35673,92,2.17 [1.12-4.19],0.021911125625987
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,40070,107,1.02 [0.91-1.15],0.7465123548100887
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",34721,91,1.14 [0.71-1.83],0.5820484198937309
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,35512,93,1.18 [0.93-1.49],0.1642037908048723
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,40070,107,0.98 [0.80-1.21],0.862312882664075
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,34552,89,0.50 [0.29-0.87],0.0142595408391445
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,41133,105,5.33 [2.59-10.97],5.3826803601188345e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,34646,90,0.95 [0.47-1.92],0.8768022820850341
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,34955,92,1.06 [0.88-1.27],0.5543709319942365
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,34721,91,0.36 [0.24-0.54],1.3957392025998257e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,35020,92,0.98 [0.59-1.63],0.9382088052088694
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,35728,94,0.37 [0.15-0.89],0.0261995891243331
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,34580,87,1.11 [0.81-1.52],0.5362048144958041
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,40843,105,1.34 [1.11-1.62],0.0022171356931587
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,41123,104,1.52 [1.17-1.98],0.0017242259530841
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,40985,104,1.62 [1.26-2.08],0.0001718821559095
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,40915,106,1.62 [1.04-2.53],0.0336470070643909
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,41006,104,1.35 [0.98-1.88],0.0698938374406994
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,41186,106,1.78 [1.19-2.66],0.004795329938311
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,35512,93,1.00 [0.83-1.19],0.9621402004874045
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,40976,105,1.36 [0.97-1.91],0.0707343450849595
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,41416,105,1.33 [0.87-2.04],0.1895457440133811
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,35512,93,1.07 [0.74-1.55],0.7079473041881832
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,40780,105,1.37 [0.72-2.58],0.3334131130678556
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,34646,90,1.25 [0.55-2.83],0.5912062759763013
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,41133,105,3.86 [2.75-5.40],4.672760947687172e-15
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,41523,108,2.13 [1.23-3.67],0.0066384004940073
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,40961,107,1.27 [1.02-1.59],0.0355033790191883
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,35699,94,4.22 [2.30-7.75],3.439577911307108e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,34360,87,1.07 [0.86-1.33],0.5501655432772777
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,41024,108,3.85 [2.49-5.96],1.5263372042155954e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,41030,106,1.61 [1.08-2.41],0.0195402070591162
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,41042,106,1.33 [0.92-1.94],0.132015211106059
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,40838,108,1.84 [1.14-2.98],0.0132706358763462
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,40295,104,4.17 [2.80-6.21],2.140760764738588e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,34552,89,0.66 [0.49-0.90],0.0074504783413265
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,34384,90,1.07 [0.59-1.94],0.8170941430319218
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,35446,93,0.83 [0.66-1.04],0.1014321477294419
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,41387,108,5.91 [3.75-9.33],2.2007361261838343e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,39849,102,0.92 [0.80-1.07],0.2957060663729152
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,41523,108,1.69 [1.03-2.78],0.0389409708676352
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39994,107,1.31 [0.94-1.83],0.1069774582617762
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,35020,92,1.73 [1.28-2.34],0.0003464763306368
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,41173,106,2.39 [1.67-3.40],1.565000217072603e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,35673,92,0.91 [0.55-1.51],0.7205324841727272
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,35607,94,0.88 [0.70-1.11],0.2784413794940051
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,40580,104,2.88 [1.80-4.61],1.1135882134549808e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,35673,92,0.96 [0.43-2.11],0.9157416210171554
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,41183,104,0.99 [0.86-1.13],0.8408732231055497
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,41030,106,0.87 [0.57-1.34],0.5344991359758169
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,40900,108,3.62 [1.79-7.31],0.000345462680299
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,41133,105,0.89 [0.72-1.10],0.2807668147261346
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,34580,87,0.87 [0.52-1.46],0.5975673726492562
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",35020,92,1.51 [1.11-2.06],0.008919882862406
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,34646,90,1.30 [0.61-2.75],0.4978887976812345
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,35020,92,1.90 [0.82-4.42],0.1338536551266566
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,41489,105,1.16 [0.87-1.55],0.3199606712453617
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,34646,90,1.65 [0.91-2.96],0.0968718575585918
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,34721,91,0.93 [0.63-1.37],0.6980948373116691
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,35020,92,1.11 [0.79-1.55],0.5510867341356775
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,34552,89,0.64 [0.34-1.21],0.171884384186031
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,34552,89,0.64 [0.40-1.04],0.0725895723834565
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,35522,93,0.91 [0.75-1.10],0.3153945730627355
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,35512,93,0.86 [0.64-1.14],0.2964610310961219
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,34731,91,0.87 [0.63-1.21],0.4067534914347421
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,35622,93,1.46 [1.07-2.01],0.0178368813928421
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,34425,87,1.28 [0.80-2.04],0.2990601838666773
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,34580,87,0.94 [0.70-1.25],0.6528148114901533
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,35534,94,1.43 [0.90-2.28],0.1328503898706229
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,40829,105,0.95 [0.79-1.15],0.5993672606399878
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,40528,106,1.31 [0.83-2.07],0.2515805900188982
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,41030,106,1.19 [0.95-1.48],0.1301504789544971
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,41173,106,1.59 [1.13-2.24],0.0077771432723743
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,40229,104,1.89 [1.57-2.29],4.935810777672424e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,35522,93,1.19 [0.81-1.73],0.3753982883382267
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40286,102,0.76 [0.47-1.25],0.2833416960205726
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,34910,89,0.74 [0.53-1.04],0.0833622190897719
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40725,107,2.27 [1.58-3.25],8.144189227144403e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40725,107,1.48 [1.25-1.75],3.598973011810837e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,41100,108,0.91 [0.65-1.27],0.5628286377290068
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,41489,105,2.59 [1.81-3.72],2.261780468118113e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40984,104,1.39 [0.79-2.47],0.257080559696324
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,41133,105,2.80 [1.88-4.19],5.056350873366456e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,41056,104,0.15 [0.09-0.23],1.2258130331257796e-15
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40286,102,1.48 [0.99-2.23],0.0570725620439118
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,41056,104,2.63 [1.61-4.27],0.0001017500257005
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,34910,89,0.63 [0.39-1.03],0.0649935535021736
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,41396,106,3.33 [2.25-4.92],1.701738817444236e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,41030,106,4.92 [3.33-7.25],9.275780508611901e-16
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,41030,106,2.07 [1.73-2.47],8.403835835621288e-16
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,41387,108,3.69 [2.16-6.29],1.7033265911995915e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,41416,105,5.12 [3.79-6.92],1.740214792687272e-26
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40725,107,1.86 [1.49-2.32],2.9608778399370343e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,41387,108,3.17 [2.50-4.03],3.243540315049275e-21
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40725,107,3.76 [2.91-4.84],1.8492446302549645e-24
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,41489,105,2.71 [1.41-5.21],0.0026996249371365
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,40976,105,1.18 [0.89-1.56],0.2583344294649969
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,41489,105,0.43 [0.24-0.79],0.0062713854015226
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,41183,104,5.29 [3.01-9.29],6.964189177905451e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,41453,108,,
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,40725,107,1.03 [0.77-1.38],0.8266075634007093
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,35680,94,1.98 [1.22-3.20],0.0054736497053329
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,35607,94,0.89 [0.71-1.12],0.3122699813976062
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,35680,94,0.76 [0.48-1.19],0.2276936151072257
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",40295,104,1.28 [1.03-1.59],0.0266685098332276
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,35020,92,0.73 [0.40-1.30],0.2833756264269319
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,40725,107,0.54 [0.37-0.80],0.0021930492794105
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,41030,106,1.06 [0.55-2.06],0.8597986015205161
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,35673,92,1.11 [0.87-1.43],0.4020061099927693
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,35522,93,0.86 [0.72-1.03],0.0987224210728586
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",34425,87,0.79 [0.49-1.27],0.3296844747131202
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,34646,90,0.88 [0.67-1.14],0.3286773101355721
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,34731,91,0.83 [0.55-1.25],0.3709341155989056
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,40092,103,1.05 [0.70-1.57],0.830514833924294
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,34646,90,0.99 [0.78-1.25],0.9257278841858604
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,34147,88,1.08 [0.74-1.60],0.680182032140755
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,40295,104,1.54 [1.05-2.25],0.027296462018067
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,34721,91,0.81 [0.45-1.46],0.4777325218425332
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,34721,91,0.97 [0.59-1.59],0.8899166785357544
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,34910,89,0.79 [0.66-0.94],0.0098979571480197
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,35673,92,2.64 [1.35-5.17],0.0044026985678949
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,34552,89,1.64 [1.18-2.26],0.0029400208018366
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,40092,103,0.84 [0.65-1.08],0.1808522635547983
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,40724,103,1.12 [0.79-1.61],0.5218566640395318
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,35020,92,0.90 [0.68-1.18],0.4489676151549258
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,40070,107,0.98 [0.63-1.52],0.9294233488436736
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,34552,89,1.40 [1.08-1.81],0.0119714611689585
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,34425,87,0.84 [0.58-1.22],0.3623657806698392
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,41426,105,0.89 [0.65-1.24],0.4981692693705992
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,35622,93,1.23 [0.78-1.95],0.3667810176631458
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,34646,90,0.91 [0.42-1.98],0.8083774156375216
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,40286,102,0.82 [0.59-1.13],0.2253931643490948
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,40976,105,1.02 [0.80-1.30],0.8641044261872062
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",34646,90,0.79 [0.44-1.43],0.4375638805232472
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,34552,89,1.08 [0.73-1.60],0.7028707839065617
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,35020,92,0.77 [0.59-1.01],0.0568245431004887
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,35680,94,0.95 [0.73-1.23],0.6853758472868476
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,40984,104,1.91 [1.42-2.57],1.8689542847776547e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,35699,94,0.73 [0.50-1.08],0.1145990748371202
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,41030,106,1.73 [1.06-2.83],0.0275271214024166
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,41396,106,1.07 [0.81-1.39],0.6437409837592598
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,40976,105,0.97 [0.77-1.21],0.7621167441681727
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,34950,92,1.04 [0.77-1.41],0.7849391681778355
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,35522,93,1.02 [0.85-1.23],0.8055045727401243
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,34425,87,0.61 [0.39-0.95],0.0304625099294751
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,34721,91,0.77 [0.57-1.03],0.076899789462457
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,40976,105,0.99 [0.81-1.21],0.9528110743417972
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,35512,93,1.15 [0.91-1.44],0.2359323489356807
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,34552,89,1.08 [0.73-1.60],0.7115519864666182
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,34646,90,1.01 [0.76-1.32],0.969716057003771
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,35622,93,1.00 [0.74-1.35],0.9947164072697028
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSHB,Thyrotropin subunit beta,41024,108,1.12 [0.90-1.38],0.3143590320548717
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,40295,104,0.79 [0.57-1.12],0.1849614274968005
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,34552,89,1.13 [0.68-1.86],0.6395306852470093
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,40295,104,1.16 [0.90-1.50],0.2391282321482145
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,34552,89,1.00 [0.67-1.50],0.9943443527479175
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,34580,87,0.81 [0.61-1.06],0.1268201095880023
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,35522,93,1.17 [0.96-1.41],0.1200266722005863
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,34646,90,0.59 [0.34-1.03],0.0643198809073034
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,40003,107,0.99 [0.79-1.25],0.9528527849753692
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,34721,91,0.93 [0.61-1.41],0.7359850625958844
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TTN,Titin,34552,89,1.36 [1.09-1.69],0.0065234350316515
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,35338,92,0.53 [0.25-1.12],0.0957677408384816
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,34580,87,1.36 [0.68-2.71],0.3807667282529821
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,35680,94,0.83 [0.65-1.05],0.1177022602716701
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,35020,92,1.10 [0.87-1.40],0.4209475803817695
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,40725,107,0.99 [0.81-1.20],0.9024076676591056
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,35101,92,0.84 [0.52-1.37],0.4889363382688708
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,41133,105,2.27 [1.29-4.01],0.0044903535451824
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,41387,108,1.06 [0.83-1.36],0.6413125043370322
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,35607,94,0.81 [0.55-1.21],0.309009141824921
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,34516,86,1.10 [0.91-1.32],0.3451012148980278
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",41030,106,0.94 [0.64-1.36],0.7348442405826943
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,40765,108,1.18 [0.91-1.51],0.2083551250610414
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,41024,108,2.61 [1.44-4.74],0.001577474313197
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",34646,90,2.51 [1.78-3.55],1.6661448504918217e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,40829,105,1.76 [1.08-2.87],0.0226614054228264
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,35512,93,1.38 [0.74-2.58],0.3049919449404079
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,35673,92,1.33 [0.97-1.81],0.0732481734148526
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,34646,90,1.07 [0.77-1.49],0.694170470206588
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,34552,89,1.01 [0.67-1.53],0.9548650608196472
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,34910,89,0.77 [0.56-1.04],0.0924727530931362
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,35522,93,0.90 [0.78-1.04],0.1581302446869624
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,34552,89,1.12 [0.95-1.33],0.1759133618792916
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,34552,89,1.15 [0.68-1.95],0.6066104541658169
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,40725,107,2.68 [1.86-3.86],1.2148711550871753e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,41395,108,0.61 [0.46-0.80],0.0003793796424117
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,34646,90,1.74 [0.89-3.40],0.1079096067468458
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,34425,87,0.90 [0.61-1.31],0.5733591721750493
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,35512,93,1.16 [0.68-1.97],0.580853700349496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,35673,92,1.07 [0.87-1.33],0.5135929443032625
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,34580,87,0.72 [0.47-1.10],0.1299226729773955
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,34954,92,0.83 [0.53-1.29],0.4033128071094333
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,34910,89,0.85 [0.63-1.14],0.2732151902540044
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,34721,91,0.78 [0.56-1.09],0.1494354208321201
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,40829,105,0.95 [0.79-1.15],0.6074414873084639
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,35512,93,1.06 [0.81-1.40],0.66619678015659
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,35607,94,1.54 [1.06-2.23],0.0225176857318767
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,34552,89,0.94 [0.74-1.21],0.6489664964760602
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,40295,104,0.94 [0.78-1.13],0.4984597728327052
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,40092,103,1.18 [0.87-1.60],0.2895021976467019
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,40295,104,1.36 [1.07-1.72],0.012638237201573
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,34646,90,0.87 [0.69-1.10],0.2400060929114399
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,40976,105,0.80 [0.65-1.00],0.0495578464989055
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,40366,103,3.19 [1.86-5.49],2.689413121347949e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,35699,94,0.80 [0.60-1.05],0.1108456247521913
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40829,105,2.05 [0.89-4.72],0.0931483010817901
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,34580,87,0.97 [0.78-1.19],0.7482844698694687
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,41114,106,6.85 [4.35-10.78],1.0626201657013692e-16
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,41387,108,2.25 [1.33-3.81],0.0025600052590677
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,34425,87,0.77 [0.57-1.06],0.1085362474222222
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,41365,105,1.45 [1.11-1.90],0.0072081944912457
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,34646,90,0.65 [0.32-1.32],0.2330051141219014
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,41133,105,0.79 [0.58-1.07],0.1229816739126802
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,41422,105,0.96 [0.60-1.54],0.861109494351836
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,35622,93,2.22 [1.24-3.99],0.0073825634671808
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,40295,104,0.96 [0.83-1.11],0.5984140033410784
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,34731,91,1.07 [0.49-2.38],0.8582683366396776
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,35673,92,1.81 [1.09-3.03],0.0228767525756102
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,40829,105,1.41 [1.07-1.86],0.0156159765179313
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,35699,94,1.36 [1.02-1.82],0.0369967445951912
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,40829,105,0.74 [0.53-1.05],0.0939517969247031
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,35020,92,0.86 [0.63-1.18],0.3489011358135804
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,40829,105,0.98 [0.79-1.22],0.8650683795529748
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,35512,93,0.85 [0.69-1.05],0.142291108555953
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,40829,105,0.96 [0.77-1.20],0.717521400329383
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,35512,93,1.25 [0.77-2.03],0.3608055661327757
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,34552,89,1.14 [0.63-2.05],0.6625924359581007
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,35512,93,1.67 [1.29-2.18],0.0001313240761479
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,40975,106,3.32 [2.45-4.49],6.500015693627028e-15
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40959,107,0.86 [0.65-1.15],0.319869425107552
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,35607,94,1.35 [0.84-2.16],0.2125037285964108
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,40070,107,1.12 [0.80-1.57],0.5127046545640057
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,35020,92,1.01 [0.63-1.63],0.9543498856180378
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40295,104,1.09 [0.83-1.45],0.5329180844622134
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,41387,108,0.86 [0.68-1.10],0.2252720421805706
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,40092,103,0.93 [0.53-1.63],0.797915444452534
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,34910,89,0.98 [0.69-1.39],0.8972634693341057
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,41334,106,1.80 [1.23-2.63],0.0026032263161431
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,34425,87,1.16 [0.94-1.42],0.1633396265809975
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,40580,107,1.73 [1.13-2.63],0.0107345922458354
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,35622,93,0.97 [0.62-1.50],0.8834372978493763
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,41523,108,1.16 [0.92-1.45],0.2166596607179539
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",41030,106,2.28 [1.49-3.47],0.0001340087905451
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,40286,102,0.98 [0.75-1.28],0.891198028879311
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,40295,104,0.98 [0.81-1.18],0.8107561140109019
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,40070,107,1.04 [0.85-1.27],0.720844940860768
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,35607,94,0.98 [0.75-1.27],0.8512268681808898
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,34646,90,0.63 [0.41-0.96],0.031055519799565
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,35512,93,0.92 [0.52-1.63],0.7813604858506855
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,34791,92,1.26 [0.96-1.65],0.0919559793166053
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,41332,105,1.37 [1.06-1.77],0.0148379430550614
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,38924,100,3.16 [2.35-4.24],2.1721538294646192e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40596,107,0.65 [0.43-1.00],0.047329280664879
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",41056,104,0.82 [0.49-1.36],0.4444541312795427
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,41396,106,1.60 [0.99-2.61],0.0569227385445895
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,40286,102,1.68 [0.99-2.85],0.0559788388980511
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40725,107,0.97 [0.70-1.33],0.8348467801064252
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,41396,106,1.51 [1.20-1.89],0.0003399920715972
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,41320,107,2.39 [1.56-3.68],6.928428337686964e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,34646,90,0.85 [0.59-1.22],0.370240565601096
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,41133,105,0.86 [0.73-1.02],0.0759383433091942
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,40070,107,1.25 [0.81-1.93],0.3048603628525952
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,35607,94,3.77 [2.46-5.76],9.99357799072203e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",35522,93,0.97 [0.85-1.11],0.6748266081835456
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,40829,105,1.05 [0.91-1.23],0.4953669803655242
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,35512,93,0.93 [0.50-1.73],0.8295204278374528
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,34552,89,1.26 [0.92-1.73],0.1506667651394375
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,40286,102,1.00 [0.81-1.22],0.9623148828901557
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,34910,89,0.78 [0.59-1.04],0.0890166035944994
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,34646,90,0.84 [0.40-1.76],0.6424287963496419
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,34646,90,1.47 [1.01-2.12],0.0436573781162085
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,40092,103,0.96 [0.75-1.23],0.753580649036057
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,40295,104,1.80 [1.40-2.32],4.180511426170706e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,34552,89,1.21 [0.92-1.58],0.1682038003210781
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,35522,93,0.83 [0.67-1.04],0.1016934682293841
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,35607,94,1.38 [0.91-2.10],0.1268787958172171
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,34646,90,0.61 [0.30-1.24],0.1694331249062358
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,35020,92,1.13 [0.84-1.50],0.415855164036909
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,35512,93,0.61 [0.42-0.87],0.0066761772314235
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,35522,93,1.25 [0.95-1.64],0.1103086244073535
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,35512,93,0.65 [0.44-0.97],0.0367967424437669
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,34731,91,1.01 [0.93-1.09],0.8626643684361214
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,34425,87,0.85 [0.42-1.70],0.6398865141898081
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,34580,87,1.02 [0.83-1.26],0.8319788368933881
